Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFGE8,Lactadherin,39093,-0.0807636260249758,0.00389443928803428,-0.088396727029523,-0.0731305250204286,3.12721166276633e-94
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS15,Enteropeptidase,39023,-0.161106260974933,0.00794784765650104,-0.176684042381675,-0.145528479568191,3.66143422199448e-90
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,39147,0.0575433089113654,0.00285967985365426,0.051938336398203,0.0631482814245277,6.64942947540591e-89
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCG,Pro-glucagon,38727,-0.208506956760533,0.0109126745483635,-0.229895798875325,-0.18711811464574,2.03283279358459e-80
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYY,Peptide YY,36391,-0.155800021948293,0.00827564198067229,-0.172020280230411,-0.139579763666175,5.45302798284776e-78
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,39093,0.0512154903204993,0.00273022273293738,0.0458642537639421,0.0565667268770566,1.229725653655e-77
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIP,Gastric inhibitory polypeptide,36420,-0.0687372747212397,0.00390314032732945,-0.0763874297628054,-0.0610871196796739,1.35606338212975e-68
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,39253,0.176566322547319,0.0110483738869365,0.154911509728924,0.198221135365715,4.96714026716721e-57
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9,Complement component C9,36796,0.072391498322886,0.00478769399409331,0.0630076180944631,0.0817753785513089,3.25658876777208e-51
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,39255,-0.0504446977973421,0.00334093292084287,-0.0569929263221941,-0.04389646927249,3.82099312465225e-51
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,38987,-0.0782602060808402,0.00529771408398143,-0.0886437256854438,-0.0678766864762366,4.84365883692304e-49
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1A,Meprin A subunit alpha,36743,-0.09191271410853,0.00645900514030208,-0.104572364183522,-0.0792530640335379,1.31883443754239e-45
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,36791,-0.0503070849729237,0.00360665083652143,-0.0573761206125057,-0.0432380493333417,6.68790102472182e-44
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOF,Apolipoprotein F,36796,0.0318953287876597,0.00230066428014035,0.0273860267985847,0.0364046307767348,2.15220467731777e-43
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG2,Secretogranin-2,39178,-0.0380663658330319,0.00279941093442909,-0.043553211264513,-0.0325795204015509,7.20212065554955e-42
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPY,Pancreatic prohormone,39064,-0.122068452361586,0.00900403517271552,-0.139716361300108,-0.104420543423064,1.25568144097833e-41
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPA,Apolipoprotein(a),36552,0.20992690118807,0.0158201651085204,0.17891937757537,0.24093442480077,6.40893698456834e-40
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY1,Aminoacylase-1,39106,-0.0722310990993839,0.00557997585787451,-0.0831678517808179,-0.0612943464179498,3.99802347417744e-38
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,36430,-0.140147862260153,0.0108537433530317,-0.161421199232095,-0.118874525288211,6.67209253170032e-38
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF9,Protein turtle homolog A,36792,-0.0956437494715409,0.00744968415614017,-0.110245130417576,-0.0810423685255061,1.6876128032718e-37
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,36747,0.0419334979015283,0.00328698075284405,0.0354910156259539,0.0483759801771026,4.74567047454036e-37
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES1,Liver carboxylesterase 1,39095,-0.0917737592471107,0.00720712073039931,-0.105899715878693,-0.0776478026155281,5.92312552506984e-37
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RB,Interleukin-17 receptor B,38886,0.0611938927886811,0.00484752719265917,0.0516927394910691,0.0706950460862931,2.38930423639999e-36
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSE,Cathepsin E,36500,-0.0587456521240354,0.00473849306473014,-0.0680330985309064,-0.0494582057171643,4.30942828367025e-35
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFASC,Neurofascin,39291,-0.0302579780324472,0.00249390694110443,-0.0351460356370119,-0.0253699204278826,1.00858963964169e-33
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39106,-0.035565556071144,0.00296538537314378,-0.0413777114025058,-0.0297534007397821,5.40492394140198e-33
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA2,Apolipoprotein A-II,36796,0.0513260335584407,0.00428634521612592,0.0429247969348339,0.0597272701820475,7.22631703555707e-33
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,39023,-0.037726099173977,0.00321366027700685,-0.0440248733169105,-0.0314273250310436,1.09914163811524e-31
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,38625,-0.104943761042828,0.00899338799412837,-0.12257080151132,-0.0873167205743364,2.51964406242554e-31
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,38864,-0.0303294471826962,0.00263257922290965,-0.0354893024595992,-0.0251695919057933,1.39357864483831e-30
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,39083,0.0323230122598035,0.00282904854662734,0.0267780771084139,0.0378679474111931,4.14138850140266e-30
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPH,Hephaestin,36792,-0.0262976499242325,0.00234869087031114,-0.0309010840300423,-0.0216942158184226,5.74929960688133e-29
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS8,Prostasin,39039,-0.0397043548536577,0.00361892877660427,-0.0467974552558021,-0.0326112544515133,6.6843039604525e-28
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC13,Mucin-13,38741,-0.0495327607876264,0.00456482114905029,-0.058479810239765,-0.0405857113354878,2.49730329407505e-27
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,39162,0.0271110204246201,0.00254352146550302,0.0221257183522341,0.032096322497006,1.96279409200937e-26
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,39086,-0.046797544009397,0.0043913158059111,-0.0554045229889828,-0.0381905650298113,2.00755892741867e-26
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,38832,-0.0474126047670579,0.00453909385964055,-0.0563092287319534,-0.0385159808021625,1.88147282098269e-25
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,36791,-0.0297586351650825,0.00286598489863742,-0.0353759655664119,-0.0241413047637532,3.70544343132154e-25
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MET,Hepatocyte growth factor receptor,39118,0.0181575416316631,0.00175486023697543,0.0147180155671913,0.021597067696135,5.22364606323851e-25
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL5,Fc receptor-like protein 5,39093,0.0514714952867678,0.00505069471461569,0.041572133646121,0.0613708569274145,2.60379965030253e-24
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,38672,-0.0497458210167877,0.00494123088396575,-0.0594306335493606,-0.0400610084842148,9.17114072752279e-24
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3B,Protein FAM3B,39023,-0.032261487636691,0.00321659281825702,-0.0385660095604748,-0.0259569657129072,1.33680799271189e-23
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS2,Thrombospondin-2,39093,-0.0327187114358649,0.00326392353349271,-0.0391160015615106,-0.0263214213102192,1.40974255663353e-23
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSD,Cathepsin D,38007,-0.0356073116299589,0.00355338173092252,-0.042571939822567,-0.0286426834373507,1.48158584426198e-23
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL2,C-C motif chemokine 2,38960,-0.0462809551346265,0.00464176404123311,-0.0553788126554434,-0.0371830976138096,2.42157725803263e-23
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15,Interleukin-15,39099,-0.0292410122091799,0.00293785929245647,-0.0349992164223946,-0.0234828079959652,2.87674919987313e-23
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA2,Carboxypeptidase A2,39166,-0.0574020455022003,0.00581023374798415,-0.0687901036482492,-0.0460139873561513,5.98542489863253e-23
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,36728,-0.0755237535953494,0.00764823436687436,-0.0905142929544232,-0.0605332142362757,6.46713275728919e-23
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP2,Neuropilin-2,39093,0.0251263461217845,0.00257270635103623,0.0200838416737535,0.0301688505698156,1.82468180558024e-22
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,38795,-0.0657047963329401,0.00677107474064328,-0.0789761028246009,-0.0524334898412793,3.37971043856664e-22
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,38987,-0.0610872310344458,0.00637314340235308,-0.0735785921030578,-0.0485958699658338,1.06453728520962e-21
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,39093,-0.045338435021265,0.00475885602718323,-0.0546657928345441,-0.0360110772079858,1.85476209288549e-21
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,36500,0.032832745869349,0.00350533108086261,0.0259622969508583,0.0397031947878397,8.75309636054553e-21
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAST,Gastrin,36747,-0.0981536972759637,0.0105183141879328,-0.118769593084312,-0.0775378014676153,1.21028431025048e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR3,Anterior gradient protein 3,38714,-0.0493082073719158,0.00532215116112051,-0.059739623647712,-0.0388767910961196,2.21953635845634e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHBG,Sex hormone-binding globulin,36796,0.0428389723821247,0.00464691691397828,0.0337310152307273,0.0519469295335221,3.46382327216009e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF21,Fibroblast growth factor 21,39237,-0.099456007831755,0.0107963868731235,-0.120616926103077,-0.078295089560433,3.60791037838726e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,39099,-0.0334874808693948,0.0036438510580392,-0.0406294289431516,-0.0263455327956379,4.42082931846132e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,36731,-0.0453662427800204,0.00499291156324931,-0.0551523494439891,-0.0355801361160517,1.17460817288969e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACHE,Acetylcholinesterase,36500,-0.0268276172193455,0.00296149137470436,-0.0326321403137661,-0.021023094124925,1.51055633590032e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39224,-0.0246478538632997,0.00272311650254941,-0.0299851622082966,-0.0193105455183029,1.57878015805357e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO3,Beta-enolase,36420,-0.0489173946162227,0.00544234334045503,-0.0595843875635146,-0.0382504016689308,2.86680699652294e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,39291,0.0233443195024477,0.00259805813182701,0.0182521255640668,0.0284365134408287,2.87420601071376e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,39291,0.0209220202314187,0.00233365496684354,0.0163480564964053,0.025495983966432,3.44206795283205e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBKS,Ribokinase,38750,-0.0397600215468818,0.00443590349159427,-0.0484543923904066,-0.031065650703357,3.52198976490806e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MME,Neprilysin,39023,-0.0637650046486756,0.00713004225084746,-0.0777398874603366,-0.0497901218370146,4.21264828024702e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39165,0.0309988447248232,0.00346890759731254,0.0241997858340906,0.0377979036155558,4.48005975298601e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,39237,-0.0344513723369062,0.00385890461169437,-0.0420148253758272,-0.0268879192979853,4.830934029251e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK14,Kallikrein-14,39255,0.0359038067061256,0.0040636295876221,0.0279390927143863,0.0438685206978649,1.10353177753192e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH17,Cadherin-17,39106,-0.0527472500533352,0.00598144717244376,-0.064470886511325,-0.0410236135953455,1.28404780039808e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,38951,-0.0568293711424809,0.00648497280064889,-0.0695399178317527,-0.044118824453209,2.0964729513038e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPM,Carboxypeptidase M,39189,-0.027022803780383,0.00311015897474728,-0.0331187153708876,-0.0209268921898783,4.03674883846531e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,36490,-0.0372301878385027,0.00430736664401299,-0.0456726264607682,-0.0287877492162372,6.11035757065596e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOE,Apolipoprotein E,36806,-0.0561256316037138,0.00649476420140603,-0.0688553694384696,-0.0433958937689579,6.18455716742653e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTG,Protogenin,39255,-0.0193731924602477,0.0022428368786154,-0.0237691527423339,-0.0149772321781615,6.28563830426454e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KITLG,Kit ligand,39106,0.0288987085488885,0.00335770653729491,0.0223176037357905,0.0354798133619865,8.2461490759657e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSF,Cathepsin F,39147,-0.0313512871586812,0.00364391297748252,-0.0384933565945469,-0.0242092177228155,8.45703594428651e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA1,Glutathione S-transferase A1,39079,-0.0660000447345564,0.00769683217010783,-0.0810858357879678,-0.0509142536811451,1.08554154452545e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,36391,-0.0433711449766087,0.00506739082922445,-0.0533032310018886,-0.0334390589513287,1.2717259861564e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,39100,-0.0731021347119147,0.00859295804974803,-0.0899443324894209,-0.0562599369344086,1.94551996219906e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO1,R-spondin-1,38987,0.0269748862899909,0.00317299752695676,0.0207558111371556,0.0331939614428261,2.04654299492099e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM1,Isthmin-1,39099,-0.0303542508092331,0.00359640578105765,-0.0374032061401061,-0.0233052954783601,3.45116279756429e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,36500,-0.0576654914001849,0.00686497990219272,-0.0711208520084826,-0.0442101307918872,4.94072753607856e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,38832,-0.0641505739592997,0.00764540309262342,-0.0791355640208416,-0.0491655838977578,5.25875011803786e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC4,Syndecan-4,39106,0.0344226909102606,0.00410706823769172,0.0263728371643848,0.0424725446561364,5.68596141665962e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSZ,Cathepsin Z,39103,-0.0234161496237822,0.00280093944250051,-0.0289059909310832,-0.0179263083164812,6.80267645136797e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH1,Somatotropin,39086,0.134815198156323,0.0162880273103017,0.102890664628132,0.166739731684514,1.3676600409753e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,39023,0.0304112301044253,0.00367479900350636,0.0232086240575529,0.0376138361512978,1.38343636955234e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,39246,0.0463701315200832,0.00560693906039798,0.0353805309617031,0.0573597320784632,1.44662899346161e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAN,Neurocan core protein,39241,0.0272987905565421,0.00330471833867295,0.0208215426127431,0.0337760385003411,1.56712287268144e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,39283,0.0209698418740964,0.00257634642382792,0.0159202028833937,0.0260194808647992,4.27453288584845e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,38841,-0.0399912941410999,0.00492583518350165,-0.0496459311007631,-0.0303366571814366,5.077045605877e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",36420,-0.0420120336167638,0.00518224060683673,-0.0521692252061638,-0.0318548420273638,5.67080567159558e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,39283,0.0185292664391674,0.0022864156109981,0.0140478918416111,0.0230106410367237,5.71099013483298e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP5,Platelet glycoprotein V,36500,0.026399581434641,0.00325802641772357,0.0200138496559028,0.0327853132133792,5.85563912069293e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,39283,0.0177169221210862,0.0022073098883107,0.0133905947399972,0.0220432495021752,1.0749475993095e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPB1,Beta-ureidopropionase,36792,-0.0667647301187602,0.00833689199530779,-0.0831050384295634,-0.0504244218079569,1.2615812732667e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FEN1,Flap endonuclease 1,38727,-0.0451501032684151,0.00564366089999174,-0.0562116786323989,-0.0340885279044313,1.33393110323448e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EZR,Ezrin,39241,-0.0173257836961241,0.00217033261375492,-0.0215796356190837,-0.0130719317731644,1.52839992751883e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,39139,0.0353208981448867,0.00444990687197291,0.0265990806758198,0.0440427156139536,2.20646290725367e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,39063,-0.0140574358834744,0.00177119277589142,-0.0175289737242216,-0.0105858980427272,2.22036128704889e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH15,Cadherin-15,39205,-0.0385349296422959,0.00487635183686366,-0.0480925792425487,-0.0289772800420431,2.92045600398384e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA4,Apolipoprotein A-IV,36806,-0.0251406858791584,0.00318368582903266,-0.0313807101040624,-0.0189006616542544,3.09323019411974e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,36791,-0.0381695039552587,0.00484327242548785,-0.0476623179092148,-0.0286766900013025,3.50857485816511e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,36430,-0.0318480010319681,0.00404670863549224,-0.0397795499575329,-0.0239164521064033,3.83292781993862e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39099,0.0275385597058681,0.00350511196372751,0.0206685402569622,0.034408579154774,4.20649020040599e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,36500,-0.0348297459452804,0.00443399217986461,-0.043520370617815,-0.0261391212727457,4.31403782129128e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCS1,Neuronal calcium sensor 1,39255,-0.0198195749654768,0.00252638532969478,-0.0247712902116785,-0.014867859719275,4.61138135796812e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FURIN,Furin,39147,-0.0239194117756726,0.00305273407444686,-0.0299027705615884,-0.0179360529897567,4.97949589041981e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,39057,0.0332481534078678,0.00426590779649778,0.0248869741267322,0.0416093326890035,6.91516294951202e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT2,Angiopoietin-2,39255,-0.026570716391822,0.00341251403106833,-0.033259243892716,-0.0198821888909281,7.33994057855296e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELE,E-selectin,39283,-0.0349482230708636,0.00448948750663559,-0.0437476185838693,-0.0261488275578578,7.44402865675052e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,38832,-0.0257178060676078,0.00330931579052521,-0.0322040650170372,-0.0192315471181784,8.26908804157656e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A14,Protein S100-A14,36767,-0.0358837104740985,0.00463449274035481,-0.0449673162451939,-0.0268001047030031,1.04522360333352e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA3,Glutathione S-transferase A3,38727,-0.0530792008449183,0.00691450359241226,-0.0666316278860463,-0.0395267738037903,1.73636557165512e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,36420,-0.0249196422348448,0.00325382890855093,-0.0312971468956046,-0.018542137574085,2.01779989473479e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39093,0.016719988571756,0.00219750764991969,0.0124128735779134,0.0210271035655986,2.93225547590281e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN8,Tetraspanin-8,36743,-0.0668697439671246,0.0088406868805849,-0.084197490253071,-0.0495419976811782,4.17770449288702e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,39099,-0.0188178947453739,0.00249400058748235,-0.0237061358968393,-0.0139296535939085,4.76837741502936e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,39079,-0.0665033969167579,0.00881716105312091,-0.0837850325808749,-0.0492217612526409,4.87073849700936e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMPD3,AMP deaminase 3,36747,-0.048058685711378,0.00637180187467888,-0.0605474173857486,-0.0355699540370074,4.92275426833983e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMNL1,Formin-like protein 1,38741,-0.0412162582211964,0.00548462493112657,-0.0519661230862044,-0.0304663933561883,6.02066884853435e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPA33,Cell surface A33 antigen,39023,-0.0891259915107589,0.0118631967316102,-0.112377857104715,-0.0658741259168029,6.1095114480005e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS4,Galectin-4,39095,-0.0356347016092952,0.00477177603981998,-0.0449873826473424,-0.026282020571248,8.59570011434713e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,39147,-0.016842710333763,0.00226437476393444,-0.0212808848710745,-0.0124045357964515,1.075434687552e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA14,Carbonic anhydrase 14,39255,0.0234097442782867,0.0031706561684136,0.0171952581881961,0.0296242303683774,1.62375638423844e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRP,Agouti-related protein,39291,-0.0348983400946618,0.00473578617311678,-0.0441804809939707,-0.0256161991953529,1.8052445105001e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3D,Protein FAM3D,36743,-0.0550222958783139,0.00753621777769447,-0.069793282722595,-0.0402513090340327,3.02291499659093e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,36500,-0.02539202723418,0.00350119785825975,-0.0322543750363691,-0.0185296794319909,4.33359171950892e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MVK,Mevalonate kinase,38841,-0.0519225022137267,0.00716553402074432,-0.0659669488943855,-0.0378780555330678,4.49719613422006e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",39023,-0.053510747441327,0.00740324420851293,-0.0680211060900123,-0.0390003887926416,5.13492693090688e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",36792,-0.0442449275623333,0.00617572644081102,-0.0563493513863229,-0.0321405037383437,8.24041834398779e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD84,SLAM family member 5,39099,0.0201410292857204,0.00281481462161451,0.014623992627356,0.0256580659440849,8.72534543700476e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF19,Fibroblast growth factor 19,39162,-0.049348905212726,0.00693189872662018,-0.0629354267169016,-0.0357623837085504,1.13462376753332e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,39140,0.0288740887706642,0.00406164634487125,0.0209132619347165,0.0368349156066118,1.22096791376531e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMBS,Porphobilinogen deaminase,39255,-0.0274261768944446,0.00386735416357724,-0.0350061910550559,-0.0198461627338332,1.38224125443295e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHK,Ketohexokinase,36420,-0.0412934270612419,0.00583461024764503,-0.0527292631466262,-0.0298575909758577,1.5477465240214e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,39062,-0.0316940993205889,0.00451332525685071,-0.0405402168240163,-0.0228479818171615,2.27432090609387e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THOP1,Thimet oligopeptidase,39042,-0.0193390021223875,0.00275503724857094,-0.0247388751295865,-0.0139391291151884,2.32087441747873e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML2,Trem-like transcript 2 protein,39093,0.0209374896683027,0.00300111436311649,0.0150553055165944,0.026819673820011,3.14932977734241e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,36731,-0.023657805318469,0.00340561098111278,-0.0303328028414501,-0.016982807795488,3.9187488573225e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4D,Semaphorin-4D,39241,0.0187865254508241,0.00271009853165788,0.0134747323287746,0.0240983185728735,4.31296080003653e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,39059,0.0204315709623503,0.002954062489138,0.0146416084836399,0.0262215334410608,4.81639422849893e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,39099,-0.0315489037722836,0.00457521503631309,-0.0405163252434573,-0.02258148230111,5.57421294351615e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APCS,Serum amyloid P-component,36693,0.0215610023691149,0.00313138513646878,0.0154234875016361,0.0276985172365937,6.02862068752542e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,38727,-0.0388940745512217,0.00566255171265844,-0.0499926759080322,-0.0277954731944112,6.7385416149594e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS1,Protein MTSS 1,36743,-0.0686449016457407,0.0100044903213177,-0.0882537026755233,-0.049036100615958,7.13025063970529e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AREG,Amphiregulin,39023,-0.0286869788823111,0.0041952294190147,-0.0369096285435799,-0.0204643292210423,8.33749371575976e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,36791,-0.0142692233932793,0.00209308873356355,-0.0183716773110639,-0.0101667694754948,9.68827072562023e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKB,Creatine kinase B-type,36791,0.0357618217527925,0.00524635670663354,0.0254789626077907,0.0460446808977942,9.74206092241781e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,36500,-0.0138059913627453,0.00203426744166445,-0.0177931555484077,-0.00981882717708302,1.19835709976139e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN2,Matrilin-2,39117,-0.0181791027565396,0.00268090770775769,-0.0234336818637446,-0.0129245236493345,1.23772071046825e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,39023,-0.0334826708830501,0.00495273777706917,-0.0431900369261057,-0.0237753048399945,1.42599457916864e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,38841,0.0242907569342519,0.00360702684743731,0.0172209843132748,0.0313605295552291,1.70730533405538e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLB1,Beta-galactosidase,38987,-0.0255147588079151,0.00380980440209351,-0.0329819754360184,-0.0180475421798119,2.20044519635703e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCTN3,Tectonic-3,36792,-0.0178739320924507,0.00266872314860463,-0.0231046294637158,-0.0126432347211856,2.20693636553308e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM20A,Pseudokinase FAM20A,36792,-0.0170244412675075,0.0025476496251204,-0.0220178345327435,-0.0120310480022715,2.44676270706651e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXT,Oxytocin-neurophysin 1,39241,-0.0832834006291393,0.0125242241061394,-0.107830879877173,-0.0587359213811061,3.03412221358443e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,39145,0.0173542818334359,0.00261310656255778,0.0122325929708227,0.0224759706960492,3.21538526897808e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,36791,-0.0160847647465701,0.00242590650747136,-0.020839541501214,-0.0113299879919262,3.48046083471051e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL3,Myosin light chain 3,36420,-0.0435615330381605,0.00657042647923854,-0.0564395689374681,-0.030683497138853,3.49563147913516e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS4,Thrombospondin-4,39131,-0.0267667751482034,0.00404575457395397,-0.0346964541131532,-0.0188370961832536,3.81284592022138e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,39023,-0.0205298952621182,0.00310520854742017,-0.0266161040150618,-0.0144436865091747,3.93320436444791e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR4,Complement factor H-related protein 4,36763,0.0426989613618399,0.0064902038111423,0.029978161892001,0.0554197608316788,4.91951067179177e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD27,CD27 antigen,39147,0.0230911044573222,0.00351304440111841,0.0162055374311301,0.0299766714835143,5.09213706264167e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,36792,-0.0382103156272807,0.00582015049854066,-0.0496178106044204,-0.026802820650141,5.39561714979851e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCXR,L-xylulose reductase,39147,-0.0319145778997407,0.00488383514984766,-0.0414868947934421,-0.0223422610060393,6.57374192827196e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR5,Complement factor H-related protein 5,36628,0.0242262930686876,0.00372801342017558,0.0169193867651434,0.0315331993722317,8.41688774677808e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPY,Pro-neuropeptide Y,39255,-0.0383663611260114,0.00591560767885096,-0.0499609521765593,-0.0267717700754635,9.10638759756601e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP1,Neuropilin-1,39182,0.016195172890377,0.00250742255362721,0.0112806246852677,0.0211097210954864,1.08650405299606e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,36806,0.0152003198770694,0.00235702565330179,0.0105805495965979,0.0198200901575409,1.16636558202464e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADM,Pro-adrenomedullin,39255,-0.0152168084620201,0.0023676101449332,-0.0198573243460892,-0.0105762925779511,1.33908126484944e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN2,Calsyntenin-2,39291,-0.0227556282743358,0.00354712369810133,-0.0297079907226144,-0.0158032658260572,1.44702156888038e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKLR,Pyruvate kinase PKLR,39114,-0.0369033506900668,0.00577506598783205,-0.0482224800262176,-0.025584221353916,1.70567597789709e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,39071,-0.048977822948652,0.00767283601272521,-0.0640165815335934,-0.0339390643637106,1.78362485917844e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP2,Retinol-binding protein 2,39023,0.0440054756688538,0.00689904631654401,0.0304833448884276,0.0575276064492801,1.84029378073412e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDUA,Alpha-L-iduronidase,39255,-0.02636530963858,0.00413506640950599,-0.0344700398012117,-0.0182605794759483,1.86915321087247e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39165,0.0248141559692814,0.003895299221971,0.0171793694942183,0.0324489424443446,1.94069686536724e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,39023,-0.0382704411531125,0.00600976274838742,-0.0500495761399518,-0.0264913061662731,1.96964977171066e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,36747,-0.016376777683709,0.0025943524507994,-0.0214617084872759,-0.0112918468801422,2.8361817601621e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,39023,-0.0337916063978174,0.00540704555730406,-0.0443894156901333,-0.0231937971055014,4.22638085938234e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,39093,-0.024101477356708,0.00386290547357677,-0.0316727720849185,-0.0165301826284976,4.51412125218482e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C4BPB,C4b-binding protein beta chain,39147,0.0221908511187393,0.00357299205683138,0.0151877866873498,0.0291939155501288,5.41068680400723e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,39106,-0.0233609659964336,0.00377264120266015,-0.0307553427536475,-0.0159665892392198,6.08492736087034e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUSB,Beta-glucuronidase,39153,-0.0328313750624898,0.00531126163773627,-0.0432414478724529,-0.0224213022525267,6.51214743734313e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP2,Dipeptidase 2,39023,0.0162531018444022,0.00263281253622864,0.0110927892733941,0.0214134144154104,6.85888098199373e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEG1,Protein HEG homolog 1,36500,-0.0151143348708006,0.00244855226299565,-0.0199134973062721,-0.0103151724353292,6.91602199342236e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,39241,0.0433840560614498,0.00703084546768697,0.0296035989447834,0.0571645131781163,6.97660199624837e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",36743,0.0576658135421159,0.00934686015586888,0.0393459676366129,0.0759856594476189,7.05414483338133e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREG1,Protein CREG1,38905,-0.020928734388957,0.00339986242454944,-0.0275924647410739,-0.0142650040368401,7.6615118699065e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP5,Retinol-binding protein 5,39023,-0.031336701483609,0.00509073021487365,-0.0413145327047614,-0.0213588702624567,7.66577970581511e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCLY,Selenocysteine lyase,39211,-0.0274442316069397,0.00445986182641107,-0.0361855607867054,-0.018702902427174,7.76218583174054e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",36767,0.0506805589277837,0.0082512097387688,0.0345081878397969,0.0668529300157705,8.37789138731649e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,39229,-0.0331223987329394,0.00541963782272913,-0.0437448888654885,-0.0224999086003903,1.01049001196359e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC4A1,Band 3 anion transport protein,36791,-0.0256690535816699,0.00422220350572172,-0.0339445724528845,-0.0173935347104553,1.23922351041578e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,39099,-0.0340171257275804,0.00560518151645338,-0.045003281499829,-0.0230309699553318,1.31863593134269e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,39147,0.015106813097427,0.00249147654684832,0.0102235190656043,0.0199901071292497,1.36411476923762e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,36792,-0.0160627004818672,0.00265109048529483,-0.021258837833045,-0.0108665631306893,1.40860733723391e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGR1,Prostaglandin reductase 1,36792,-0.0435001069903849,0.00720295978205184,-0.0576179081632065,-0.0293823058175633,1.59129415604473e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY96,Lymphocyte antigen 96,38987,0.0192628581555912,0.00319755653011861,0.0129956473565587,0.0255300689546237,1.73841320053473e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,36538,-0.0235471641127207,0.00391949741883693,-0.0312293790536411,-0.0158649491718004,1.93332208934202e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3F,Semaphorin-3F,39106,-0.0138146535569917,0.00230045204999103,-0.0183235395749741,-0.00930576753900929,1.95447713629968e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,39255,-0.0699199745990424,0.011668051902339,-0.0927893563276268,-0.0470505928704579,2.11340379788446e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBN,Nibrin,38841,-0.0280389993569077,0.00468197415804863,-0.037215668706683,-0.0188623300071324,2.16345343494407e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA9,Carbonic anhydrase 9,39255,-0.0233466033162999,0.00391374095352088,-0.0310175355852008,-0.0156756710473989,2.49548748923749e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,39106,-0.042049472775397,0.00705085771056662,-0.0558691538881075,-0.0282297916626864,2.51979888544541e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELN,Elastin,36792,-0.0180293664433552,0.00302511514314431,-0.0239585921239181,-0.0121001407627924,2.58972489594096e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",36420,-0.0199911627607893,0.00335548664449616,-0.0265679165840018,-0.0134144089375769,2.6257632487215e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,38935,0.0140372026574641,0.00235853227587686,0.00941447939674543,0.0186599259181827,2.71308862812244e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KEL,Kell blood group glycoprotein,38741,-0.019066102996424,0.00320484682512413,-0.0253476027736673,-0.0127846032191807,2.75591032456785e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPO,Erythropoietin,39099,-0.0410674686539773,0.00691521413334916,-0.0546212883553416,-0.0275136489526129,2.93517210490981e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,38922,-0.0249552376750006,0.00421042535959348,-0.0332076713798038,-0.0167028039701974,3.15235146907095e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,38741,-0.0302685840815471,0.0051190467918375,-0.0403019157935487,-0.0202352523695456,3.43427495911394e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPOCK1,Testican-1,38987,0.0135128142586171,0.00229051652194187,0.00902340187561102,0.0180022266416231,3.72475189145822e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,36747,-0.0167366201247357,0.00283785321787557,-0.0222988124317718,-0.0111744278176995,3.77994262612847e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH2,Cadherin-2,39106,-0.0185498389097475,0.00315555558891669,-0.0247347278640242,-0.0123649499554708,4.22724009883978e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,36796,0.0134254741826015,0.0022855058028972,0.00894588280892298,0.01790506555628,4.35386010261404e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXN,"Frataxin, mitochondrial",39255,0.038821845271246,0.00663410708781909,0.0258189953791206,0.0518246951633714,4.95990852705466e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40LG,CD40 ligand,39291,0.0411024593327706,0.00702576320659379,0.0273319634478468,0.0548729552176944,5.00777492361621e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFM,Afamin,36806,-0.0100414353311096,0.00171701254070398,-0.0134067799108894,-0.00667609075132984,5.08911640768717e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2,Complement C2,39145,0.0125422591270653,0.00214656829327649,0.00833498527224341,0.0167495329818872,5.233230895875e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,36725,-0.0220504651559642,0.00377826832916189,-0.0294558710811215,-0.0146450592308069,5.47146121517707e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,36731,-0.0280547712991829,0.00482151674748334,-0.0375049441242502,-0.0186045984741155,6.07329074948465e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDN1,Endothelin-1,36420,-0.0147053525306655,0.00252770777558069,-0.0196596597708037,-0.00975104529052737,6.11309799484841e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMSB10,Thymosin beta-10,39093,0.0406243167928415,0.0069938962784698,0.0269162800870406,0.0543323534986423,6.42773435627031e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCA2A,Guanylin,39034,-0.0168799719962405,0.00290754949402635,-0.0225787690045321,-0.0111811749879488,6.54305277578397e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR37,Prosaposin receptor GPR37,38832,-0.0336881992140271,0.00580327897250596,-0.0450626260001388,-0.0223137724279155,6.56580422883205e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELL,L-selectin,36806,0.0118353931546445,0.00204143668366762,0.00783417725465592,0.015836609054633,6.88480312690165e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM2,Paralemmin-2,36747,-0.0198470727829951,0.00343059138787378,-0.0265710319032277,-0.0131231136627625,7.40560307872181e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVR,Poliovirus receptor,39241,-0.0194556674106218,0.0033652941843383,-0.0260516440119248,-0.0128596908093187,7.55771660924917e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM1,Dynamin-1,36743,0.0599133564833457,0.0103628703261474,0.0396021306440968,0.0802245823225946,7.57360291805807e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG1,Arginase-1,38996,-0.026956584954259,0.00466973232772193,-0.0361092603165939,-0.017803909591924,7.95778007033998e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH,Parathyroid hormone,36421,-0.0416372213496142,0.00722125373123696,-0.0557908786628387,-0.0274835640363898,8.31217762613096e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,38987,-0.0119382382664359,0.00207522602594031,-0.0160056812772789,-0.00787079525559286,8.95058798118917e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",36791,-0.0219613527383168,0.00381900230309795,-0.0294465972523887,-0.0144761082242448,9.09672178979639e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMB1,Laminin subunit beta-1,36420,-0.0157456433084733,0.00274183805325374,-0.0211196458928506,-0.010371640724096,9.53192079023552e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,38727,-0.0286001548702845,0.00499406684184392,-0.0383885258802985,-0.0188117838602704,1.04304992956224e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,39117,0.012291487953099,0.00214836474234827,0.00808069305809643,0.0165022828481016,1.07681296337989e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39023,-0.0224163516203442,0.00391828315780473,-0.0300961866096414,-0.0147365166310469,1.07921683541268e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDA,Cytidine deaminase,36778,-0.0238968472066819,0.00419056160685814,-0.0321103479561238,-0.0156833464572399,1.20620912673413e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",38832,-0.0470601800092211,0.00825671867828289,-0.0632433486186555,-0.0308770113997866,1.22335365238259e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",39283,0.0149034276757665,0.00261524328115616,0.0097775508447004,0.0200293045068325,1.22946973150478e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHR,Growth hormone receptor,36500,-0.0147530678574061,0.00259174123859476,-0.0198328806850518,-0.00967325502976035,1.28098027834374e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOM,Apolipoprotein M,39145,0.0136162867898166,0.00240249473973748,0.00890739709993113,0.018325176479702,1.47458407480917e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,39099,-0.0363445298821956,0.00641382009091919,-0.0489156172603972,-0.023773442503994,1.48297258452666e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAN,Brevican core protein,38987,0.0170886539370925,0.00301710237435107,0.0111751332833644,0.0230021745908205,1.50637241015487e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP4,Bone morphogenetic protein 4,38960,-0.0233948070200707,0.00413429866239559,-0.031498032398366,-0.0152915816417753,1.55282667809376e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39206,-0.0294592976509323,0.00520715733060384,-0.0396653260189158,-0.0192532692829488,1.56369884887044e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,39092,0.048434765282779,0.00857410640766807,0.0316295167237496,0.0652400138418085,1.64309893043057e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",36743,0.0447902270934909,0.00793484847610984,0.0292379240803156,0.0603425301066662,1.68914339387892e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,36743,-0.0404181989688154,0.00716480287228383,-0.0544612125984917,-0.0263751853391391,1.72409103115485e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,38832,-0.0278075190549792,0.00493139046072066,-0.0374730443579917,-0.0181419937519667,1.74252122881969e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39023,0.0100807477422498,0.00179078636054838,0.00657080647557499,0.0135906890089246,1.84223576093631e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIT,Vitrin,36792,-0.018646045734997,0.00331580493817949,-0.0251450234138288,-0.0121470680561652,1.91131486831155e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS1,Galectin-1,39106,0.0171033861360146,0.00304850698015136,0.011128312454918,0.0230784598171113,2.05353659549518e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OCLN,Occludin,36767,-0.021806285564117,0.00389152025208676,-0.029433665258207,-0.014178905870027,2.14318380089527e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100P,Protein S100-P,38832,-0.0265978120258017,0.00474925496375909,-0.0359063517547695,-0.0172892722968339,2.17597046977808e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,38832,-0.0189176676852791,0.00337968562372668,-0.0255418515077834,-0.0122934838627748,2.21328338999548e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,36806,0.0128983140494208,0.00230557863181952,0.00837937993105456,0.0174172481677871,2.25884199092155e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,39162,0.0101843311152756,0.00182196853282772,0.00661327279093333,0.013755389439618,2.31293343411111e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML1,Trem-like transcript 1 protein,36796,0.0268534955736637,0.00480453350929469,0.0174366098954461,0.0362703812518813,2.32731958708938e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,36500,-0.0200006815982994,0.00358601130911321,-0.0270292637641613,-0.0129720994324375,2.49127224509067e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAT,Catalase,36616,-0.0265563807474232,0.00476397909690397,-0.035893779777355,-0.0172189817174915,2.5340911706967e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,39137,0.0157344301730444,0.0028257429693542,0.0101959739531102,0.0212728863929786,2.6165353589857e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB1,Carboxypeptidase B,39283,-0.0288035683658633,0.00517951828428491,-0.0389554242030617,-0.0186517125286648,2.72607094193553e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,39291,0.0126709236725267,0.00227855799467904,0.00820495000295575,0.0171368973420976,2.72779222968225e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPF,Centromere protein F,36538,-0.0270946997063688,0.00487631249199649,-0.0366522721906819,-0.0175371272220557,2.80963324104273e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCOF1,Treacle protein,36792,-0.0154111948123804,0.00277770383673673,-0.0208554943323844,-0.00996689529237644,2.94335282160031e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF15,Growth/differentiation factor 15,39283,-0.021163044905772,0.00383207959118148,-0.0286739209044876,-0.0136521689070563,3.39417050305101e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,36500,-0.0185152326478366,0.00335548346171052,-0.0250919802327892,-0.011938485062884,3.4982160582408e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,39076,-0.0413310823358381,0.0074923888974809,-0.0560161645749007,-0.0266460000967756,3.51640237553038e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,39099,0.0199782877353322,0.00362232977854271,0.0128785213693884,0.0270780541012759,3.53823061561119e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL4,Myosin light chain 4,36420,-0.0258298976256524,0.00469069920490253,-0.0350236680672614,-0.0166361271840435,3.72977637302596e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROC,Vitamin K-dependent protein C,39145,0.0128294409247625,0.00233280482919312,0.00825714345954397,0.017401738389981,3.86810834184321e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39093,0.0236797335154167,0.00431328484368132,0.0152256952218013,0.0321337718090321,4.08468261400212e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,39099,-0.0120266471509778,0.00220304260812817,-0.016344610662909,-0.00770868363904658,4.86015586378768e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFA,Protransforming growth factor alpha,39099,0.0226649176271687,0.00415504800585864,0.0145210235356858,0.0308088117186517,4.97948287534306e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,38713,-0.0346865604623404,0.00636874541517199,-0.0471693014760775,-0.0222038194486033,5.22247593262095e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HJV,Hemojuvelin,36767,-0.0217056509567689,0.00398595646852508,-0.0295181256350781,-0.0138931762784597,5.25963843661675e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,39147,0.0178289357080393,0.00327502185015175,0.0114098928817419,0.0242479785343367,5.29261717338635e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39117,0.0156333443637695,0.00287177593485271,0.0100046635314581,0.0212620251960808,5.29645002609044e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,36791,-0.0175966496470205,0.00323804419139399,-0.0239432162621527,-0.0112500830318882,5.59948062675772e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,36470,-0.0139989147217583,0.00257858525498303,-0.019052941821525,-0.00894488762199154,5.77481740721173e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",36420,0.0447340897570796,0.00826867410999235,0.0285274885014946,0.0609406910126646,6.41561931234379e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL2,Chordin-like protein 2,39106,-0.0273893357759403,0.00507355369022088,-0.0373335010087732,-0.0174451705431074,6.82241051670682e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,36792,-0.0286803865487258,0.00531509957470778,-0.0390979817151531,-0.0182627913822986,6.93362319549061e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5L,CD5 antigen-like,36737,0.0227732148122484,0.00422492847928528,0.0144923549928492,0.0310540746316475,7.16195566421773e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBB,Inhibin beta B chain,36500,0.024019401442451,0.00445806425636806,0.0152815954999696,0.0327572073849324,7.25823598472287e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SBSN,Suprabasin,36774,0.0165222068164676,0.00307177991945149,0.0105015181743427,0.0225428954585925,7.63301646145115e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORD,Sorbitol dehydrogenase,39190,-0.0333508010541973,0.00620838726933774,-0.0455192401020993,-0.0211823620062954,7.90509705006779e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLVRB,Flavin reductase,39093,-0.0312205904101178,0.00582222235266912,-0.0426321462213492,-0.0198090345988863,8.33606637329145e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,39255,0.0283422028194485,0.00529639292810003,0.0179612726803724,0.0387231329585246,8.86104498703814e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,39255,-0.016287310201256,0.00306115325651767,-0.0222871705840306,-0.0102874498184814,1.04847655329169e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,39093,0.0115705845643657,0.00217557599871021,0.00730645560689372,0.0158347135218377,1.06162372260699e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLK1,Protein delta homolog 1,39283,-0.0267897181226399,0.00505172905505771,-0.036691107070553,-0.0168883291747267,1.1543662730788e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,36391,-0.0293778971412973,0.00554225869699023,-0.0402407241873982,-0.0185150700951965,1.17312200002293e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL11,Eotaxin,39291,-0.0181384115707423,0.00342693934694516,-0.0248552126907549,-0.0114216104507298,1.22046496635089e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PZP,Pregnancy zone protein,36806,0.0259403182935061,0.00490751958029277,0.0163215799161323,0.0355590566708799,1.27168560077348e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTN,Pleiotrophin,38832,0.0240032274742514,0.00454818494217063,0.015088784987597,0.0329176699609059,1.32756202001834e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID1,Nidogen-1,39131,0.0179509060868238,0.00340157460193122,0.0112838198670386,0.024617992306609,1.32941291191662e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGLN1,Egl nine homolog 1,39099,-0.0255514778282171,0.00484400686672612,-0.0350457312870003,-0.0160572243694339,1.34671616508969e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,39099,-0.0236186932095707,0.00448192562327717,-0.032403267431194,-0.0148341189879475,1.38460081884476e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,36731,-0.0248810935977979,0.00472163643752861,-0.034135501015354,-0.0156266861802418,1.38935756958543e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,38946,0.013454383411606,0.00256969902997102,0.00841777331286285,0.0184909935103492,1.66493139171281e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,36500,-0.0195471998411785,0.00373491919473496,-0.026867641462859,-0.012226758219498,1.68870741779963e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,36743,-0.0283450553367579,0.0054171303807311,-0.0389626308829908,-0.0177274797905249,1.69870704614402e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES3,Carboxylesterase 3,39023,-0.0325406187622571,0.00622243704247828,-0.0447365953655146,-0.0203446421589997,1.72170909020937e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,39211,0.034235740105376,0.0065583329027674,0.0213814076159519,0.0470900725948001,1.81070554773926e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,39023,-0.0375502571788383,0.00719416304458751,-0.0516508167462299,-0.0234496976114468,1.81729789711604e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,36430,-0.0331823091369009,0.00639488086242792,-0.0457162756272597,-0.0206483426465422,2.14849930868282e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,38832,0.0227740384037669,0.00438988162852028,0.0141698704118672,0.0313782063956667,2.1551446344496e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",39106,0.036415044775077,0.00702049693640018,0.0226548707797326,0.0501752187704213,2.16490624528394e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,39099,-0.0297109710996274,0.00573916368222128,-0.0409597319167811,-0.0184622102824737,2.28494153615093e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA1,Ephrin-A1,39062,0.0122866798217948,0.00237905621650586,0.00762372963744328,0.0169496300061463,2.44102870947515e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTL1,Cytokine-like protein 1,36791,0.0106860289762013,0.00207044405885636,0.00662795862084288,0.0147440993315598,2.48974895555e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,38977,-0.0171852362999216,0.00333259152503853,-0.0237171156889971,-0.0106533569108461,2.54488208353611e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",36767,-0.0192358660261137,0.00374385660210664,-0.0265738249662428,-0.0118979070859847,2.81757557234757e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,36785,0.00892083951549821,0.00173719097176458,0.00551594521083963,0.0123257338201568,2.85928146963964e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMCN2,Hemicentin-2,36478,-0.0263095612365564,0.00512445744852388,-0.0363534978356632,-0.0162656246374496,2.87692041911205e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP6,Platelet glycoprotein VI,39071,0.0410753840719843,0.00802683570224915,0.025342786095576,0.0568079820483926,3.13785892909198e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD1,Polycystin-1,36792,-0.0120805246057131,0.00236167391256617,-0.0167094054743428,-0.0074516437370834,3.17830810919046e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,36743,-0.0135871589026835,0.00265716587213847,-0.0187952040120749,-0.00837911379329208,3.20947268802527e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPL,Lipoprotein lipase,39106,0.0217840598598568,0.00426457382543239,0.0134254951620094,0.0301426245577043,3.29263266288601e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,39255,0.029410141008399,0.00575784797534635,0.0181247589767202,0.0406955230400779,3.29762872295619e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,38630,0.0168267705698911,0.0032989710872845,0.0103607872388134,0.0232927539009687,3.42750885336589e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39117,0.0153220749361177,0.00300499666140693,0.00943228147976011,0.0212118683924753,3.45785621515978e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOL1,Apolipoprotein L1,36796,0.0280441554988943,0.00550045581862613,0.0172632620943871,0.0388250489034015,3.47165701743296e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA1,Carbonic anhydrase 1,38788,-0.0272927230871943,0.0053591384888382,-0.0377966345253171,-0.0167888116490714,3.57216077633807e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,38987,0.0264382210032394,0.00519241357945912,0.0162610903874995,0.0366153516189793,3.59126233448491e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOA,Elongin-A,39023,-0.0236224313055931,0.00464158621990377,-0.0327199402966045,-0.0145249223145817,3.63683242492674e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADIPOQ,Adiponectin,36806,0.0303756764504893,0.00597476488990706,0.0186651372662715,0.0420862156347072,3.74737570103278e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,36796,-0.0279840715901173,0.00551229358574684,-0.0387881670181811,-0.0171799761620535,3.89453503709414e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN8,Septin-8,36718,-0.0145541762571163,0.00286742939633587,-0.0201743378739346,-0.00893401464029797,3.914907316406e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,39053,-0.0244578773624048,0.00483111064979485,-0.0339268542360027,-0.0149889004888069,4.18460757501436e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPC,C-type natriuretic peptide,39099,-0.0209506530244165,0.00414135140242811,-0.0290677017731756,-0.0128336042756574,4.26600616066053e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSO,Cathepsin O,39291,-0.0136045771266452,0.00269559835812976,-0.0188879499085795,-0.00832120434471085,4.54002142672519e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUOM,Fucose mutarotase,36500,-0.0290951285613254,0.00576789100932145,-0.0404001949395954,-0.0177900621830554,4.61434883599523e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,36420,-0.0110123141460043,0.00218342239843976,-0.0152918220469462,-0.00673280624506239,4.63224026497902e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,36614,-0.0116611610740968,0.00231667204337104,-0.016201838279104,-0.00712048386908954,4.87960737614501e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39099,0.0279565467770549,0.00555656442500409,0.0170656805040469,0.0388474130500629,4.92800779145071e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G1B,Phospholipase A2,39264,0.0184293938837761,0.00366402082744768,0.0112479130619786,0.0256108747055735,4.96442039070178e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX2,Peroxiredoxin-2,36608,-0.0276727867989661,0.00550189049347019,-0.0384564921661677,-0.0168890814317646,4.97963709119512e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39106,-0.0127515322990636,0.0025360161750807,-0.0177221240022218,-0.00778094059590546,5.00790897234188e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFAP,Glial fibrillary acidic protein,38704,0.0198980079652313,0.00395924015642719,0.012137897258634,0.0276581186718286,5.07399908868745e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,39291,0.033557619797943,0.00667898879178796,0.0204668017660386,0.0466484378298474,5.10771129820097e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,38727,-0.0269519690549419,0.00536938603430767,-0.0374759656821849,-0.0164279724276988,5.23881483317765e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,38741,-0.0228788560828264,0.00456123739066302,-0.0318188813685259,-0.0139388307971268,5.33850297765156e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MENT,Protein MENT,36500,0.0100881749930236,0.00201169082139742,0.00614526098308465,0.0140310890029625,5.38158858968888e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM3,Myomesin-3,36500,-0.0423940147723455,0.00846410530923053,-0.0589836611784373,-0.0258043683662536,5.5543679010257e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39165,-0.0187167529625246,0.0037514104260677,-0.0260695173976173,-0.0113639885274319,6.1276729771196e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH1,Cadherin-1,38578,-0.0181876713497003,0.00364851940522502,-0.0253387693839413,-0.0110365733154593,6.26840264835638e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN5,CCN family member 5,39093,0.0173168297068473,0.00347397655215876,0.0105078356646161,0.0241258237490784,6.27304456249074e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,38727,-0.0195186643518094,0.00394165844649912,-0.0272443149069476,-0.0117930137966711,7.43019733793099e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREH,Trehalase,36791,-0.0337850882926933,0.00682225646054847,-0.0471567109553683,-0.0204134656300183,7.43105853123077e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL16,Pro-interleukin-16,39291,-0.0183689211950948,0.00371844426850297,-0.0256570719613606,-0.011080770428829,7.89615968814152e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,38931,0.0188522940582278,0.00382322200400291,0.0113587789303821,0.0263458091860735,8.26822194007361e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RETN,Resistin,39031,0.0180175297161197,0.00365775629269022,0.0108483273824469,0.0251867320497925,8.48825980899408e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR3,Small proline-rich protein 3,36747,-0.0289753800951257,0.00589009661118009,-0.0405199694530387,-0.0174307907372127,8.79091826939885e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,36747,-0.0281417296592086,0.00572589821203106,-0.0393644901547895,-0.0169189691636278,8.99596272467227e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,36806,0.00820658122602141,0.00167151152138234,0.00493041864411202,0.0114827438079308,9.23392644028782e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,39241,0.0197642746439293,0.00402988437586823,0.0118657012672276,0.027662848020631,9.46575119116078e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,39095,-0.0177645131299812,0.00362586090465411,-0.0248712005031033,-0.0106578257568592,9.71213151576596e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTNB,Dystrobrevin beta,36712,-0.0194925021949892,0.00398041972415499,-0.027294124854333,-0.0116908795356455,9.84458852224514e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,39183,-0.013728405246435,0.00280802502191546,-0.0192321342893893,-0.00822467620348066,1.02381518590218e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WDR46,WD repeat-containing protein 46,36731,-0.0160225512568776,0.00327715754265991,-0.0224457800404911,-0.00959932247326423,1.02488904736773e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB6,Integrin beta-6,38841,-0.0131239198200356,0.00268490636890781,-0.0183863363030949,-0.00786150333697631,1.0290127613207e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,36500,-0.00955148134066531,0.00195653182880034,-0.013386283725114,-0.00571667895621665,1.06383289799213e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,38987,-0.0139718044989546,0.00286909477228918,-0.0195952302526414,-0.00834837874526777,1.12862782538619e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,36747,-0.0273276545285998,0.00561494939849722,-0.0383329553496544,-0.0163223537075453,1.14678510226859e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,36731,-0.0213609709781044,0.00439109185620608,-0.0299675110162683,-0.0127544309399404,1.16037382301572e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,36762,0.00633514514392186,0.00130546095828942,0.00377644166567459,0.00889384862216913,1.23152491076495e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",39106,-0.0318486570270398,0.00657976907435135,-0.0447450044127685,-0.0189523096413112,1.30853039504727e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL5,Insulin-like peptide INSL5,36743,-0.0423242394550726,0.00874461931617405,-0.0594636933147737,-0.0251847855953714,1.31323560183025e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDK,Midkine,39079,0.0221864773619669,0.00458671364450958,0.0131965186187281,0.0311764361052056,1.33024226923536e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,39023,-0.023903935298673,0.00494240299532439,-0.0335910451695088,-0.0142168254278372,1.3344232722172e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG2,Desmoglein-2,39093,0.0116397526097011,0.00241033381985774,0.00691549832277994,0.0163640068966223,1.38481296293908e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,39147,-0.00941967594311076,0.00195564247714189,-0.0132527351983089,-0.00558661668791267,1.47376226102027e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF2,Trefoil factor 2,39140,-0.0246491221121065,0.00513353967573938,-0.0347108598765557,-0.0145873843476573,1.58906835247085e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",36363,-0.0288311114202716,0.00600976865325015,-0.0406102579806418,-0.0170519648599013,1.62615407820074e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,36731,-0.0248216058803175,0.00517589962816747,-0.0349663691515257,-0.0146768426091092,1.63995643860593e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",36792,-0.0328708589734408,0.0068682363885205,-0.046332602294941,-0.0194091156519406,1.72084979421117e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,38727,0.0200454079374748,0.0041941689168584,0.0118248368604324,0.0282659790145173,1.77543640405177e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NADK,NAD kinase,39106,-0.023072000100247,0.00482785257417221,-0.0325345911456246,-0.0136094090548695,1.77868068446073e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,38684,-0.0377229248089313,0.00789641156760131,-0.0531998914814298,-0.0222459581364327,1.79434118900659e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39117,-0.0114242465261183,0.00240270894078229,-0.0161335560500516,-0.00671493700218503,2.0052142192487e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSNL1,Visinin-like protein 1,36747,-0.0163337192976228,0.00343693817128083,-0.0230701181133332,-0.00959732048191237,2.03183631603662e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,36767,-0.0249549714386448,0.00525478381302064,-0.0352543477121652,-0.0146555951651243,2.06623265312219e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",39076,-0.0280522560707551,0.00590812346288202,-0.0396321780580038,-0.0164723340835063,2.07225673308696e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',36747,-0.0174452865831339,0.00367469230497151,-0.0246476835008781,-0.0102428896653898,2.08250528213852e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39147,-0.0149154094730864,0.00314463050643298,-0.021078885265695,-0.00875193368047775,2.12335950800679e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,39165,0.0246841998174035,0.00522042371558725,0.0144521693348525,0.0349162302999545,2.28324485529688e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,39255,0.0136059053448937,0.00288255451332132,0.0079560984987839,0.0192557121910035,2.37820012944705e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THPO,Thrombopoietin,38832,0.0162595375278449,0.0034487635592187,0.00949996095177621,0.0230191141039135,2.44369587611074e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2R,Proteinase-activated receptor 1,39140,0.0248897099519108,0.00528993538836275,0.0145214365907198,0.0352579833131018,2.5595625549394e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,36796,0.0108802707670599,0.00231301891374002,0.0063467536961295,0.0154137878379904,2.57845293464409e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,36420,0.0255267327575922,0.00544141305857338,0.0148615631627884,0.0361919023523961,2.74477348728251e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAA4,Serum amyloid A-4 protein,36806,-0.0139368426183914,0.00297986664266248,-0.0197773812380098,-0.0080963039987729,2.940423984898e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,36391,-0.0320405198729947,0.00685739143272968,-0.0454810070811449,-0.0186000326648445,3.00789260644074e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,39099,0.0228846264032542,0.00491081908237186,0.0132594210018053,0.032509831804703,3.18819968483943e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",36420,0.0294835363812823,0.00633903121204973,0.0170590352056648,0.0419080375568998,3.3352008278605e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7,Interleukin-7,39099,0.0274057594058747,0.00589488361948904,0.0158517875116762,0.0389597313000732,3.36222960971492e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIP2,Cysteine-rich protein 2,38987,-0.0150006646513336,0.00324019672704922,-0.0213514502363501,-0.00864987906631712,3.69501795646929e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,38907,-0.0150755033096689,0.0032566002724397,-0.0214584398436507,-0.00869256677568709,3.7012171542524e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,38727,-0.0228735599702323,0.00494334509482892,-0.032562516356097,-0.0131846035843676,3.7387677842465e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMMT,MICOS complex subunit MIC60,36731,-0.0183014131953839,0.00395914202368636,-0.0260613315618091,-0.0105414948289586,3.82698389284199e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDI2,Protein DDI1 homolog 2,36500,-0.031311468659872,0.00678036469921031,-0.0446009834703242,-0.0180219538494198,3.91348252145849e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,39291,-0.0138978386474172,0.00301005620916988,-0.0197975488173901,-0.0079981284774442,3.92211038849422e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",36420,0.0324526409046909,0.00702951187712409,0.0186747976255277,0.0462304841838542,3.93892194421562e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRN,Progranulin,39024,0.0103058985056959,0.00223393299847498,0.00592738982868493,0.0146844071827069,3.99486785758433e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",38841,-0.0249833254175366,0.00542582027693998,-0.0356179331603389,-0.0143487176747342,4.16807684617717e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,36743,0.0475615994121424,0.0103314342178617,0.0273119883451336,0.0678112104791512,4.19256498696981e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39162,0.0500377876256008,0.0108919199831014,0.028689624458722,0.0713859507924795,4.38239863577888e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD70,CD70 antigen,39099,0.0175570496698764,0.00382547445342166,0.01005911974117,0.0250549795985829,4.47836216724726e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39099,0.0343833450307864,0.0075109503337048,0.019661882376725,0.0491048076848478,4.73691133633508e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYNU,Kynureninase,39291,-0.018801249485873,0.00410725506990016,-0.0268514694228773,-0.0107510295488687,4.74078544944132e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,36420,-0.0248372438329693,0.00542935040390302,-0.0354787706246192,-0.0141957170413194,4.81639060762133e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39073,-0.0301795337233402,0.00660273512099547,-0.0431208945604914,-0.0172381728861891,4.89777977778364e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD6,Programmed cell death protein 6,39106,0.0288265272611366,0.00631137715045313,0.0164562280462484,0.0411968264760247,4.97699967519886e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,38727,-0.0210377681375642,0.00460772605176575,-0.0300689111990251,-0.0120066250761033,5.01681606574238e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX6,Peroxiredoxin-6,39255,-0.0243328869406788,0.00533287710495243,-0.0347853260663856,-0.0138804478149721,5.08642687577015e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPPK1,Epiplakin,36420,-0.0307400364080496,0.00673853539957657,-0.0439475657912197,-0.0175325070248795,5.11904397615014e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB6,Heat shock protein beta-6,39255,-0.0153997897081553,0.00338326695323593,-0.0220309929364977,-0.00876858647981288,5.36084269334489e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA3,Carbonic anhydrase 3,39253,-0.0246998429138737,0.00543979193203813,-0.0353618351006684,-0.0140378507270789,5.65235181472312e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZU1,Azurocidin,38608,-0.0313896207760708,0.00692096821910531,-0.0449547184855172,-0.0178245230666244,5.79371963118981e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO3,R-spondin-3,39255,0.0110337929957895,0.00243384743926111,0.00626345201483775,0.0158041339767413,5.84577053730563e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,38987,-0.0212796016250211,0.00470325017625794,-0.0304979719704867,-0.0120612312795555,6.10148611670364e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,38727,-0.0291040700202275,0.00643407670202701,-0.0417148603562004,-0.0164932796842546,6.13174972031359e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,38824,-0.0586913300533964,0.0130416266148469,-0.0842529182184964,-0.0331297418882964,6.83668018624293e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFD,Complement factor D,36806,0.00743742775713691,0.00165375450937172,0.00419606891876835,0.0106787865955055,6.94207886198039e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,36224,-0.0130012506026567,0.00289173879554412,-0.0186690586419232,-0.00733344256339027,6.98744112869724e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39023,-0.0221758661245315,0.00494718110976445,-0.0318723410996699,-0.0124793911493932,7.43053106009079e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,39075,0.0387295771487348,0.00867451478450789,0.0217275281710994,0.0557316261263703,8.07372234181089e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMB,Granzyme B,39099,0.0258362626314847,0.00579432313064003,0.0144793892954302,0.0371931359675392,8.29729296414679e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,39086,-0.0276130726608508,0.00620202888183188,-0.0397690492692412,-0.0154570960524603,8.55735835357694e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPT,Dermatopontin,39283,0.0107259492306215,0.00241051456322495,0.00600134068670059,0.0154505577745424,8.66121855879548e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,39099,-0.0211400709200364,0.00475437721598132,-0.0304586502633598,-0.011821491576713,8.79206227644701e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL15,C-C motif chemokine 15,39283,-0.0173057031957068,0.00391026129792868,-0.024969815339647,-0.00964159105176663,9.67826526475841e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,36792,-0.0156711114447692,0.00354401491437522,-0.0226173806769447,-0.00872484221259379,9.86565757650192e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A12,Protein S100-A12,38856,-0.0297542740174156,0.00672941146987491,-0.0429439204983704,-0.0165646275364608,9.86948693912364e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR2,Cadherin-related family member 2,39023,-0.02918760127561,0.00660336578157035,-0.0421301982074879,-0.0162450043437321,9.93358556183027e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,36767,-0.0148079435230027,0.00335874424200682,-0.021391082237336,-0.00822480480866929,1.04797713416283e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,39147,0.0108286183124352,0.0024567363925395,0.00601341498305779,0.0156438216418126,1.05173899259235e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,36531,-0.0174135978902138,0.00395426344019382,-0.0251639542329937,-0.00966324154743396,1.07266379727603e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPN,Asporin,36792,0.0107230379033913,0.00244163167967917,0.00593743981122014,0.0155086359955625,1.13335154610325e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLFM4,Olfactomedin-4,36052,-0.0488329394524345,0.0111233524817839,-0.070634710316731,-0.027031168588138,1.14237828299061e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1B,Interleukin-1 beta,38739,0.0220488357212415,0.00503305226231951,0.0121840532870953,0.0319136181553878,1.19048678685501e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPACAM2,HEPACAM family member 2,36747,-0.0165444422626023,0.00378618331676624,-0.0239653615634642,-0.00912352296174048,1.25397173718413e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39115,0.0194237446292209,0.00444625140786185,0.0107090918698117,0.0281383973886301,1.25890095717949e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA4,Carbonic anhydrase 4,39283,0.009225685094869,0.00211378618245895,0.00508266417724947,0.0133687060124885,1.2822443110169e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,39029,0.0250567003761054,0.00574124485257609,0.0138038604650563,0.0363095402871545,1.28354734449456e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBS,Cystathionine beta-synthase,36420,-0.0201780894819882,0.00462479949810385,-0.0292426964982717,-0.0111134824657046,1.29303347255775e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D17,TBC1 domain family member 17,38741,-0.0173450232804327,0.00398235567852898,-0.0251504404103495,-0.00953960615051587,1.3367089566515e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39140,0.035183493536493,0.00810460152674597,0.0192984745440709,0.0510685125289151,1.42634301050783e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,36747,-0.0272821380480864,0.00628704751759024,-0.0396047511825633,-0.0149595249136095,1.43947677291977e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1,Programmed cell death protein 1,39223,0.0160968502915731,0.00371146114638879,0.00882238644465111,0.0233713141384952,1.45317916868199e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCA,Calcitonin,38951,-0.0239210520613336,0.00551977712229376,-0.0347398152210294,-0.0131022889016378,1.47573288838405e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXN,Paxillin,38741,-0.020206592923241,0.00466836296588627,-0.0293565843363781,-0.0110566015101039,1.51169925044445e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFLAM,Pikachurin,36743,-0.012013494336906,0.00277573595471976,-0.0174539368081568,-0.00657305186565532,1.51577525462337e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,39131,-0.0136976589040224,0.00316959139969298,-0.0199100580474207,-0.00748525976062419,1.55892135853008e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGN,Biglycan,38699,-0.0465194814444592,0.0107744181714478,-0.067637341060497,-0.0254016218284215,1.58767908382176e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI2,Serpin I2,36743,-0.0223737640650363,0.00518481542550588,-0.0325360022990279,-0.0122115258310448,1.60612990112441e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPD52L2,Tumor protein D54,36500,0.0425193413632225,0.0098601049165803,0.0231935357267251,0.0618451469997198,1.62819147181926e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPQ,Carboxypeptidase Q,36784,-0.0147403114344305,0.00341889854655852,-0.0214413525856852,-0.00803927028317581,1.63410591480502e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL5,C-C motif chemokine 5,39165,0.0394961739841442,0.00916571593721959,0.0215313707471938,0.0574609772210946,1.64928143470406e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39149,0.0117161396143557,0.00272359674068943,0.00637789000260444,0.017054389226107,1.70532496185588e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,36500,0.0116744283912632,0.00271472897109724,0.00635355960791261,0.0169952971746138,1.7176704177802e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASN,Vasorin,38888,0.0106502433819037,0.00248203235556302,0.00578545996500022,0.0155150267988073,1.790340711347e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNLY,Granulysin,39093,0.0196915200468753,0.00458946085254155,0.0106961767758939,0.0286868633178568,1.79293912347837e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL1,Follistatin-related protein 1,36420,-0.00884077701813143,0.00206649987717573,-0.0128911167773959,-0.004790437258867,1.89856106013415e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,36727,0.0341966715678288,0.00801557886486069,0.0184861369927018,0.0499072061429557,2.00183919234769e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP6,Gastrotropin,38811,0.0208649995121376,0.00489434623463018,0.0112720808922625,0.0304579181320128,2.02863033800931e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,36646,-0.0122756043710495,0.00288040649129224,-0.0179212010939823,-0.00663000764811674,2.04275568820812e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENSA,Alpha-endosulfine,36731,0.0202008754344342,0.00474647197214639,0.0108977903690273,0.0295039604998411,2.09612056864257e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD276,CD276 antigen,39095,-0.0135065633478059,0.00317700075012023,-0.0197334848180415,-0.00727964187757024,2.13744890291931e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,36430,0.0122194485821108,0.00287877069793716,0.00657705801415394,0.0178618391500676,2.20480991725656e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,38741,-0.01050631089059,0.00247738123567016,-0.0153619781125035,-0.00565064366867652,2.239761850324e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,39162,0.0496038110961943,0.0117523790665706,0.0265691481257159,0.0726384740666726,2.4489930673655e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2AP,CD2-associated protein,39106,-0.024205217122743,0.00573684940984008,-0.0354494419660295,-0.0129609922794564,2.46530605515763e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN3,Ataxin-3,36747,-0.0233496763162724,0.00554642474766525,-0.0342206688216963,-0.0124786838108485,2.57261700968496e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDT,D-dopachrome decarboxylase,36791,-0.0152717991601507,0.00362814482203132,-0.022382963011332,-0.00816063530896927,2.57941632048827e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,36391,0.00981887103660641,0.00234623016756478,0.00522025990817945,0.0144174821650334,2.87166507128027e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,38727,-0.0232555942564731,0.005562936127668,-0.0341589490667023,-0.0123522394462438,2.92593964044618e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK13,Kallikrein-13,38736,-0.0159250759012735,0.00380950250286517,-0.0233917008068892,-0.00845845099565777,2.92718188095734e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB7,Integrin beta-7,39255,-0.0171558800382379,0.00410872560112945,-0.0252089822164516,-0.00910277786002412,2.99001435954259e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",36430,-0.0134898273811837,0.00323375226615157,-0.0198279818228408,-0.00715167293952667,3.04538926128508e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39099,-0.0230038411178438,0.00552061955767365,-0.0338242554508841,-0.0121834267848034,3.10479889908508e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA6,Integrin alpha-6,39099,0.0200485781762287,0.00481345685880541,0.0106142027329701,0.0294829536194873,3.12915843584531e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",36500,0.0337541992798695,0.00810380730135192,0.0178707369692198,0.0496376615905193,3.1310850726602e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BECN1,Beclin-1,36420,-0.0228066879419226,0.00547804578429099,-0.0335436576791329,-0.0120697182047123,3.1578904583258e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMM2,Phosphomannomutase 2,36391,0.0227520865931312,0.00546706150018231,0.0120366460527739,0.0334675271334886,3.18043415653129e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",39023,-0.0397194175880853,0.00955112670223751,-0.0584396259244708,-0.0209992092516998,3.219505142186e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,36743,0.0361230229207899,0.00873566926083065,0.0190011111695618,0.0532449346720179,3.57021213450994e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNF,Tumor necrosis factor,38805,0.0142439759175431,0.00344662702609736,0.00748858694639232,0.020999364888694,3.60435032411188e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRP,Gastrin-releasing peptide,36420,-0.019309569647549,0.00467378583018235,-0.0284701898747064,-0.0101489494203916,3.62798880081623e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,39099,-0.0280934535861147,0.00680243427252356,-0.0414262247602608,-0.0147606824119685,3.64837193763782e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RFC4,Replication factor C subunit 4,36731,-0.00801577562584146,0.00194518467100607,-0.0118283375810134,-0.00420321367066958,3.7987356411449e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,39165,-0.016979011927347,0.00412865292616461,-0.0250711716626297,-0.0088868521920644,3.93472217468995e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG3,Proteoglycan 3,36791,0.0184600586398126,0.00449412168756156,0.00965158013219192,0.0272685371474332,4.02251463361587e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,39283,0.0158789378698692,0.00386989525362191,0.00829394317277026,0.0234639325669681,4.09576281951188e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39099,0.0445951410588355,0.0108721779004037,0.0232856723740443,0.0659046097436266,4.12136719183333e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA10,Annexin A10,38741,-0.0288025684601671,0.00705071702570431,-0.0426219738305476,-0.0149831630897867,4.42971423933562e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,39023,0.0125526307021619,0.00308134016054505,0.00651320398749364,0.0185920574168302,4.64960705633863e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGN,Secretagogin,38841,-0.0158221807204181,0.00388949519056324,-0.023445591293922,-0.00819877014691413,4.76762019523371e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,36363,0.0175030996842155,0.00430546844460304,0.00906438153279353,0.0259418178356374,4.82606243580584e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH2,Neutral ceramidase,38987,-0.0191790196194648,0.00471801215564916,-0.0284263234445371,-0.00993171579439244,4.82622058075212e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,38475,-0.0138182356920414,0.00340495818036455,-0.0204919537255559,-0.00714451765852686,4.96949914883518e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,36791,0.00795021644535902,0.00195969372879314,0.00410921673692448,0.0117912161537936,5.00275070624902e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF7,SLAM family member 7,39099,0.021190942871918,0.00523223820775772,0.0109357559847128,0.0314461297591231,5.14552704486665e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100G,Protein S100-G,36767,0.0164864903440361,0.0040711176394731,0.00850709977066884,0.0244658809174034,5.16000690399934e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,38727,-0.0206953375768902,0.00512109238001303,-0.0307326786417157,-0.0106579965120646,5.34469091718206e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN1,Perilipin-1,38741,-0.0126842152176888,0.00313887996473053,-0.0188364199485607,-0.00653201048681698,5.34911888705016e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39211,0.0124179757179291,0.00307336704146821,0.00639417631665137,0.0184417751192068,5.35944268336309e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHPS,Deoxyhypusine synthase,36731,-0.0149255144485624,0.00369400005228335,-0.0221657545510378,-0.00768527434608701,5.3653005291789e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA2,Carbonic anhydrase 2,39057,-0.024745011680348,0.00612781289877416,-0.0367555249619453,-0.0127344983987506,5.413944572011e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,38987,-0.019679284381992,0.00487636584317603,-0.029236961434617,-0.010121607329367,5.47202455529916e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTP1,Glutathione S-transferase P,38652,0.0252377335282372,0.00626830669140902,0.0129518524130755,0.0375236146433988,5.69574630827517e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,36631,-0.0201841654545774,0.00501297986150149,-0.0300096059831203,-0.0103587249260345,5.69692579000501e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,36421,-0.0221932111744958,0.00552169363810485,-0.0330157307051813,-0.0113706916438103,5.87179254961459e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLB,Beta-klotho,38741,0.0266627763279162,0.00664083335457757,0.0136467429529441,0.0396788097028882,5.97438229497484e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR2,Folate receptor beta,39241,0.0104414472375714,0.00260234666775935,0.00534084776876307,0.0155420467063797,6.04095282775959e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,36391,0.0101007356097297,0.00252024499624461,0.00516105541709026,0.0150404158023691,6.1631545058917e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,38926,-0.0131746829081474,0.00329048297183705,-0.019624029532948,-0.00672533628334675,6.26119776868363e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFR,Epidermal growth factor receptor,39283,0.00578690051304558,0.0014497711942257,0.00294534897236321,0.00862845205372795,6.59339422585571e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD46,Membrane cofactor protein,39022,0.0102261486129506,0.00256798457861808,0.00519289883885922,0.0152593983870421,6.86078344530145e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MESD,LRP chaperone MESD,39093,0.0439512773957386,0.0110599828278772,0.0222737110530993,0.0656288437383778,7.10307466766377e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,38741,-0.0186367051987627,0.00469169698912063,-0.0278324312974391,-0.00944097910008624,7.15251016942284e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB44,Ras-related protein Rab-44,36731,-0.0151389263156125,0.0038205532149594,-0.0226272106169329,-0.00765064201429208,7.45705170566965e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,36500,0.023091427657601,0.00582847011931065,0.0116676262237522,0.0345152290914499,7.47848559844729e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,38987,-0.0100569312164672,0.00254058298572678,-0.0150364738684917,-0.00507738856444274,7.57626318375106e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39023,-0.0137551326575066,0.00347625726084451,-0.0205685968887618,-0.00694166842625134,7.62809159740046e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK4,Dickkopf-related protein 4,38958,-0.0160904821414801,0.00406699374928631,-0.0240617898900813,-0.00811917439287894,7.64491022727685e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIT,Citron Rho-interacting kinase,36421,-0.0162555459890565,0.00411274333312482,-0.0243165229219812,-0.00819456905613188,7.77681846347868e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,36767,0.0214381901375854,0.00543532005271476,0.0107849628342644,0.0320914174409063,8.0477773014356e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPL,N-acetylneuraminate lyase,36792,-0.0156897609396787,0.00398175408961012,-0.0234939989553145,-0.00788552292404287,8.17686831269961e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSTN,Growth/differentiation factor 8,38832,-0.0184903264377497,0.00469396562622892,-0.0276904990651584,-0.00929015381034103,8.21349384714667e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL28,C-C motif chemokine 28,39049,0.0211277588849388,0.00537788905140524,0.0105870963441846,0.0316684214256931,8.58077002262711e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,36420,0.0188710365271148,0.00480717543834718,0.00944897266795429,0.0282931003862752,8.69764290640011e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,38727,-0.0227721532464719,0.00580144440412772,-0.0341429842785622,-0.0114013222143816,8.70280437065196e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39023,-0.0138578424923243,0.0035348896480715,-0.0207862262025445,-0.00692945878210419,8.88261641092703e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,39023,-0.00733614704517709,0.00187776927062914,-0.0110165748156102,-0.00365571927474397,9.39162872320706e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,39023,0.0305575902220421,0.00783163129453968,0.0152075928847443,0.0459075875593399,9.58857951445359e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POSTN,Periostin,36791,0.0130879627823452,0.00335424149488967,0.00651364945236148,0.019662276112329,9.59184853455201e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36155,-0.0174982648759261,0.00449010493963494,-0.0262988705576106,-0.00869765919424162,9.78788715140015e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPTC,Opticin,39023,0.0155266621214423,0.00399187247862045,0.00770259206334619,0.0233507321795384,0.000100851174408876
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,39237,-0.00943730392337856,0.00242678693413848,-0.01419380631429,-0.00468080153246714,0.000101162208813854
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC5D,Netrin receptor UNC5D,36430,0.00923911148827104,0.00237618439756993,0.00458179006903398,0.0138964329075081,0.000101504325064151
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSS,Cathepsin S,35946,0.00856850689183705,0.00220445963559803,0.0042477660060649,0.0128892477776092,0.000102076426452933
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA13,Carbonic anhydrase 13,38907,0.037083785239708,0.00954328219156072,0.018378952144249,0.055788618335167,0.000102408498295787
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,39283,-0.00868194308920328,0.00223522045018739,-0.0130629751715706,-0.00430091100683599,0.000103114934475616
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,36776,0.00863868132499722,0.00222549417508446,0.00427671274183168,0.0130006499081628,0.000104248454534652
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,36767,0.0129109895954628,0.00332979383739502,0.00638459367416852,0.019437385516757,0.000106095854193204
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASS1,Argininosuccinate synthase,36391,-0.0280880579300256,0.00725015354419568,-0.0422983588766491,-0.013877756983402,0.000107549606074853
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POF1B,Protein POF1B,36430,-0.0158381466466247,0.00409180575717708,-0.0238580859306918,-0.00781820736255762,0.000109072661474335
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN1,Dynactin subunit 1,39255,-0.0227413308208547,0.00588259577397286,-0.0342712185378415,-0.0112114431038679,0.000111150124834702
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,38962,0.0205366802654387,0.00531578522759456,0.0101177412193534,0.0309556193115241,0.000112314847394537
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARCO,Macrophage receptor MARCO,39106,0.00913297104734145,0.00236991185272617,0.00448794381599816,0.0137779982786847,0.000116814632013439
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,39283,-0.0102346531839812,0.00265690255840901,-0.0154421821984629,-0.00502712416949955,0.0001175831445001
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYAL1,Hyaluronidase-1,38990,0.0079706386098703,0.00207036827677537,0.00391271678739058,0.01202856043235,0.000118669195442981
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,36747,-0.0303325187441079,0.00788063956848138,-0.0457785722983314,-0.0148864651898844,0.000119177512812503
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,39093,0.00929347831095665,0.00241586409376842,0.00455838468717054,0.0140285719347428,0.000120131382682023
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL3,Follistatin-related protein 3,39037,-0.0103811558359249,0.00270480026595168,-0.0156825643571902,-0.00507974731465963,0.000124518615998409
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,38841,0.0226835671993452,0.005932432455942,0.0110559995856989,0.0343111348129915,0.000132021104879199
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID2,Nidogen-2,39093,0.0251882967447256,0.00659353520045927,0.0122649677518255,0.0381116257376258,0.000133899645818806
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,38841,0.0143074265434381,0.00375363722800433,0.00695029757654959,0.0216645555103266,0.000138613357940499
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS9,Galectin-9,39092,0.0108410334334134,0.00284520794186578,0.00526442586735644,0.0164176409994703,0.000139356221787843
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBI,Acyl-CoA-binding protein,39035,0.0275434221176499,0.00723065377563542,0.0133713407174044,0.0417155035178953,0.00013993415071451
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMN,Protein amnionless,38841,-0.0164735041456325,0.00432996914777995,-0.0249602436752812,-0.00798676461598379,0.000142637435777697
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILPL2,RILP-like protein 2,36792,0.0338724784554533,0.00892959160906264,0.0163704789016906,0.0513744780092161,0.000149344845976798
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,36430,-0.0109959175504059,0.00290268779918578,-0.01668518563681,-0.00530664946400176,0.000152459380153018
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA1,Carboxypeptidase A1,39283,-0.0201439144492913,0.00532871857452003,-0.0305882028553506,-0.00969962604323203,0.000157258224853566
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGF,Pro-epidermal growth factor,39044,0.0354514634443713,0.00938441162372382,0.0170580166618726,0.05384491022687,0.000158889590610039
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,36500,0.0123729284395044,0.00328081537490249,0.00594253030469556,0.0188033265743133,0.000163141626885021
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLNS1A,Methylosome subunit pICln,36421,-0.0114725418929332,0.00304752222647721,-0.0174456854568285,-0.00549939832903785,0.000167611173784215
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB1A1,Uteroglobin,39136,0.0185998946652238,0.00494441850367074,0.00890883439802913,0.0282909549324184,0.000169327558755046
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99,CD99 antigen,39093,0.0065010761977261,0.00172878725357805,0.00311265318071312,0.00988949921473908,0.000170219496030058
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,39283,0.00533578659146972,0.00141910830378246,0.0025543343160561,0.00811723886688334,0.000170569877744675
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39044,-0.0222172861707576,0.0059210828278645,-0.033822608513372,-0.0106119638281432,0.00017591829245928
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,38700,-0.00957557730182356,0.00255716768754203,-0.0145876259694059,-0.00456352863424118,0.000181362169611431
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39106,-0.0215264666327916,0.0057491351182285,-0.0327947714645194,-0.0102581618010637,0.000181565099277867
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,36587,0.00457198470817419,0.00122106130955453,0.00217870454144731,0.00696526487490108,0.000181715248927462
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,39241,-0.00789471993833976,0.00210947635730405,-0.0120292935986557,-0.00376014627802383,0.000182859799673368
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,39106,-0.00593840915485475,0.00158681908880617,-0.00904857456891484,-0.00282824374079466,0.000182987076747765
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39099,0.0413554514746081,0.0110556331855735,0.019686410430884,0.0630244925183321,0.00018420465775034
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRBP,Acrosin-binding protein,36731,0.0130345187668504,0.00348705815350116,0.00619988478598809,0.0198691527477126,0.000186315151103917
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,36430,-0.0111051312569369,0.00297155978180187,-0.0169293884292686,-0.00528087408460523,0.000186950579712115
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REN,Renin,39106,-0.0223219203019377,0.00597765353312712,-0.0340381212268669,-0.0106057193770086,0.000188977362044503
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,36391,0.0123347711808969,0.00330590259099492,0.00585520210254688,0.018814340259247,0.00019146029097453
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN1,CCN family member 1,38994,-0.0253347214090953,0.00680610958753738,-0.0386746962006685,-0.011994746617522,0.00019809239581503
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,38832,-0.0137072995054259,0.00368589343756678,-0.0209316506430568,-0.00648294836779499,0.000200859085878087
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",38741,-0.018155005508761,0.00488666477588191,-0.0277328684694896,-0.00857714254803247,0.000203774560545956
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C19orf12,Protein C19orf12,38741,-0.0219429369181956,0.00591015410966836,-0.0335268389731456,-0.0103590348632456,0.000205765887409381
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EREG,Proepiregulin,38951,0.0268352928246687,0.00723421061838578,0.0126562400126326,0.0410143456367049,0.000208415105488565
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,39241,-0.022381061886945,0.00604377920318986,-0.0342268691251972,-0.0105352546486929,0.000213677707125718
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRK1,Protein BRICK1,38741,0.014952250276437,0.0040399683925552,0.00703391222702876,0.0228705883258451,0.000215457161453604
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,36420,0.0194503211388521,0.00527888967248016,0.00910369738079097,0.0297969448969132,0.00023007189085115
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,38948,-0.00922192438383603,0.00250302069735579,-0.0141278449506534,-0.00431600381701868,0.000230117599615262
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,36767,0.0260446304391067,0.00707145704021267,0.0121845746402899,0.0399046862379235,0.000231388025686492
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD160,CD160 antigen,39291,0.0148669629398017,0.00403970871992546,0.00694913384874781,0.0227847920308556,0.000233838432812381
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,39283,0.0100191758593389,0.00272750926215414,0.00467325770551678,0.015365094013161,0.000240173533488341
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPS,Colipase,39071,0.0229551297308104,0.00624909611146268,0.0107069013523435,0.0352033581092773,0.000240210406760059
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,36747,-0.0101591384853004,0.00276566933860232,-0.0155798503889609,-0.00473842658163984,0.000240405762184685
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,36430,0.0199940223011542,0.0054446561074806,0.00932249633049228,0.0306655482718162,0.00024144141024661
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPR,Nucleoprotein TPR,36391,-0.0157462038108616,0.00429150559433049,-0.0241575547757493,-0.00733485284597379,0.00024436154679799
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,36796,0.0242324512338251,0.00662066181146837,0.0112559540833471,0.0372089483843031,0.000253095231663337
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",38727,-0.0275396435643151,0.00752659950992586,-0.0422917786037698,-0.0127875085248604,0.000254101140775215
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,39162,0.0282789501622984,0.00775528798344465,0.0130785857147469,0.0434793146098499,0.000266812769298713
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,36747,-0.0215330620666696,0.00591243825585534,-0.0331214410481461,-0.00994468308519317,0.000271595574816806
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN4,Cerebellin-4,39255,-0.010170934757746,0.00279581977151026,-0.0156507415099061,-0.00469112800558585,0.00027575985324812
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,36796,0.00717520760459831,0.00197524515128478,0.00330372710808014,0.0110466881011165,0.00028170268090712
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2,Brorin,38924,0.0126195235916186,0.00347676180432547,0.00580507045514072,0.0194339767280966,0.000284715359639757
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,39046,0.0110282438914748,0.00304828173787169,0.00505361168524632,0.0170028760977033,0.000298017620108619
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CX3CL1,Fractalkine,38987,0.0108225671915088,0.00299225958918149,0.00495773839671309,0.0166873959863045,0.000299175318944386
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,38841,-0.0231991444322222,0.00642743040112842,-0.0357969080184339,-0.0106013808460105,0.000307910921934479
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,36792,0.01113648514249,0.00308547992912925,0.00508894448139667,0.0171840258035833,0.000308160086121582
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA4,Laminin subunit alpha-4,39162,0.0110138463658249,0.00305260122070605,0.00503074797324101,0.0169969447584087,0.000309526117451132
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,35989,-0.0354787714858487,0.00983958863852372,-0.0547643652173552,-0.0161931777543423,0.000312541432628553
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL27,C-C motif chemokine 27,39106,-0.020279849207255,0.00562537677478862,-0.0313055876858407,-0.00925411072866932,0.000313070054152729
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS2,Trypsin-2,39165,-0.0167113683802284,0.00463640742506843,-0.0257987269333625,-0.00762400982709428,0.000313893864405209
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,36391,-0.0222931966687008,0.00619145675611862,-0.0344284519106933,-0.0101579414267083,0.000318663230438383
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4R,Reticulon-4 receptor,39255,-0.0107812041287223,0.00299490482690441,-0.0166512175894549,-0.00491119066798962,0.000319402646938451
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,39147,-0.00862707696173167,0.00239863208473695,-0.0133283958478161,-0.00392575807564725,0.000323339003107866
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22,Interleukin-22,36731,-0.0212131364681535,0.00589795424713999,-0.0327731267925479,-0.00965314614375914,0.000323494492963518
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,36538,0.011672383884924,0.00324575494203458,0.00531070419853621,0.0180340635713118,0.000324126903495518
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM17,Splicing factor 45,36767,0.0249253965085994,0.00694377062751143,0.011315606078677,0.0385351869385218,0.000332406857619836
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTBS,Di-N-acetylchitobiase,36657,-0.00890165576919434,0.00248044738620843,-0.0137633326461629,-0.00403997889222582,0.000333534398251344
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39093,0.0117358965625288,0.00327064506513201,0.00532543223487002,0.0181463608901875,0.000333947471708999
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG6,Large proline-rich protein BAG6,38832,-0.0120132790757805,0.00336072545425364,-0.0186003009661177,-0.0054262571854434,0.000351855345131413
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,36747,-0.00865120457749457,0.00242505175204981,-0.0134043060115122,-0.00389810314347694,0.00036180641699828
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALY,RNA-binding protein Raly,36731,-0.0157243179366129,0.00441040798804739,-0.0243687175931858,-0.00707991828004007,0.000364792168077412
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39099,0.0264233035868452,0.00742444331099595,0.0118713946972931,0.0409752124763972,0.000373457037306129
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,36679,0.00863510093657079,0.00242693332014927,0.00387831162907821,0.0133918902440634,0.000374996556059356
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG4A,Cysteine protease ATG4A,38727,-0.0189584729811359,0.0053291576690891,-0.0294036220125506,-0.00851332394972128,0.00037556770501776
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39093,0.038206562697041,0.0107490361787713,0.0171384517866494,0.0592746736074327,0.000379964101623956
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,36702,-0.0154977698112251,0.00436061524474243,-0.0240445756909203,-0.00695096393152993,0.000380733852481852
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,36391,-0.0216852973745891,0.00610342185750183,-0.0336480042152927,-0.00972259053388554,0.000382302473109635
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH17,Protocadherin-17,39106,-0.0112412255834917,0.00316684030438875,-0.0174482325800937,-0.00503421858688979,0.000386880980959362
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG3,Desmoglein-3,39191,-0.0107128865273945,0.00301815167747361,-0.0166284638152428,-0.00479730923954623,0.000387139301256051
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFP,Properdin,36806,0.00746063040429122,0.00210385742316069,0.00333706985489627,0.0115841909536862,0.000392258519101426
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLF4,Krueppel-like factor 4,36363,-0.0127354967965744,0.00359540164921573,-0.0197824840290372,-0.00568850956411157,0.000398306241998741
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,39106,-0.00896664918851093,0.00253322756956286,-0.0139317752248541,-0.00400152315216771,0.000401905103377483
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,38987,-0.0236540765208699,0.00670461249037239,-0.0367951170019998,-0.01051303603974,0.000419905379934653
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,39099,0.0105794468216947,0.00299968380823225,0.00470006655755948,0.0164588270858299,0.00042176467571434
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYT1,Synaptotagmin-1,36747,0.0119053708036949,0.00337581028046665,0.00528878265398026,0.0185219589534095,0.000422282647583546
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,39283,0.0228489271028614,0.00649273216235816,0.0101231720646394,0.0355746821410834,0.000434171737538491
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD209,CD209 antigen,39124,0.0122702037590879,0.00350184355340812,0.00540659039440797,0.0191338171237678,0.000459764182509009
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX,Glutaredoxin-1,39013,-0.0177611676338148,0.00507035630662477,-0.0276990659947994,-0.00782326927283028,0.00046147452499684
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDCP1,CUB domain-containing protein 1,38987,-0.0158165675002922,0.00451880088319917,-0.0246734172313625,-0.0069597177692218,0.000466301308134614
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200,OX-2 membrane glycoprotein,39099,0.00813340164927706,0.00232838137374824,0.00356977415673051,0.0126970291418236,0.000478699484266583
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,36391,0.0227778990143962,0.00653047901494327,0.00997816014510737,0.035577637883685,0.000488432527172338
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,36538,-0.0177010776694747,0.00508613847009377,-0.0276699090708585,-0.0077322462680909,0.000502614234980784
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,36767,-0.0175373878818852,0.00504081059229311,-0.0274173766427797,-0.00765739912099071,0.000504796343034463
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,39283,0.00673178286094918,0.00193922161999602,0.00293090848575698,0.0105326572361414,0.000519200393591643
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,36500,-0.016714495498483,0.00481842416393677,-0.0261586068597991,-0.00727038413716696,0.000524390179244075
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,36743,-0.0153296937596941,0.00442592741642063,-0.0240045114958785,-0.00665487602350962,0.000534707714105288
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,38727,-0.0259424775415632,0.00749222661054499,-0.0406272416982314,-0.011257713384895,0.000536516322223863
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39023,-0.0168447724210004,0.00487125035663563,-0.0263924231200062,-0.00729712172199455,0.000545699665727062
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVALB,Parvalbumin alpha,39198,0.0356474541807155,0.0103128608275726,0.0154342469586732,0.0558606614027579,0.000548514340115931
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN2,Dynactin subunit 2,39023,-0.029678609692831,0.00860781091926762,-0.0465499190945955,-0.0128073002910664,0.000566560606794872
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLA,Alpha-galactosidase A,36466,-0.011821906120473,0.0034296776279279,-0.0185440742712117,-0.00509973796973434,0.000568816264764834
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,36765,0.0150677697481634,0.00437977529879702,0.00648341016252127,0.0236521293338056,0.000582894158229735
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QL2,Complement C1q-like protein 2,36430,0.013072339625231,0.00380240048372163,0.00561963467713664,0.0205250445733254,0.000588105420708485
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMH,Granzyme H,38832,0.0234167449748971,0.00683509045475356,0.0100199676835801,0.036813522266214,0.000614275917654222
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",36420,0.0270646075132268,0.00790439659932717,0.0115719901785456,0.0425572248479081,0.000619050577977309
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39023,0.0293089247150455,0.00857716581893297,0.0124976797099369,0.0461201697201541,0.000634611536940121
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,36747,0.0202086402013929,0.00592182766594522,0.00860185797614031,0.0318154224266456,0.000645517009092622
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,38832,-0.0174643948007303,0.00511967684122531,-0.0274989614095319,-0.0074298281919287,0.000648414031772636
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA9,Serpin A9,38950,-0.0224705742154775,0.0065897452721585,-0.0353864749489082,-0.00955467348204686,0.000651495056234287
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,39147,0.0171224347491769,0.00502600862375307,0.00727145784662083,0.0269734116517329,0.000659067646706715
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTPN,Myotrophin,38832,0.00996508097984749,0.00292548573934218,0.00423112893073681,0.0156990330289582,0.000660229181218615
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL25,C-C motif chemokine 25,39291,-0.0152989724226151,0.00449304656738781,-0.0241053436946953,-0.00649260115053504,0.000663244735213312
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF23,Fibroblast growth factor 23,39234,-0.0178029293157034,0.00524093399712992,-0.028075159950078,-0.00753069868132871,0.00068326473656941
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAX,Protein max,38741,0.0324440231418148,0.00955458134597807,0.0137170437036978,0.0511710025799318,0.000686445418267979
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,38987,0.0127191948709157,0.00374916346379141,0.00537083448188449,0.0200675552599468,0.000694247133527906
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB3,Plexin-B3,39051,0.0146196031343764,0.00431330657967437,0.00616552223821463,0.0230736840305382,0.000702189944154643
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OBP2B,Odorant-binding protein 2b,38942,0.019282926743698,0.0056908167821974,0.00812892585059114,0.030436927636805,0.00070474139221877
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",38994,-0.022946670125959,0.00677794850542835,-0.0362314491965985,-0.00966189105531942,0.000712321148795871
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,36767,0.0350933516981733,0.0103724458602875,0.0147633578120098,0.0554233455843368,0.000718268339371039
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39023,0.0214149972639106,0.00633326204408303,0.00900180365750789,0.0338281908703134,0.000723118232385593
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,36430,-0.0169193978427203,0.00501427737369473,-0.026747381495162,-0.00709141419027867,0.00074242311564495
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNC,Tenascin,39165,0.0143881622748154,0.00426662321112931,0.00602558078100191,0.0227507437686288,0.000747386992634269
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",38987,0.0175590011918864,0.00520991746962178,0.00734756295142767,0.0277704394323451,0.000752732702489678
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR,GMP reductase 1,39291,-0.015017767489497,0.00445905500265019,-0.0237575152946914,-0.00627801968430262,0.000759210507969894
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A16,Protein S100-A16,38713,-0.0188030879889771,0.0055836986551135,-0.0297471373529996,-0.00785903862495467,0.00076046436781619
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GLB2,Endophilin-B2,36747,-0.0201628491209739,0.0059919299759421,-0.0319070318738205,-0.00841866636812743,0.000767668049325817
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,36430,0.00863062711279395,0.00256543404577176,0.00360237638308129,0.0136588778425066,0.000769960214298544
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,38727,-0.0160099611194088,0.00476474262294353,-0.0253488566603781,-0.00667106557843949,0.000781132618941535
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,39071,0.010753444174057,0.0032007402063885,0.00447999336953549,0.0170268949785784,0.000782262157487864
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF1,Trefoil factor 1,39029,-0.0227820170018834,0.00678331674056814,-0.0360773178133969,-0.00948671619036982,0.000785492163470885
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,36743,0.0271130296164476,0.00807745415578281,0.0112812194711133,0.0429448397617819,0.000791266439813897
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,36767,-0.0145857734378932,0.00434823411805259,-0.0231083123092762,-0.00606323456651009,0.000797625685474097
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,39099,-0.0279126291247221,0.00833237250053993,-0.0442440792257803,-0.0115811790236638,0.00081036397204305
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,39106,-0.0105351195015477,0.00315077390923304,-0.0167106363636445,-0.004359602639451,0.000828798904761491
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,36391,0.0123029523206709,0.00368016744881908,0.0050898241209855,0.0195160805203563,0.000831082397736524
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WIF1,Wnt inhibitory factor 1,39255,0.0101234099656838,0.00302906433382109,0.00418644387139445,0.0160603760599731,0.000833476655195343
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",36391,0.0257440618262468,0.00771394875193223,0.0106247222724596,0.040863401380034,0.000848309076901845
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,38939,-0.00896333500585323,0.00268813636600352,-0.0142320822832201,-0.00369458772848633,0.000856881882305999
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP9,Matrix metalloproteinase-9,39079,0.0182238355619088,0.00548293077756771,0.00747729123787606,0.0289703798859415,0.000890286290953729
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,39147,0.00811766583950137,0.00244341646828615,0.00332856956166052,0.0129067621173422,0.000895007658073395
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39101,-0.017277638777272,0.00520208078488492,-0.0274737171156465,-0.00708156043889757,0.000898117434166045
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRH,Corticoliberin,38706,0.0260948145658916,0.00785703299158439,0.0106950299023862,0.041494599229397,0.000898460300241419
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMVK,Phosphomevalonate kinase,38733,0.0331490449736264,0.00998780702089733,0.0135729432126676,0.0527251467345852,0.000905732421345579
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,38727,-0.0120078127501053,0.00361996628038485,-0.0191029466596596,-0.00491267884055102,0.00091173150941151
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XG,Glycoprotein Xg,39219,0.0090330452718802,0.00272348333586948,0.00369501793357603,0.0143710726101844,0.000912905513193415
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,39255,-0.0179282197126398,0.00541125732752072,-0.0285342840745804,-0.00732215535069919,0.000924695339861993
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF8,SLAM family member 8,38727,0.0156146774756648,0.00471458126223406,0.0063740982016861,0.0248552567496436,0.000928535326220121
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",36767,0.0130017808330277,0.00392686780632465,0.00530511993263142,0.020698441733424,0.000932249405590286
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIFBP,KIF-binding protein,39023,0.0248480021505007,0.00750677592069385,0.0101347213459408,0.0395612829550607,0.000934880890482133
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,36747,-0.0137573854763291,0.00416268341838307,-0.0219162449763599,-0.00559852597629826,0.000952587626129879
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPA1,Inositol monophosphatase 1,38987,0.0183183953538709,0.005551728806885,0.00743700689237628,0.0291997838153655,0.000970520414283912
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,36747,-0.0229712114451219,0.00696465004528392,-0.0366219255338783,-0.00932049735636538,0.00097550329186836
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GET3,ATPase GET3,36792,-0.0166611977345094,0.00505624685420991,-0.0265714415687609,-0.006750953900258,0.000986264549868064
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,36391,0.00970453580647922,0.00294721552163692,0.00392799338407087,0.0154810782288876,0.000994763473390551
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,39023,0.00940839521153395,0.00286009840748727,0.0038026023328589,0.015014188090209,0.00100581682118879
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO1,Alpha-enolase,39069,0.0234789769857073,0.00714127493836865,0.00948207810650477,0.0374758758649099,0.00101207965477678
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,36731,-0.0205016882972068,0.00623786873916541,-0.032727911025971,-0.00827546556844259,0.00101658381699477
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBC,Inhibin beta C chain,39093,-0.0122193318244136,0.00372060733184611,-0.019511722194832,-0.00492694145399523,0.00102491951166017
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,39045,0.0338452063750262,0.0103199792740682,0.0136180469978526,0.0540723657521999,0.00104195442105619
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39099,0.0273446732882408,0.00836565367247035,0.0109479920901989,0.0437413544862827,0.00108288525349534
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,39197,0.0123110234976953,0.00376884954289933,0.00492407839361258,0.019697968601778,0.00109117110873712
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",38841,0.0214298656619104,0.00656046349087488,0.00857135721979563,0.0342883741040252,0.00109124054993973
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAN,Aggrecan core protein,38974,0.00830991824317774,0.00254473436365751,0.00332223889040903,0.0132975975959464,0.00109500846636398
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39052,0.017355733519215,0.00531499276218049,0.00693834770534121,0.0277731193330887,0.00109540277210158
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARFIP1,Arfaptin-1,36767,0.020528995026612,0.00629287680988013,0.00819495647924691,0.032863033573977,0.00110815119238993
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,36507,-0.0192519810975909,0.00591095707993983,-0.0308374569742729,-0.00766650522090879,0.00112893530670789
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN1,Tetraspanin-1,38832,-0.0119032136649261,0.00365702808896622,-0.0190709887192999,-0.00473543861055229,0.00113689289458674
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST5,Cystatin-D,38807,-0.0159513623866775,0.0049035435888476,-0.0255623078208188,-0.00634041695253621,0.00114435819507393
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,36500,0.0351234085779722,0.0107984816536074,0.0139583845369016,0.0562884326190428,0.0011464436032378
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAYN,Layilin,38951,-0.00941953110425787,0.00290504186814861,-0.0151134131658292,-0.00372564904268659,0.0011875290653921
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",38951,0.0282454106874356,0.0087270550755355,0.011140382739386,0.0453504386354852,0.00121251792046426
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL18,C-C motif chemokine 18,38963,0.0206041123373993,0.00639254191846935,0.00807473017719937,0.0331334944975992,0.00127058904715002
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L,Seizure 6-like protein,39147,0.00786205367304566,0.00243990545569567,0.00307983897988215,0.0126442683662092,0.00127442109539764
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM106A,Transmembrane protein 106A,36731,0.0207020658407606,0.00646153365824306,0.00803745987060418,0.033366671810917,0.00135912962087326
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX1,Neuronal pentraxin-1,39093,-0.0118510342329304,0.00370384740614861,-0.0191105751489817,-0.00459149331687912,0.00137873990043585
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJP3,Tight junction protein ZO-3,36363,0.0127250797249312,0.00397721335058795,0.0049297415577788,0.0205204178920836,0.0013801148444752
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSN,Gelsolin,36737,0.00540223702067444,0.00169000514833417,0.00208982692993947,0.00871464711140941,0.00139402995762078
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,36430,-0.0149237247447624,0.00467007636288874,-0.0240770744160243,-0.00577037507350044,0.0013988227083813
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,39069,-0.00501003060151591,0.00157102396732606,-0.008089237577475,-0.00193082362555683,0.00143044143165528
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUS,RNA-binding protein FUS,38706,-0.0113342115649615,0.00355692180048948,-0.0183057782939209,-0.00436264483600214,0.00144292366952637
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,39095,0.00978403085796951,0.00307135705520757,0.00376417102976266,0.0158038906861764,0.00144758983770917
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSB,Cathepsin B,39085,0.0146439582591819,0.00459893678108717,0.00563004216825102,0.0236578743501127,0.00145444330654345
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG4,Regenerating islet-derived protein 4,39117,-0.0135138020818504,0.00424901298076342,-0.0218418675241467,-0.00518573663955413,0.00147337223049248
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,38741,-0.0110042940168296,0.00346017394561454,-0.0177862349502341,-0.00422235308342515,0.00147438625780573
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,36792,-0.00768063334503115,0.0024190308276449,-0.0124219337672152,-0.00293933292284714,0.00150142937002632
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,39241,0.0203285464594691,0.00641292412822441,0.00775921516814923,0.0328978777507889,0.00152772424226927
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTC,Probetacellulin,38727,0.0211752890399896,0.00668900183537582,0.00806484544265304,0.0342857326373262,0.00155029168276659
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN2,Alpha-actinin-2,36391,-0.0169754321369579,0.00537034290881747,-0.0275013042382401,-0.00644956003567564,0.00157625256761373
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY4,Protein canopy homolog 4,39023,0.0216133632997522,0.00685023199097957,0.00818690859743222,0.0350398180020721,0.00160740881410059
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",36391,0.0161000028791067,0.00510964732648362,0.00608509411919883,0.0261149116390146,0.00163149638612225
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,36791,0.0235416693832716,0.00747413796816084,0.00889235896567639,0.0381909798008669,0.00163782169729668
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,39241,0.0126844662077957,0.00403567395923807,0.00477454524768913,0.0205943871679023,0.00167494896349993
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",39162,0.0312941384739268,0.00996068674117165,0.0117711924612303,0.0508170844866232,0.0016825286404755
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1B,Lithostathine-1-beta,39283,-0.0154246044415911,0.00490989050824084,-0.0250479898377431,-0.00580121904543903,0.00168381204451403
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39204,-0.029360773183125,0.00934610791610281,-0.0476791446986865,-0.0110424016675635,0.00168405836200031
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSG,Basigin,39274,-0.00551684241416283,0.00175675637989541,-0.00896008491875783,-0.00207359990956782,0.00169060858907549
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAP,Prolyl endopeptidase FAP,39283,-0.00775016844223234,0.00246874211634887,-0.0125889029902761,-0.00291143389418855,0.00169660552055907
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,36792,-0.0161152475042985,0.00513631575131479,-0.0261824263768754,-0.00604806863172147,0.00170771377365151
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH9,Myosin-9,36791,-0.031639350953454,0.0100881177202814,-0.0514120616852057,-0.0118666402217024,0.00171478424378174
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,39128,0.00637189458324519,0.00203400641976657,0.00238524200050271,0.0103585471659877,0.00173544700595554
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,36718,0.0102082295675543,0.00326248466304898,0.00381375962797831,0.0166026995071303,0.00175809996131676
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUCB2,Nucleobindin-2,39222,0.0106290435548356,0.00339850803173183,0.00396796781264117,0.0172901192970299,0.00176592045714667
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,36792,0.00806335384966995,0.00258137885959536,0.00300385128486305,0.0131228564144768,0.00179010327586817
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK1,Dickkopf-related protein 1,39241,0.0168710719628587,0.00540298525333788,0.00628122086631642,0.0274609230594009,0.00179626369418551
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSHB,Thyrotropin subunit beta,39106,0.0210986690816081,0.00676218025949536,0.00784479577299717,0.034352542390219,0.00181127799536483
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF4,Neurotrophin-4,38727,0.0112355744629592,0.00360248759796557,0.00417469877094667,0.0182964501549717,0.00181912738464212
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADD1,Alpha-adducin,36500,-0.0194438299598535,0.0062448550515377,-0.0316837458608674,-0.0072039140588396,0.00185247761968138
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL16,C-C motif chemokine 16,39283,-0.0146404099508099,0.00470598778474513,-0.0238641460089103,-0.00541667389270942,0.00186784115198871
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EEF1D,Elongation factor 1-delta,36792,-0.0257058539801703,0.00826368017205879,-0.0419026671174055,-0.00950904084293502,0.00187048631033032
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY6D,Lymphocyte antigen 6D,38998,0.0101521182669285,0.00326734601494414,0.00374812007763795,0.016556116456219,0.0018925318220802
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,36767,-0.0106602253594824,0.0034382715626334,-0.0173992376222439,-0.00392121309672094,0.00193636018427963
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,38987,0.010775482031636,0.00347832753190265,0.00395796006910682,0.0175930039941652,0.00195259614593024
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM25,Transmembrane protein 25,36767,-0.012552357647149,0.00405493782936165,-0.0205000357926979,-0.0046046795016002,0.00196853301983894
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,38987,0.00937169271889617,0.00303337319501187,0.0034262812566729,0.0153171041811194,0.00200838083924273
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300E,CMRF35-like molecule 2,39221,0.0107177633828566,0.00347543842449997,0.00390590407083667,0.0175296226948766,0.00204696618200252
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH12,Protocadherin-12,36767,-0.00706054659180459,0.00229285043164368,-0.0115545334378262,-0.00256655974578298,0.00207870946608441
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,38832,0.0059679809687503,0.00194295814152317,0.00215978301136489,0.00977617892613571,0.00213300122170453
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,36747,-0.00613733324636679,0.00199839292915746,-0.0100541833875154,-0.00222048310521817,0.00213691301142002
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,36747,-0.0245066911472083,0.00799160783952384,-0.0401702425126751,-0.00884313978174162,0.0021699077630267
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",36743,0.028413212969012,0.0092696420849018,0.0102447144826045,0.0465817114554195,0.00217981866561154
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,38727,-0.0137309800292634,0.00448012667688425,-0.0225120283159565,-0.0049499317425703,0.00218159027035433
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,38841,0.013277296890237,0.00433355618632236,0.00478352676504521,0.0217710670154289,0.00218908196514215
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",38705,0.0130122568642475,0.00425232887715041,0.00467769226503269,0.0213468214634623,0.00221709165141588
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAXX,Protein PAXX,36500,-0.0127631196082512,0.00417431377721172,-0.0209447746115862,-0.00458146460491626,0.00223630203290794
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB1,Beta-crystallin B1,36792,0.0184255351544062,0.00602753632695575,0.00661156395357295,0.0302395063552395,0.00224100250420288
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,39106,-0.0107894015118789,0.00353212379060985,-0.0177123641414742,-0.0038664388822836,0.0022571230892765
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLC,Galectin-10,39079,0.0183300620039196,0.00600201045359992,0.00656612151486377,0.0300940024929755,0.00226212007001948
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVPL,Envoplakin,36538,0.00910900866243121,0.0029826540461416,0.00326300673199367,0.0149550105928688,0.00226284706849032
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,36767,0.0275250248992075,0.00902247802954498,0.00984096796129934,0.0452090818371157,0.00228759128480764
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL17,C-C motif chemokine 17,39069,0.0249173757050297,0.00816988081355167,0.00890440931046842,0.040930342099591,0.00229306150082399
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB2,Integrin beta-2,38976,0.00789976242105402,0.00259035441374649,0.0028226677701109,0.0129768570719971,0.00229478689188146
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,38727,0.0211942901794388,0.00696343800138309,0.00754595169672794,0.0348426286621497,0.0023413269773914
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,38973,-0.0091962266458235,0.00302541253664403,-0.0151260352176458,-0.00326641807400121,0.00237250093359677
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,36391,-0.00982956574625251,0.0032349685954103,-0.0161701041932567,-0.00348902729924833,0.00238221086096845
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,39106,-0.00896146791780879,0.0029587910580616,-0.0147606983916095,-0.00316223744400806,0.00245970541167587
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,39099,-0.0236494381360132,0.0078109053568505,-0.0389588126354402,-0.00834006363658621,0.00246796920486258
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,39106,-0.0171429817575381,0.00566516395817581,-0.0282467031155627,-0.00603926039951348,0.00248197204542403
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,36791,0.0168575370752942,0.00557959626077276,0.00592152840417958,0.0277935457464088,0.0025219841194938
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,36767,0.0208411510345384,0.00691992104419367,0.00727810578791883,0.034404196281158,0.00260239572243909
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BEX3,Protein BEX3,36339,0.012851128443245,0.0042671482835504,0.00448751780748619,0.0212147390790038,0.00260358031613268
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOB,Apolipoprotein B-100,36796,0.00616594635047235,0.00205049483917087,0.00214697646569744,0.0101849162352473,0.00264300600746288
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,36391,-0.00953983304879513,0.00317501466493276,-0.0157628617920633,-0.00331680430552692,0.00266405363068674
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,38987,-0.0144910573252335,0.0048277071988138,-0.0239533634349086,-0.00502875121555848,0.00268964352502726
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRL,Appetite-regulating hormone,39106,0.0208062453780027,0.00693823585371398,0.00720730310472332,0.0344051876512821,0.00271499963721398
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,38644,0.0158608823860873,0.005293375917134,0.00548586558850466,0.0262358991836699,0.00273673099376637
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,39162,-0.00759630675759377,0.00253812734833866,-0.0125710363603375,-0.00262157715484999,0.00276800802408838
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2,Prothrombin,36806,0.00397522340937854,0.00132846317633442,0.00137143558376308,0.00657901123499401,0.00277362906545952
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,36767,-0.0093382641126463,0.00312429670153582,-0.0154618856476565,-0.00321464257763609,0.00280495207084146
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3C,Protein FAM3C,39086,-0.00778316114433367,0.00261765952696972,-0.0129137738171943,-0.00265254847147301,0.0029505050566709
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C5,Complement C5,36806,0.00410118745692454,0.00138077048787449,0.00139487730069054,0.00680749761315853,0.00298135874566165
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,36538,0.0194746516501802,0.00656848207269459,0.00660042678769878,0.0323488765126616,0.00303381102557461
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,36391,0.0102216855990824,0.00344930429115086,0.00346104918842671,0.0169823220097381,0.00304827934896135
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,36430,-0.0096003762524633,0.00323980043540953,-0.015950385105866,-0.00325036739906063,0.0030496810947116
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",36391,0.0116309375081748,0.00392613640227697,0.00393571015971193,0.0193261648566377,0.00305785901258496
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39093,0.00935875987109382,0.00316516679603114,0.00315503295087279,0.0155624867913149,0.00311328151546259
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL1,Fc receptor-like protein 1,39106,0.0117384305569038,0.00397009467286594,0.00395704499808652,0.019519816115721,0.00311413842302164
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRSF1,G-rich sequence factor 1,36258,0.0217120855505251,0.00734314581365448,0.00731951975576228,0.0361046513452879,0.00311453127941555
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,36420,-0.0110117046978836,0.00372993353873602,-0.0183223744338063,-0.00370103496196104,0.00316048709933859
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JCHAIN,Immunoglobulin J chain,38841,0.0160799777637869,0.00545591254477021,0.00538638917603733,0.0267735663515365,0.00321100544548735
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,39098,0.00703622558356427,0.00238746356515694,0.00235679699585667,0.0117156541712719,0.00321198161485126
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,36391,0.0180932450763453,0.00614830648003307,0.00604256437548044,0.0301439257772101,0.00325853088511173
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UMOD,Uromodulin,39244,0.0140412896382978,0.00477257340223356,0.00468704576992005,0.0233955335066756,0.00326502599601889
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,36391,-0.00974399363629075,0.00331311046267685,-0.0162376901431374,-0.00325029712944412,0.00327709464758563
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,39162,0.0175833258367964,0.00598162814458999,0.00585933467340007,0.0293073170001928,0.00329175055860275
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,36391,0.00537646451790973,0.00182913524555489,0.00179135943662215,0.00896156959919731,0.00329504073583349
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,39099,0.0122290744002397,0.00416312609323073,0.00406934725750744,0.0203888015429719,0.00331393348130683
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,36538,0.0196450007146674,0.00670480888954596,0.00650357529115729,0.0327864261381775,0.00339580914175814
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,38727,-0.0177949649518507,0.00608959412825393,-0.0297305694432284,-0.005859360460473,0.0034810022519467
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39118,0.0128755236624758,0.00441155694306471,0.00422887205406898,0.0215221752708827,0.00352132489973427
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,39165,0.00794000437733085,0.00272414164877316,0.00260068674573546,0.0132793220089262,0.00356567977519695
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SATB1,DNA-binding protein SATB1,36767,-0.00785311689481906,0.00269461612559908,-0.0131345645009933,-0.00257166928864486,0.00357015772662444
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,36430,-0.0148860463799773,0.00510816312464891,-0.0248980461042891,-0.00487404665566538,0.00357266562065762
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA2,Annexin A2,36261,-0.0184340059343203,0.00632769514351165,-0.0308362884156031,-0.00603172345303749,0.00358354202015484
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSNAX,Translin-associated protein X,36391,-0.0103667080215858,0.00356754700940131,-0.0173591001600124,-0.00337431588315926,0.00366914002657869
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,36420,-0.00858244169896127,0.00295790366357178,-0.014379932879562,-0.00278495051836059,0.00371992051068389
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,36747,-0.012430894732518,0.00428910042305036,-0.0208375315616967,-0.00402425790333935,0.00375881359650672
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",36391,0.0131627309027954,0.00454499694560032,0.00425453688941876,0.022070924916172,0.00378494540116036
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,36500,-0.00736362818375578,0.00254399822930754,-0.0123498647131986,-0.002377391654313,0.00380400577518591
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB2,Carboxypeptidase B2,36779,0.00591308010428578,0.00204396838447814,0.00190690207070862,0.00991925813786294,0.00382290477832579
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",39070,0.0142225054997275,0.00491668196750024,0.00458580884342703,0.023859202156028,0.00382482850897853
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,36792,0.0257593768913955,0.00892336408451127,0.00826958328575347,0.0432491704970376,0.00389908000525849
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,39099,-0.0148268097749004,0.00513777493231313,-0.0248968486422342,-0.00475677090756669,0.00390915255597152
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,39099,0.0136583140477051,0.00474275264675548,0.00436251886006432,0.0229541092353458,0.00398445871463602
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,36767,0.0331205032027521,0.0115067122989691,0.0105673470967727,0.0556736593087315,0.00400400252185338
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39117,0.00764315417360369,0.0026557831289921,0.00243781924077917,0.0128484891064282,0.00400851386373552
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,36500,-0.00827891489571952,0.00288107619076575,-0.0139258242296204,-0.00263200556181864,0.0040656388117901
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA4,Annexin A4,39025,0.0188525458067692,0.00656102726501516,0.0059929323673395,0.0317121592461989,0.00406625805607447
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,36500,0.0229546125715304,0.00798907168880247,0.00729603206147757,0.0386131930815833,0.00406947224653521
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,36731,0.0148445366271525,0.0051700649418227,0.00471120934118002,0.024977863913125,0.00409522241579278
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,36421,0.00829775720508224,0.00289543656739945,0.00262270153297931,0.0139728128771852,0.00416640780629673
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,36421,-0.0178386332952335,0.00622829143714493,-0.0300460845120376,-0.00563118207842947,0.00418849884939874
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,36767,0.0123737939959152,0.00432068970577093,0.00390524217260414,0.0208423458192262,0.00419204852660977
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB9,Serpin B9,38987,0.00861650563466906,0.00300943611635599,0.00271801084661132,0.0145150004227268,0.00420011309004385
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",36747,-0.00995502764130467,0.00347912001059127,-0.0167741028620636,-0.00313595242054578,0.00422501746378125
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",38832,0.0241275327992423,0.00844514189400672,0.00757505468698911,0.0406800109114955,0.00428292914658145
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,39106,-0.00818342780061081,0.00286500219331672,-0.0137988320995116,-0.00256802350171004,0.00429131699869978
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,38987,0.0205057603666993,0.00719239075914709,0.00640867447877102,0.0346028462546276,0.00436360903613524
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK4,Kallikrein-4,39255,0.0154801879319474,0.00543606980268981,0.00482549111867538,0.0261348847452194,0.00440974699857363
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,39234,-0.0120026429396356,0.00422195390134515,-0.020277672586272,-0.00372761329299908,0.00447623344189546
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39023,-0.0251800000650885,0.00886053880307901,-0.0425466561191234,-0.00781334401105363,0.00449175537410261
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,38841,-0.0110586108110564,0.00389595358147647,-0.0186946798307503,-0.00342254179136254,0.00453890204927491
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APP,Amyloid-beta precursor protein,39067,0.0170723099476219,0.00602814602619768,0.00525714373627442,0.0288874761589693,0.00463042045118757
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,38987,-0.0120214855252541,0.00425675773608027,-0.0203647306879715,-0.00367824036253682,0.00474764163170199
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAB2,Disabled homolog 2,39255,0.0284767009968978,0.010085742217456,0.00870864625068392,0.0482447557431116,0.00475691726612829
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTF1,Cardiotrophin-1,38832,0.0216884530693327,0.00768715361178477,0.00662163199023456,0.0367552741484309,0.00478790822362467
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,39241,-0.00713609293707579,0.00252991210248977,-0.0120947206579557,-0.00217746521619584,0.00479821234431727
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST1,Cystatin-SN,35080,-0.0258282742025311,0.0091564337868551,-0.0437748844247671,-0.00788166398029515,0.00479913262424925
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,36430,-0.0122329714592135,0.00434067994392367,-0.0207407041493039,-0.00372523876912308,0.00483668058948996
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG2,Bone marrow proteoglycan,36791,0.012898411221981,0.00458270480298602,0.00391630980812838,0.0218805126358336,0.00489140928798374
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL1,Delta-like protein 1,39147,0.00723920655911355,0.00257211338206509,0.00219786433026597,0.0122805487879611,0.00489159982703068
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39086,0.0080444733840483,0.00285845020161991,0.00244191098887328,0.0136470357792233,0.00489496466396541
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA6,Carbonic anhydrase 6,39058,-0.0161686118438777,0.00574812937587458,-0.0274349454205919,-0.00490227826716356,0.00491679086142582
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,38727,-0.0129916448569938,0.00462092420796358,-0.0220486563046024,-0.00393463340938518,0.00493784144200313
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,38841,0.00935055616057699,0.00332624884397477,0.00283110842638644,0.0158700038947675,0.00494301708431643
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39136,-0.0128796852116492,0.00459042299553233,-0.0218769142828926,-0.00388245614040586,0.00502595091371931
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,38727,0.011959763285731,0.00426809860779496,0.00359429001445284,0.0203252365570091,0.00508322134851556
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGFR,Opioid growth factor receptor,39023,-0.00827733224696475,0.00295677723179096,-0.014072615621275,-0.00248204887265447,0.00512553870553848
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,36421,-0.0197246786336663,0.00706647831930507,-0.0335749761395043,-0.00587438112782841,0.00525756338858593
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYMP,Thymidine phosphorylase,39006,0.0170812995272412,0.00613234348173638,0.00506190630303794,0.0291006927514446,0.0053520882489943
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLG,Plasminogen,36527,0.0056921348194743,0.00204463310341868,0.00168465393677369,0.00969961570217491,0.00537826845000587
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,38506,-0.0154922414091939,0.00557463159273115,-0.0264185193309469,-0.00456596348744081,0.00545857517096896
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FADD,FAS-associated death domain protein,39106,0.0193435302863972,0.00696082567570922,0.00570031196200715,0.0329867486107873,0.00546078515279276
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,38727,-0.0112147072469028,0.00404190809956614,-0.0191368471220524,-0.00329256737175315,0.00553374001152768
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,38741,-0.0102354123303737,0.00368936922923021,-0.0174665760196649,-0.00300424864108246,0.00553898093855501
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39023,0.0222780325852342,0.00803253736618711,0.00653425934750746,0.0380218058229609,0.00555290627903494
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTD,Deoxycytidylate deaminase,36500,0.0239921363930361,0.00865355569460779,0.00703116723160479,0.0409531055544673,0.00557059335054251
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1F,Protein phosphatase 1F,36792,0.0133710675736871,0.00482950285362937,0.0039052419805735,0.0228368931668006,0.0056374066800884
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA11,Serpin A11,39283,0.0102323710196968,0.00369966236224004,0.00298103278970627,0.0174837092496872,0.00568581937467019
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,39291,0.0104536612670848,0.00378120559613224,0.00304249829866565,0.017864824235504,0.0057053796698497
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36108,0.0272105348500559,0.00986235714838906,0.00788031483921334,0.0465407548608985,0.00580593633198285
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",36767,-0.0156599858463986,0.00570142985125744,-0.0268347883548632,-0.00448518333793405,0.00602858616729339
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39078,-0.00603024411416451,0.00219568018859901,-0.0103337772838186,-0.00172671094451044,0.00603217181576924
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,38979,0.00971986263216088,0.00354822001241697,0.00276535140782361,0.0166743738564982,0.0061630517018222
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC1,Stanniocalcin-1,39241,-0.0103649507044753,0.00378865110278591,-0.0177907068659357,-0.00293919454301495,0.00623022431356813
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,39147,0.0167902959477085,0.00614253417528394,0.00475092896415202,0.028829662931265,0.00627471673189184
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINC1,Antithrombin-III,36779,0.00359493405760177,0.00131692669881446,0.00101375772792543,0.00617611038727811,0.00634604244155324
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39147,-0.0112172568377381,0.00411002782075302,-0.019272911366414,-0.0031616023090622,0.0063552889517946
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,36538,-0.00829763153605171,0.00304360902692107,-0.014263105228817,-0.0023321578432864,0.00641469560919395
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPO,Lactoperoxidase,38602,-0.0146665755105565,0.00538854213231016,-0.0252281180898844,-0.00410503293122855,0.00650021739528197
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,36466,-0.00954627484457177,0.00351008722200483,-0.0164260457997012,-0.00266650388944229,0.00654368415113354
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,36445,0.0083182970199399,0.00305972380776182,0.00232123835672673,0.0143153556831531,0.00656401177907632
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,38832,0.0276208429291295,0.0101648977071029,0.00769764342320786,0.0475440424350511,0.00658971655402587
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,39291,0.0185847157935782,0.00684132325092622,0.00517572222176283,0.0319937093653936,0.00660421019033315
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNR,Tenascin-R,38987,0.0102818524803676,0.00379007919351749,0.00285329726107333,0.0177104076996619,0.00667861526461972
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSA,Arylsulfatase A,39093,-0.0109867307546128,0.0040616763371779,-0.0189476163754815,-0.00302584513374409,0.00683855839240817
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,39283,0.00752925769792316,0.00278356628149165,0.00207346778619951,0.0129850476096468,0.00684007644347653
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,36731,0.0130727463322915,0.00483679511383298,0.00359262790917882,0.0225528647554041,0.0068854459183808
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN1,Ficolin-1,36782,-0.0137105883268395,0.00507524477346378,-0.0236580680828285,-0.00376310857085048,0.00691251232968693
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",36792,-0.0119749935797529,0.00443971756409794,-0.0206768400053849,-0.00327314715412099,0.00700070253301752
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,38727,0.00960701636296965,0.00356220336333295,0.00262509777083707,0.0165889349551022,0.00700606587549529
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL32,Interleukin-32,39099,0.0104512712141022,0.00387972852568205,0.00284700330376535,0.018055539124439,0.00707166903734972
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,36791,0.00722760595758524,0.00268461139123544,0.00196576763076377,0.0124894442844067,0.00710662155467689
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39076,-0.0154867575028651,0.00575458940984924,-0.0267657527461696,-0.00420776225956061,0.00712730606395185
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA1,Apolipoprotein A-I,36806,0.00663708143437146,0.00246827298499782,0.00179926638377573,0.0114748964849672,0.00717673099138984
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNLZ,DNL-type zinc finger protein,36363,0.0219310961979621,0.00815934736963943,0.00593877535346878,0.0379234170424554,0.00720090604430804
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39136,-0.0155704071134751,0.00581872781256713,-0.0269751136261067,-0.00416570060084355,0.00746055589070837
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,38727,-0.0238272294270177,0.00890495874890485,-0.0412809485748712,-0.00637351027916417,0.00746492811150025
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOD,Apolipoprotein D,36157,0.010454156683075,0.00391139543663537,0.0027878216272697,0.0181204917388803,0.0075333014080695
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,36420,-0.0145004215489052,0.0054299448070438,-0.025143113370711,-0.00385772972709933,0.00758461417788348
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",39291,0.0166314207270945,0.00623548407222005,0.00440987194554318,0.0288529695086458,0.00765609324877056
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,38727,0.0118598669862015,0.00444832652477707,0.00314114699763848,0.0205785869747646,0.00768104301830942
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4C,Semaphorin-4C,39023,0.0068316667869017,0.00256627587222471,0.00180176607734127,0.0118615674964621,0.00777381697433702
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,39147,-0.0117946083836014,0.00443345259233794,-0.0204841754645838,-0.00310504130261904,0.00781371552228217
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN2,Transcobalamin-2,39246,0.00702332247666883,0.0026467754132407,0.00183564266671705,0.0122110022866206,0.00797343516577715
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD83,CD83 antigen,39099,0.00788357742504658,0.00297199286819328,0.00205847140338776,0.0137086834467054,0.00799517197163893
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRGN,Neurogranin,36796,0.0220205887699806,0.00830357078701473,0.00574559002743169,0.0382955875125294,0.00801278747932343
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",36767,0.0168304062472347,0.00635260719867355,0.00437929613783453,0.0292815163566349,0.00807402474320895
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39023,0.0102809469601471,0.00388120539211028,0.00267378439161093,0.0178881095286832,0.00808365435650575
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC3,Membrane primary amine oxidase,39165,-0.00719781109394311,0.00271742538819184,-0.0125239648547991,-0.00187165733308711,0.00808702972955459
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,38727,0.0303594833823975,0.0114846275795894,0.00784961332640224,0.0528693534383927,0.0082142588853174
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN7,Septin-7,36538,0.0121841887191779,0.00460904627567427,0.00315045801885635,0.0212179194194995,0.00821455165199638
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR1,Folate receptor alpha,39046,-0.00656319960479617,0.00248292097488424,-0.0114297247155693,-0.00169667449402306,0.0082177315007517
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMA,Repulsive guidance molecule A,39241,-0.00740100187333347,0.00280093720802929,-0.0128908388010709,-0.00191116494559606,0.00824210258665703
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,38987,-0.00692942634074052,0.00262771507442128,-0.0120797478866062,-0.00177910479487482,0.00837150192826201
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,38987,0.0244148619382439,0.00926618383115768,0.00625314162917482,0.0425765822473129,0.00842640716045976
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX101,Testis-expressed protein 101,36421,0.0117125561552899,0.00444907715899153,0.0029923649236665,0.0204327473869133,0.00848424903827898
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD10,Frizzled-10,36421,-0.014248410858501,0.00541823814081803,-0.0248681576145044,-0.00362866410249767,0.00855611560262072
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,38841,0.00845261995988222,0.00322333771239985,0.00213487804357852,0.0147703618761859,0.00874219794762087
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,39241,-0.00691779140727566,0.00263809607592864,-0.0120884597160958,-0.00174712309845553,0.00874331194114968
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTOA,Otoancorin,36363,0.0125797251737383,0.00480034808293744,0.00317104293118093,0.0219884074162957,0.00878849361789789
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROK1,Prokineticin-1,39099,0.0151945428804832,0.0058090091666353,0.00380888491387797,0.0265802008470884,0.00891362218950009
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELB,Transcription factor RelB,36430,0.0115984758483461,0.00443542705221492,0.00290503882600483,0.0202919128706873,0.00893437556216204
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR3,Toll-like receptor 3,39291,-0.0143707780729718,0.00549651139257553,-0.0251439404024199,-0.0035976157435238,0.00894379008814746
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39023,-0.0104970011260528,0.00401718150714413,-0.0183706768800553,-0.0026233253720503,0.00898329585116368
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,36767,0.0184918946416611,0.00707700819458239,0.00462095858027962,0.0323628307030426,0.00898675387035342
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,38741,0.00769410637515884,0.00294826811744635,0.001915500864964,0.0134727118853537,0.00907113848761457
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,36731,-0.0141264281904127,0.00541445788279617,-0.0247387656406932,-0.00351409074013224,0.00909069766351104
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,38630,0.0291361255079595,0.0111692604352838,0.00724437505480326,0.0510278759611157,0.00910051794062537
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,38727,-0.0159718700768921,0.00613016178905698,-0.0279869871834438,-0.0039567529703404,0.00918433253813855
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL1,Chordin-like protein 1,39140,0.00718912017962622,0.00276506417721535,0.00176959439228413,0.0126086459669683,0.00933180432025554
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD59,CD59 glycoprotein,38444,0.00496872171085275,0.00191161670177915,0.00122195297536561,0.00871549044633988,0.00935286267295049
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLI2,Zinc finger protein GLI2,36430,0.00800952144467265,0.00308347160350883,0.00196591710179535,0.01405312578755,0.00939964822811766
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,36538,0.0103786741374764,0.00399805242817495,0.00254249137825353,0.0182148568966993,0.00944433893479616
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39147,0.0170653714934067,0.00657646954391621,0.00417549118733097,0.0299552517994825,0.00947050067827453
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,39229,-0.00706805846926941,0.00272721199479062,-0.012413393979059,-0.0017227229594798,0.00955991231382729
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,P4HB,Protein disulfide-isomerase,39016,0.0091498294817377,0.00353120637176398,0.00222866499308031,0.0160709939703951,0.00957518589800954
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39211,-0.0165260947504944,0.00639113367472822,-0.0290527167529618,-0.00399947274802713,0.00972488876252646
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,38727,0.0134317377167683,0.00519495159168066,0.00324963259707424,0.0236138428364624,0.00973217924851004
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGMN,Legumain,39162,0.00840617446438876,0.0032532600946899,0.00202978467879655,0.014782564249981,0.00977753247882369
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,39147,-0.00557560914246789,0.00215799334741573,-0.00980527610340272,-0.00134594218153306,0.00978384714303211
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,38727,-0.0151667765027206,0.00587140296191275,-0.0266747263080696,-0.00365882669737165,0.0097994350998734
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGT1,Protein SGT1 homolog,38727,0.0189306617163009,0.0073302807444831,0.00456331145711407,0.0332980119754878,0.00981738420120964
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDS,Iduronate 2-sulfatase,39291,0.00209511966513295,0.000813969320326943,0.000499739797292139,0.00369049953297376,0.0100636032899017
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",36747,0.0248317684904298,0.00964778854389668,0.00592210294439234,0.0437414340364673,0.0100690342172073
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,39099,-0.0130082793012465,0.0050553613441132,-0.0229167875357084,-0.00309977106678469,0.0100866824113019
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,36743,0.0230662543719746,0.0089708273458049,0.00548343277419698,0.0406490759697522,0.010144282854645
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,36743,-0.00981848992355724,0.00382242355937661,-0.0173104400999354,-0.00232653974717908,0.0102205438338388
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BACH1,Transcription regulator protein BACH1,39099,-0.0172394429558377,0.00671617587271863,-0.0304031476663662,-0.00407573824530917,0.0102720401033731
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP8,Neutrophil collagenase,39218,0.0166651324752218,0.00649252604938795,0.00393978141842141,0.0293904835320222,0.0102730341491953
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPP1,Osteopontin,39246,0.0104060035532094,0.00405560836193331,0.00245701116382014,0.0183549959425987,0.010302294865711
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",39023,-0.0142590237633211,0.00555809642770768,-0.0251528927616281,-0.00336515476501399,0.0103137054048198
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPSE,Heparanase,36665,0.0218715194145003,0.0085257694232082,0.00516101134501219,0.0385820274839883,0.0103186808079833
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB6,Serpin B6,39202,0.0139403707551611,0.00544737095826764,0.0032635236769565,0.0246172178333657,0.0105038392950872
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,38727,-0.0197255708284156,0.00771962882284144,-0.0348560433211848,-0.00459509833564638,0.0106210630791321
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39023,-0.0102322860783341,0.00400578961898791,-0.0180836337315504,-0.00238093842511775,0.0106475681774434
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D5,TBC1 domain family member 5,39099,-0.0179589523552362,0.00704340441586273,-0.0317640250103272,-0.00415387970014529,0.0107895817988939
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,39229,-0.00758490016165539,0.00297661066851799,-0.0134190570719506,-0.00175074325136013,0.0108387147818918
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,38727,-0.011942284778586,0.00468944892707194,-0.021133604675647,-0.00275096488152504,0.0108869042771987
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGCR6,Protein DGCR6,36363,-0.0100774396087572,0.0039580162221313,-0.0178351514041345,-0.00231972781337982,0.010905805051291
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,39062,0.0202949617687554,0.00797581315195159,0.00466236799093028,0.0359275555465805,0.0109512478486765
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGR,Progesterone receptor,36430,0.0240130818143808,0.00947581951356209,0.00544047556779912,0.0425856880609625,0.0112843078014047
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL23,C-C motif chemokine 23,39162,0.00940853061547517,0.00371647294726407,0.00212424363883761,0.0166928175921127,0.0113650715491405
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,36363,0.0137665700086641,0.00545219029706032,0.00308027702642591,0.0244528629909024,0.0115833628473817
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NENF,Neudesin,36731,0.0250690745709991,0.00992918124683349,0.00560787932720549,0.0445302698147928,0.0115887357240716
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,39072,-0.00656109917628214,0.00260262854291151,-0.0116622511203887,-0.00145994723217558,0.0117139500429259
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR1,Cadherin-related family member 1,38741,-0.00969126568882879,0.00384494448274105,-0.0172273568750012,-0.00215517450265634,0.0117284730006096
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFC1,Cryptic protein,38727,-0.0105795056069562,0.0041976317385848,-0.0188068638145824,-0.00235214739932998,0.0117341654601919
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,36731,-0.0261071204435118,0.0103592409243981,-0.046411232655332,-0.0058030082316916,0.0117415789360376
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM132A,Transmembrane protein 132A,36420,-0.0142672580292581,0.00566244736349582,-0.0253656548617099,-0.00316886119680626,0.0117602101688764
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP15,Matrix metalloproteinase-15,36792,0.0112890042260043,0.00448076832911338,0.00250669830094203,0.0200713101510665,0.011766287190274
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",39057,0.0249987171753285,0.00992561364299183,0.00554451443506455,0.0444529199155925,0.0117921987684324
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,36791,0.00569045954083466,0.00226094266899375,0.00125901190960691,0.0101219071720624,0.0118528298341082
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,36761,0.0140370778046705,0.00557893956721417,0.00310235625293073,0.0249717993564103,0.0118787435256228
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL22,C-C motif chemokine 22,38925,0.0114592103144273,0.00455649985686428,0.00252847059497333,0.0203899500338813,0.011916429972531
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,36792,-0.0076258769193875,0.00304177046569981,-0.0135877470321591,-0.00166400680661587,0.0121864417190486
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMB,RGM domain family member B,39241,0.00576804654950694,0.00230781734679068,0.00124472454979721,0.0102913685492167,0.0124524250836566
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,36391,0.00849480489715442,0.00340503555495352,0.00182093520944552,0.0151686745848633,0.0126163982718683
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,36420,0.0139400082337423,0.00558836012700302,0.00298682238481643,0.0248931940826683,0.0126272139617227
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,39093,0.00758682520563344,0.0030447165994773,0.00161918067065794,0.0135544697406089,0.0127203042564962
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,39023,0.0263701083891584,0.0105998906962272,0.00559432262455302,0.0471458941537637,0.0128652802149742
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,38987,0.011102464445156,0.00446576759460673,0.00234955995972685,0.0198553689305852,0.0129249035284902
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,38841,0.0192017418127734,0.00772366011902017,0.00406336797949386,0.0343401156460529,0.0129262136907538
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,39023,0.00540522576049336,0.00217882570762631,0.00113472737354579,0.00967572414744093,0.0131196382351994
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,36500,0.00633802801175451,0.00255592353267723,0.00132841788770714,0.0113476381358019,0.0131607201650034
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TST,Thiosulfate sulfurtransferase,38707,0.0171546010308948,0.00692489578263843,0.00358180529692347,0.0307273967648661,0.0132514786229312
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,36726,-0.0183301394822561,0.00741055957195669,-0.0328548362432912,-0.00380544272122096,0.0133918847062587
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,36391,0.00935131784883196,0.00378170851654703,0.00193916915639978,0.0167634665412641,0.013419985201389
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA12,Carbonic anhydrase 12,39023,-0.00712569163131477,0.00288239234481885,-0.0127751806271597,-0.00147620263546981,0.0134413972759639
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,38987,-0.00876681416856516,0.0035473694087626,-0.0157196582097399,-0.00181397012739046,0.0134710885176999
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,36391,0.0109204397909657,0.00442527417195089,0.00224690241394201,0.0195939771679895,0.0136100458877588
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,39162,0.0196459553811654,0.00798990653729944,0.00398573856805846,0.0353061721942723,0.0139494021212582
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAM,Integrin alpha-M,39093,0.0069644153264773,0.00284158202075868,0.00139491456579029,0.0125339160871643,0.0142613640902948
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,36391,0.0081736513360495,0.00333970208570789,0.00162783524806203,0.014719467424037,0.0144019633019331
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA1,Laminin subunit alpha-1,36391,0.0120015683048817,0.00491027338896366,0.00237743246251295,0.0216257041472505,0.0145320635518866
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPE,Carboxypeptidase E,39139,0.00849871069361612,0.00348086282388172,0.00167621955880794,0.0153212018284243,0.0146355111637163
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,36767,-0.0133261302273345,0.00546162356491693,-0.0240309124145717,-0.00262134804009733,0.0147023477646525
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MELTF,Melanotransferrin,36792,-0.00641727954319845,0.00263146222404287,-0.0115749455023225,-0.00125961358407443,0.0147546050119861
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN1,Pantetheinase,36796,-0.0159955668448886,0.00656027809639734,-0.0288537119138274,-0.00313742177594981,0.0147721221046609
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEPR,Leptin receptor,39106,0.00674800333886507,0.00276917618575127,0.00132041801479259,0.0121755886629376,0.0148281261398491
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOMO1,Nodal modulator 1,39093,0.00523372451898594,0.00214884622535501,0.00102198591729011,0.00944546312068177,0.0148786057012956
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,36339,0.0141655870234129,0.00581593096604609,0.0027663623299626,0.0255648117168632,0.01487885730156
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,39274,0.00790896900328792,0.00325053226140085,0.00153792577094224,0.0142800122356336,0.0149801989276231
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,36724,-0.00893551789262916,0.00367478243585575,-0.0161380914669064,-0.00173294431835189,0.0150467945252847
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALLD,Palladin,36430,0.00901360083562949,0.00371116537787944,0.00173971669498579,0.0162874849762732,0.0151636869732968
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,36743,0.0200088808525286,0.00823889570985581,0.00386064526121123,0.036157116443846,0.0151713498755256
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,39092,0.0110783944290836,0.00456988218834877,0.00212142533992002,0.0200353635182472,0.0153529194128724
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCG,Gamma-synuclein,38987,-0.0142519346546542,0.00587973316228451,-0.0257762116527318,-0.00272765765657654,0.0153661236336855
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,39147,-0.0065272227326507,0.00269615319622183,-0.0118116829972455,-0.00124276246805591,0.0154920388160189
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,39162,0.0142105740590186,0.00587511667929765,0.00269534536759516,0.0257258027504419,0.0155845418780688
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,39023,0.0185297767141246,0.00766191698209235,0.0035124194292236,0.0335471339990256,0.0155995316373247
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA1,Annexin A1,36450,-0.00955811284804856,0.00395217368318091,-0.0173043732670831,-0.00181185242901398,0.0156011148944726
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,39067,0.00603722886295938,0.00249644058918161,0.00114420530816343,0.0109302524177553,0.0156033978384987
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39023,0.0125641360918559,0.00520131822916979,0.00236955236268306,0.0227587198210287,0.015722448609976
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC1,Syndecan-1,39106,0.00869330150094736,0.00360325320338118,0.00163092522232026,0.0157556777795745,0.0158497982120282
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUK1,Guanylate kinase,36391,0.00910815400803212,0.00377555416582876,0.00170806784300774,0.0165082401730565,0.0158620727683096
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,39106,0.0190202015561345,0.00789879660493703,0.00353856021045793,0.0345018429018111,0.0160525369509419
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,39093,-0.00869850043585844,0.0036169506870705,-0.0157877237825166,-0.00160927708920026,0.0161875726819847
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,39023,-0.0130192136772564,0.0054166373873432,-0.023635822956449,-0.00240260439806369,0.0162482244611424
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C8B,Complement component C8 beta chain,36806,0.00657926188934198,0.00273863702161527,0.00121153332697605,0.0119469904517079,0.0163025245445165
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,36430,-0.009831970895292,0.00409925864690022,-0.0178665178432164,-0.00179742394736757,0.0164779661735053
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1S,Complement C1s subcomponent,36806,0.0045363431994723,0.00189163020284262,0.000828748001900763,0.00824393839704384,0.0164938434760237
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,36747,-0.0123555336168935,0.0051556094408108,-0.0224605281208827,-0.00225053911290432,0.0165656420837937
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB8,Serpin B8,39291,-0.0119230631298088,0.00497576314063541,-0.0216755588854542,-0.00217056737416343,0.0165766119539838
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMFG,Glia maturation factor gamma,36792,0.0156245641074247,0.00652165942291413,0.00284211163851297,0.0284070165763363,0.0165984526277802
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,36420,0.019851510919787,0.00828906781803047,0.00360493799644727,0.0360980838431267,0.0166393360241433
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,38823,0.0073286962203649,0.0030652120682827,0.0013208805665308,0.013336511874199,0.0168182078215103
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSH,Pro-cathepsin H,38795,-0.015592547129873,0.00653581242648288,-0.0284027394857795,-0.00278235477396659,0.017058615943544
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,38951,-0.00505123318691956,0.00212197441575351,-0.00921030304179644,-0.000892163332042675,0.0173043074813775
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRDT,Bromodomain testis-specific protein,36391,0.00785803466895212,0.00330184502164813,0.00138641842652178,0.0143296509113825,0.0173325822459666
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,36743,0.00999487449263984,0.00421112779552141,0.00174106401341787,0.0182486849718618,0.0176376632063123
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",36731,0.00943813233657125,0.00397823453128836,0.00164079265524607,0.0172354720178964,0.0176855300676737
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IST1,IST1 homolog,36655,0.0214193117662057,0.00903930354963078,0.00370227680892938,0.039136346723482,0.0178232726447512
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",38741,0.00584030185112754,0.00246519973325218,0.00100851037395326,0.0106720933283018,0.0178441778023405
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39140,0.0164045123458303,0.00692873328030646,0.00282419511642964,0.029984829575231,0.0179159597088401
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,38841,-0.00655060480473363,0.00277018158518517,-0.0119801607116966,-0.00112104889777069,0.0180581225137728
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,36421,0.00782118967862555,0.0033113241813768,0.00133099428312703,0.0143113850741241,0.0181941497251577
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MBL2,Mannose-binding protein C,36618,0.0229222830824627,0.00971401795480998,0.00388280789103511,0.0419617582738902,0.0183041098174771
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6AP2,Renin receptor,38727,-0.00865687516507913,0.00366879200546743,-0.0158477074957953,-0.00146604283436296,0.0183075873759967
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,36339,0.00641786907248792,0.00272161241992656,0.00108350872943187,0.011752229415544,0.0183834493685263
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,36421,0.0113001298945313,0.00479613725601559,0.00189970087274069,0.0207005589163218,0.018483730129786
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL1,Growth-regulated alpha protein,39075,0.0201458179341968,0.00857016699101336,0.00334829063181066,0.036943345236583,0.0187512605662046
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,39241,0.0273392505220933,0.0116334294936495,0.00453772871454023,0.0501407723296465,0.0187829805696524
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLR,Low-density lipoprotein receptor,39119,0.0110976871303271,0.00472506144192102,0.00183656670416193,0.0203588075564923,0.0188524586321911
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMS1,PMS1 protein homolog 1,36421,-0.0106213915312111,0.00452634473174307,-0.0194930272054275,-0.00174975585699467,0.0189624828508165
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,38951,0.00639466125773325,0.00272775459276576,0.00104826225591236,0.0117410602595541,0.0190759869229607
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,38741,0.0238767452857318,0.0101930356437112,0.00389839542405792,0.0438550951474057,0.019170360653299
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAG1,Dystroglycan,39162,0.0102957817846613,0.00439994153417319,0.00167189637768187,0.0189196671916408,0.0192974793516803
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFRC,Transferrin receptor protein 1,39151,0.00822582814205004,0.00352064597719641,0.00132536202674508,0.015126294257355,0.0194804280804803
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBP,Protein AMBP,39229,-0.00407526298160429,0.00174778826358528,-0.00750092797823143,-0.000649597984977141,0.0197309871629489
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,36391,-0.00983061853378955,0.00421742794518472,-0.0180967773063516,-0.00156445976122749,0.0197717147031024
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,36363,0.0123446925556853,0.00529915809744387,0.00195834268469534,0.0227310424266753,0.0198454004296496
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,38915,-0.0123854924826445,0.00532208649623982,-0.0228167820152746,-0.00195420295001445,0.0199684865669999
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,38727,-0.0126819808674787,0.00545615630446025,-0.0233760472242208,-0.00198791451073659,0.0201204998035144
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",36391,0.0100641344515459,0.00433175630471432,0.00157389209430578,0.0185543768087859,0.0201769172971948
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,36500,-0.00787805647882697,0.00339258694658916,-0.0145275268941417,-0.00122858606351221,0.0202412890707008
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,36391,0.0133196818103538,0.00573628035386469,0.00207657231677895,0.0245627913039285,0.0202485164497216
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRIB,Protein scribble homolog,36420,-0.018819842678717,0.00811857444592262,-0.0347322485927253,-0.00290743676470863,0.0204586944584511
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,39147,0.0207815082885918,0.00898750082910123,0.00316600666355335,0.0383970099136302,0.0207761514725121
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,36731,-0.00709685790932603,0.00307122123099424,-0.0131164515220747,-0.00107726429657732,0.0208617930646654
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39023,-0.00939467126869771,0.00406960321961108,-0.0173710935791354,-0.00141824895825999,0.0209848332594882
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,39084,0.00464062037730101,0.0020122783499164,0.000696554811464877,0.00858468594313715,0.021115489545703
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,38727,0.00634396963798618,0.00275829506040157,0.000937711319599101,0.0117502279563733,0.0214642433796827
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,36743,0.0247289155545181,0.0107583600766865,0.00364252980421261,0.0458153013048235,0.0215449216136052
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39023,-0.00582462206705112,0.00253586767457197,-0.0107949227092122,-0.000854321424890062,0.0216383161380796
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,38841,-0.0124145333195333,0.00540582214221221,-0.0230099447182692,-0.00181912192079735,0.0216603789874557
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,39291,0.0118392581421652,0.00515953574392216,0.00172656808407777,0.0219519482002526,0.0217673353422252
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,36791,-0.0102747705518695,0.00448233245691022,-0.0190601421674136,-0.00148939893632549,0.0219053551203222
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,38987,-0.0124885448727649,0.00545479128174953,-0.023179935784994,-0.00179715396053584,0.0220661519613867
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,39241,0.0142073141281998,0.0062090720144934,0.00203753297979269,0.0263770952766068,0.0221420454743816
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJAP1,Tight junction-associated protein 1,39147,-0.0171798563831988,0.00752233409528912,-0.0319236312099655,-0.00243608155643209,0.0223942041380178
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,36363,0.0159901815074657,0.00700674269450079,0.00225696582624413,0.0297233971886872,0.0224993673201259
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,36731,0.0201322480558222,0.00882703680453786,0.002831255918928,0.0374332401927164,0.0225796214699639
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB2,Plexin-B2,39217,-0.00486275360238258,0.00213215572919852,-0.00904177883161168,-0.000683728373153484,0.022581339980378
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGA,Chromogranin-A,36791,-0.0161759853113578,0.00709397239083901,-0.0300801711974023,-0.00227179942531336,0.0226094455329906
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPY30,Protein dpy-30 homolog,39206,-0.0122696579593048,0.00538160953086466,-0.0228176126397996,-0.0017217032788101,0.0226258839208304
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKKL1,Dickkopf-like protein 1,39023,-0.0173591509495408,0.00761449022310726,-0.0322835517868311,-0.00243475011225059,0.0226362130662126
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,36792,-0.004959514895192,0.0021756520111805,-0.00922379283710577,-0.00069523695327823,0.0226504039232116
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGA4,Pepsin A-4,36796,-0.0128715270928124,0.00564968540016273,-0.0239449104771314,-0.00179814370849349,0.0227265338485228
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,36731,0.019495764326786,0.00856765764521059,0.00270315534217326,0.0362883733113988,0.0228919004918873
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,39165,0.00680609936481391,0.00299281136101945,0.000940189097215785,0.012672009632412,0.0229708023459699
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,36261,-0.0110061206464032,0.00484628744373422,-0.0205048440361223,-0.00150739725668418,0.0231615230186561
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,36591,0.0114705365104491,0.00505898676193686,0.00155492245705283,0.0213861505638453,0.0233850269156738
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,36391,0.00651349093028374,0.00287689768543718,0.000874771466826871,0.0121522103937406,0.0235869734084852
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD69,Early activation antigen CD69,39024,0.0179339433527158,0.0079440902904809,0.00236352638337326,0.0335043603220584,0.0239897586568372
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36363,0.012525193458391,0.00555447411746733,0.00163842418815503,0.0234119627286269,0.0241521989609441
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,36393,-0.00815534341625865,0.00361817190189995,-0.0152469603439826,-0.00106372648853474,0.0242136477147956
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST7,Cystatin-F,39114,0.0188505218419607,0.00837207448946183,0.0024412558426155,0.0352597878413059,0.0243620398255582
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7,Complement component C7,36512,-0.00655044012678055,0.00291000269110334,-0.0122540454013431,-0.000846834852218011,0.0244021067509776
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,36500,-0.00857149974202778,0.00381779004668135,-0.0160543682335232,-0.00108863125053234,0.0247759154825982
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAL,Galanin peptides,39162,0.0131129480297242,0.00584226309623419,0.00166211236110516,0.0245637836983432,0.0248146059570147
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,36731,-0.0147939137283614,0.00659797851284235,-0.0277259516135324,-0.0018618758431904,0.0249661306114616
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRY2,Protein sprouty homolog 2,38841,0.0188395449353865,0.00840258694302353,0.00237047452706035,0.0353086153437126,0.0249686766556432
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLGN,Calmegin,36421,-0.008885404016564,0.00396334470608417,-0.016653559640489,-0.00111724839263903,0.0249855213485849
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39099,-0.0199268622427712,0.00889016118798964,-0.0373515781712309,-0.00250214631431154,0.0250112001923075
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL8,C-C motif chemokine 8,39229,0.0122109278663797,0.00545443143897741,0.001520242245984,0.0229016134867755,0.0251885968748499
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPACT,Protein IMPACT,36747,-0.0111832442205665,0.00499907659702555,-0.0209814343507366,-0.00138505409039647,0.0252993191644848
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STEAP4,Metalloreductase STEAP4,36363,0.0152694483045028,0.00683358828004636,0.00187561527561196,0.0286632813333937,0.0254697621749938
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,39162,-0.00768316408915867,0.00344069139506724,-0.0144269192234905,-0.000939408954826884,0.0255614264686628
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,36391,0.00626416638925921,0.00280560230528228,0.000765185870905939,0.0117631469076125,0.0255840197737308
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPS10,40S ribosomal protein S10,36391,0.00870432617490715,0.00390614234011859,0.00104828718827472,0.0163603651615396,0.025873596907501
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5A,Cytochrome b5,36339,0.0145456056856662,0.00652931491464306,0.00174814845296583,0.0273430629183666,0.0259157214731276
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2,Ataxin-2,36363,0.0224961511545442,0.0101155655289799,0.0026696427177435,0.0423226595913449,0.0261720023920803
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39023,-0.00659106674562098,0.00296808417901419,-0.0124085117364888,-0.000773621754753174,0.0263896119916271
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,38913,0.0236052443942395,0.0106407566693212,0.00274936132237005,0.044461127466109,0.0265437799607446
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNN,Tenascin-N,36791,-0.00859262658092032,0.00387621605564781,-0.01619001004999,-0.000995243111850621,0.026657076296798
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,36430,-0.0100603248375047,0.00453899281029435,-0.0189567507456816,-0.00116389892932779,0.0266804293145961
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,38832,-0.00613549574614564,0.00277696180705722,-0.0115783408879778,-0.000692650604313495,0.0271600003877575
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,39283,0.011670233332424,0.00528276410797147,0.0013160156807999,0.0220244509840481,0.027181287434378
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,36538,0.00827152384944081,0.00374458600326835,0.000932135283034846,0.0156109124158468,0.0271974111029261
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,39093,-0.00600857367359538,0.00272428657178196,-0.011348175354288,-0.000668971992902732,0.0274297992636681
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,38832,-0.00977423586438457,0.00443301889693138,-0.0184629529023701,-0.00108551882639907,0.0274782797615091
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,39162,0.00562190903824202,0.00255232287241598,0.000619356208306705,0.0106244618681773,0.0276333123110022
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL13,C-C motif chemokine 13,39260,-0.013649510562309,0.00620618941765563,-0.025813641820914,-0.00148537930370394,0.0278686795074271
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,36731,-0.00872593119218372,0.00397121126509749,-0.0165095052717748,-0.000942357112592628,0.0280169856198867
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,39241,-0.0128864017648311,0.00587020877837917,-0.0243920109704543,-0.00138079255920798,0.0281626826803473
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHD3,EH domain-containing protein 3,36420,0.0231759009434923,0.0106044747412236,0.00239113045069414,0.0439606714362905,0.0288718454225594
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,36363,0.00972926732484454,0.00445300313155226,0.0010013811870021,0.018457153462687,0.0289163142765621
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,38741,0.0145456970450314,0.00666165820245953,0.00148884696821069,0.0276025471218521,0.0290149453334856
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSMB,Beta-microseminoprotein,39024,0.0132011957374288,0.00604917341848905,0.00134481583719031,0.0250575756376674,0.0291016595673124
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS6,Growth arrest-specific protein 6,39184,-0.00502605540606693,0.00230392798499497,-0.00954175425665708,-0.000510356555476776,0.0291604276080527
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,37339,-0.00608785618618697,0.00279100787084495,-0.0115582316130431,-0.000617480759330874,0.0291829394235383
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,36430,-0.00855737240779496,0.00392572296873614,-0.0162517894265178,-0.000862955389072126,0.0292892430115336
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GM2A,Ganglioside GM2 activator,36548,0.00716761404688336,0.00328818415411878,0.000722773104810543,0.0136124549889562,0.0292899286636189
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,36747,-0.0123788362490829,0.0056834997190686,-0.0235184956984573,-0.00123917679970844,0.0294218277621791
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,38960,0.00455913240510116,0.00209723972492498,0.000448542544248197,0.00866972226595413,0.0297301705343685
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA11,Annexin A11,39062,0.0130938947626272,0.00602605441913661,0.00128282810111947,0.024904961424135,0.0298047220263758
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA2,Adenosine deaminase 2,39025,0.00811636499114797,0.00373674762034813,0.000792339655265628,0.0154403903270303,0.0298680944676164
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,36608,0.00159426052477375,0.000734093942872171,0.000155436396744291,0.0030330846528032,0.0298937224819039
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1,DNA topoisomerase 1,36743,-0.0223982592323566,0.0103173175383064,-0.0426202016074372,-0.00217631685727609,0.0299540376670013
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRADD,Death domain-containing protein CRADD,38951,0.0149600607265945,0.00689491734638214,0.00144602272768551,0.0284740987255035,0.0300433890222124
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,38832,-0.010370487932171,0.00478424239779333,-0.019747603031846,-0.000993372832496103,0.0302022285304374
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,36430,-0.00716462720994422,0.00330772639435611,-0.0136477709428822,-0.000681483477006245,0.030327802181882
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,36806,0.0036560220130514,0.00169092252498644,0.000341813864077977,0.00697023016202483,0.0306251543304042
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOC,Brother of CDO,38832,-0.00458429137699676,0.00212165175389482,-0.00874272881463061,-0.000425853939362904,0.0307329300825335
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,36391,0.0099221593787134,0.00459307350446457,0.00091973530996284,0.018924583447464,0.0307726848227762
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",36420,0.00983876296616898,0.00455877892674525,0.000903556269748286,0.0187739696625897,0.0309310681041434
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS2,Growth arrest-specific protein 2,36538,-0.0104353411047797,0.00483540543227501,-0.0199127357520388,-0.000957946457520708,0.0309379271436502
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39117,0.00646942432918764,0.00300004524358549,0.000589335651760072,0.0123495130066152,0.0310647241771892
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP10,Stromelysin-2,39091,0.0114222862256051,0.00530227878298126,0.00102981981096186,0.0218147526402484,0.0312383918894558
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THTPA,Thiamine-triphosphatase,36708,0.0171997133835345,0.00799319280819561,0.00153305547947109,0.0328663712875979,0.0314320697311353
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCB,Tubulin-folding cofactor B,38987,0.0196389415979927,0.00913399050545798,0.00173632020729501,0.0375415629886903,0.0315635528376194
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,36743,-0.00988276436609066,0.00459752016615762,-0.0188939038917596,-0.000871624840421735,0.0316065510832991
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYDGF,Myeloid-derived growth factor,36792,0.0196874018553606,0.00916190029834239,0.00173007727060955,0.0376447264401117,0.0316660759934729
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI2B,Protein EVI2B,36339,0.00805855088047608,0.00375385232042442,0.000701000332444216,0.0154161014285079,0.0318330748822809
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN3,Contactin-3,39093,-0.0063208630133557,0.00294866940086811,-0.0121002550390572,-0.000541470987654211,0.0320781448303587
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,36792,-0.00498401620553717,0.00232510979203882,-0.00954123139793326,-0.000426801013141089,0.0320866210802713
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,39023,-0.0167761946783851,0.00784129292013434,-0.0321451288018484,-0.00140726055492175,0.0324137094345213
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,36743,-0.00749624024179661,0.00350434328143155,-0.0143647530734025,-0.000627727410190761,0.0324440122791302
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN3,Centrin-3,36743,0.0153145644462168,0.00716306214112709,0.00127496264960771,0.0293541662428259,0.0325362111412796
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,36421,-0.00938591527088748,0.00439021819703792,-0.0179907429370818,-0.000781087604693153,0.0325428498537943
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39099,0.0186154436781426,0.00871291745934548,0.00153812545782546,0.0356927618984597,0.0326518003391908
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",38727,0.00979817203830159,0.00459222111247726,0.000797418657846161,0.018798925418757,0.0328881288368259
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R9B,Neurabin-2,39291,-0.0182390548854083,0.00855268190621535,-0.0350023114215904,-0.00147579834922618,0.0329770805113266
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",36791,0.0119536417492805,0.00560591140381772,0.000966055397797773,0.0229412281007633,0.0329986797181414
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUOX2,Dual oxidase 2,38832,0.0137455054164741,0.00645137570445081,0.00110080903575053,0.0263902017971977,0.0331357479328858
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPL14,60S ribosomal protein L14,36420,-0.0077096512508592,0.00362114751974914,-0.0148071003895675,-0.000612202112150883,0.0332684451180604
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,36747,0.010404836292739,0.00488825866655976,0.000823849306281864,0.0199858232791961,0.0333115533050468
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH2,Growth hormone variant,38727,0.0316493294430961,0.0148820479275629,0.00248051550507282,0.0608181433811194,0.0334632381158159
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,36430,-0.00604067398030893,0.00284301600010647,-0.0116129853405176,-0.00046836262010025,0.0336276482663282
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS22,Brain-specific serine protease 4,36430,-0.00647169171005188,0.00304689916147988,-0.0124436140665524,-0.000499769353551318,0.0336874750301588
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TALDO1,Transaldolase,36770,-0.00859172802919934,0.00404915681328849,-0.0165280753832448,-0.000655380675153911,0.0338688175926806
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,36345,-0.0188742783471288,0.00889822947349172,-0.0363148081151726,-0.00143374857908505,0.0339307343810189
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARF6,ADP-ribosylation factor 6,36743,-0.0204448279227811,0.00964091487142058,-0.0393410210707655,-0.00154863477479678,0.0339718765751547
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,36421,-0.00567671152266963,0.00267954181855317,-0.0109286134870338,-0.000424809558305421,0.0341490960501745
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,36724,0.0136213641679304,0.00644263579560187,0.000993798008550754,0.0262489303273101,0.0345128238171652
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,36743,-0.0097198030369597,0.00459756863865657,-0.0187310375687266,-0.000708568505192814,0.0345243437406993
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILP,Rab-interacting lysosomal protein,39211,-0.0113511127834686,0.00537145321834057,-0.0218791610914162,-0.000823064475521117,0.0345972323662535
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,39291,-0.00688160348517771,0.0032565018278165,-0.013264347067698,-0.000498859902657366,0.0346006139398748
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN2,Contactin-2,39255,-0.00846921046849682,0.00401389148236506,-0.0163364377739323,-0.000601983163061296,0.0348766060927664
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,36420,-0.00745505832668281,0.00353657924792529,-0.0143867536526164,-0.000523363000749231,0.035051988707805
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPBP,Platelet basic protein,36729,0.0162230737771951,0.00771599065224761,0.00109973209878982,0.0313464154556005,0.0355265669172933
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,36796,0.00470007825446094,0.00223844877406227,0.000312718657298884,0.009087437851623,0.0357742702258621
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,36743,-0.0159760454453513,0.00761692903539504,-0.0309052263547255,-0.00104686453597698,0.0359741520127223
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,39055,0.00378095333773346,0.00180409225170187,0.000244932524397788,0.00731697415106913,0.0361195480662832
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,36538,0.00669232280478621,0.00319464148893028,0.000430825486482859,0.0129538201230896,0.0362033411978063
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,36631,0.0120303274241169,0.00574540875114519,0.000769326271872371,0.0232913285763615,0.0362883062258133
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,36420,0.00684174650082747,0.00327120996632917,0.000430174966822293,0.0132533180348326,0.03650300550515
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,39023,-0.020173239121422,0.00964846940729711,-0.0390842391597243,-0.00126223908311962,0.0365605639321404
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,36500,0.0239067734836867,0.0114356625713424,0.00149287484385557,0.0463206721235177,0.0365887466077278
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPE4,NXPE family member 4,36391,0.00666172760134096,0.00318951591483053,0.000410276408273122,0.0129131787944088,0.0367609196651886
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA7,Carbonic anhydrase 7,36538,0.00635643037332715,0.00304753390856711,0.000383263912535628,0.0123295968341187,0.037020133201856
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,36430,-0.0151124518450807,0.00724554026754347,-0.0293137107694659,-0.000911192920695489,0.0370205623257935
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,36747,-0.00529463498236044,0.00254018565643427,-0.0102733988689716,-0.000315871095749272,0.0371480218716012
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD63,CD63 antigen,38960,0.009687281192176,0.00464910993553848,0.000575025718520583,0.0187995366658314,0.0372055927935598
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLO1,Lactoylglutathione lyase,38832,-0.0108892863681341,0.00523166931423563,-0.021143358224036,-0.000635214512232288,0.0374126870262788
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",38832,-0.016692505443021,0.00803347136862242,-0.032438109325521,-0.000946901560521091,0.0377383752198418
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,36391,0.0121730829031139,0.00586696118915227,0.000673838972375411,0.0236723268338523,0.0380205065050026
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,36767,-0.00596832704112677,0.00287746171110722,-0.0116081519948969,-0.000328502087356622,0.0380838744546345
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",36767,0.0067912787552885,0.00327429649982123,0.000373657615638893,0.0132088998949381,0.0380880904430588
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,38882,0.0321425799921763,0.0155004881193381,0.00176162327827375,0.0625235367060789,0.0381288710397323
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,39023,-0.023339419367066,0.0112856659663154,-0.0454593246610442,-0.00121951407308777,0.0386514240811315
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMI,N-myc-interactor,36677,0.0134809139272804,0.00652368708972846,0.000694487231412584,0.0262673406231481,0.0388054599636897
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP2,Caspase-2,39099,0.0127933719765577,0.00619613493105421,0.000648947511691414,0.0249377964414239,0.0389650306273828
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,39162,-0.00524257616378748,0.00254156807440239,-0.0102240495896162,-0.000261102737958803,0.0391548446571671
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP1,Guanylate-binding protein 1,36735,-0.0119048033185549,0.00577680770053466,-0.0232273464116028,-0.000582260225506949,0.0393428580310789
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,38642,-0.00360776030512017,0.00175335225164696,-0.00704433071834822,-0.000171189891892129,0.0396426083831569
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,38741,-0.00607426498957015,0.00295243975772094,-0.0118610469147032,-0.000287483064437116,0.0396679032363786
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA4,Kallistatin,36607,-0.00435170990699165,0.00211684635568019,-0.00850072876412483,-0.000202691049858476,0.0398268039474497
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,36792,0.0132663337350964,0.00646685034172443,0.000591307065316507,0.0259413604048763,0.0402445421199406
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIF,Leukemia inhibitory factor,38741,-0.00937619872947086,0.00457233063678835,-0.018337966777576,-0.000414430681365695,0.0403196089234058
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN15,Tetraspanin-15,36391,0.00916798874774111,0.00447330008716352,0.000400320576900601,0.0179356569185816,0.0404348891480542
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM2,Junctional adhesion molecule B,39241,-0.00463893716880309,0.00226487826683296,-0.00907809857179569,-0.000199775765810491,0.0405567627616686
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",38832,-0.0155459163162238,0.00759280332687463,-0.0304278108368981,-0.000664021795549533,0.0406309320987193
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACYBP,Calcyclin-binding protein,36466,0.0191809929022155,0.0093831870510845,0.000789946282089841,0.0375720395223411,0.0409557691862125
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK10,Kallikrein-10,39092,0.00728153401772008,0.00356213183415479,0.000299755622776688,0.0142633124126635,0.0409558284494459
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F7,Coagulation factor VII,39133,-0.00552745412054973,0.00270806701284411,-0.0108352654657242,-0.000219642775375276,0.041257361069366
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36A,Interleukin-36 alpha,36430,0.0108338757701253,0.00530918224961353,0.000427878560882784,0.0212398729793678,0.0413122302083183
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",39283,-0.00893643811274286,0.00438123050734074,-0.0175236499071307,-0.000349226318355015,0.0413962581923688
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM19,Probable RNA-binding protein 19,36391,0.00882383299498242,0.00432786284208637,0.000341221824493138,0.0173064441654717,0.0414866386740074
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,38832,0.010523491047857,0.00516578228435591,0.000398557770519404,0.0206484243251946,0.041652220423831
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,36421,0.00581274213160441,0.0028580806315862,0.000210904093695469,0.0114145801695134,0.0419935222600847
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN2,CCN family member 2,39114,0.0107842105446202,0.00530400113373946,0.000388368322490848,0.0211800527667495,0.0420474000911948
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOBR,Apolipoprotein B receptor,36420,0.00781796601598138,0.00384689677052069,0.00027804834576083,0.0153578836862019,0.0421464564701041
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD6,T-cell differentiation antigen CD6,39274,-0.00962191742144578,0.00473907408383498,-0.0189105026257623,-0.000333332217129225,0.0423394309787831
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",38741,-0.00931140801210064,0.00458716507006875,-0.0183022515494354,-0.000320564474765883,0.0423861961935705
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD207,C-type lectin domain family 4 member K,38743,-0.00691781215335586,0.00340968133293433,-0.0136007875659071,-0.00023483674080458,0.0424889401189787
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP3,Caspase-3,39283,0.0163100107134957,0.00803923105462614,0.000553117846428502,0.032066903580563,0.0424955717178018
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD72,B-cell differentiation antigen CD72,36500,0.0076116747232317,0.00375265912013232,0.000256462847772347,0.0149668865986911,0.0425463188102794
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,36743,0.0162024541536606,0.0080008048560714,0.000520876635760639,0.0318840316715606,0.0428773664464901
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,36420,-0.00796867888664844,0.00393985052164412,-0.0156907859090709,-0.00024657186422597,0.0431371973581803
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD248,Endosialin,36791,0.00722321722663829,0.00357371502722866,0.000218735773270124,0.0142276986800065,0.0432789217364451
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POMC,Pro-opiomelanocortin,36420,0.0129570314715641,0.00641822756032801,0.000377305453321212,0.025536757489807,0.0435306173703826
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,36391,0.00898813128938439,0.004455859382732,0.000254646899229671,0.0177216156795391,0.0437012721669771
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39106,0.0152016339254683,0.00754448908892595,0.000414435311173461,0.0299888325397632,0.0439292747335826
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,38987,-0.0127740295788449,0.00634143731094759,-0.0252032467083022,-0.000344812449387624,0.0439878951893773
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,39123,0.0218629620218044,0.0108566039939268,0.000584018193708007,0.0431419058499009,0.0440486999364728
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,36363,0.0102495896073683,0.00509101358183575,0.000271202986970247,0.0202279762277664,0.0441075253024472
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,38727,0.00990758689971051,0.00492832670881797,0.000248066550427292,0.0195671072489937,0.0444137878065195
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNW1,Interferon omega-1,36391,0.00650116411497404,0.00323590622177544,0.000158787920294183,0.0128435403096539,0.0445510512053666
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANK2,Ankyrin-2,36391,0.0129160628559918,0.00642964354021839,0.000313961517163754,0.0255181641948198,0.0445765419774239
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,36421,-0.0101298517283912,0.00505288268135163,-0.0200335017838404,-0.000226201672942034,0.0450093977403836
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,36421,-0.0145900597932049,0.00728995206034129,-0.0288783658314739,-0.000301753754936022,0.0453715144342944
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMA,Granzyme A,39291,0.0061149628204275,0.00305585177336563,0.000125493344630871,0.0121044322962241,0.0454026983823299
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,39255,-0.00698659847979017,0.00349178974051183,-0.0138305063711933,-0.00014269058838699,0.0454245086354047
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARTN,Artemin,38841,0.0080911853383683,0.00405259926980132,0.000148090769557713,0.0160342799071789,0.0458930043289674
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,39093,0.00479154048728418,0.0024001094682457,8.73259295226187e-05,0.00949575504504575,0.0459098923199036
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,36420,-0.0152878885800181,0.00767358653622973,-0.0303281181910283,-0.000247658969007778,0.0463625889986803
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,36420,0.017396108978693,0.00873507503628455,0.000275361907575239,0.0345168560498107,0.0464449627979354
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,36731,0.00875440969733836,0.00439588995779637,0.000138465380057479,0.0173703540146192,0.0464471726610968
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE2,Glia-derived nexin,36792,0.0116519799729051,0.00585546808885686,0.000175262518745681,0.0231286974270646,0.0466195115479815
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,36731,0.00758532115702938,0.00381372362672461,0.000110422848649154,0.0150602194654096,0.0467274075151647
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,38997,-0.0108345862785058,0.00544806034323548,-0.0215127845512473,-0.000156388005764268,0.0467517192149819
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,36391,0.00935388998708529,0.00470723887141198,0.000127701799117811,0.0185800781750528,0.0469298601281611
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20,Interleukin-20,38841,0.00876225037402256,0.00440971722722772,0.000119204608656224,0.0174052961393889,0.0469370047487346
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39099,0.0180717318626107,0.0090989728978245,0.000237744982874707,0.0359057187423467,0.047036912846795
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB5,Serpin B5,38832,-0.0087319215126239,0.00439928643640709,-0.0173545229279818,-0.000109320097266007,0.0471794378893286
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,36500,-0.0124621049386567,0.00627909820342568,-0.024769137417371,-0.000155072459942377,0.0471998200334889
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,36767,-0.0120233679408286,0.00606294712226217,-0.0239067443004625,-0.000139991581194789,0.0473785724476876
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,36747,0.00540554315663097,0.00272970121956614,5.53287662813451e-05,0.0107557575469806,0.0476945253043612
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF20,Fibroblast growth factor 20,36430,0.00764930876025969,0.00386302975995943,7.77704307392147e-05,0.0152208470897802,0.0477104719441987
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANG,Angiogenin,39083,0.00603740240865672,0.00305010629611307,5.9194068275102e-05,0.0120156107490383,0.0477881624890089
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,39140,0.00933988702874165,0.00472000566354034,8.86759282025806e-05,0.0185910981292807,0.0478578905370217
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE4,Ribonuclease 4,36418,0.00466879160238853,0.00235960675839608,4.39623559322019e-05,0.00929362084884485,0.0478793557214191
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLNL,Mesothelin-like protein,36421,0.00646730353075016,0.00326972494891373,5.86426308792441e-05,0.0128759644306211,0.0479578548128592
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENAH,Protein enabled homolog,38841,-0.00861404998123571,0.00435822360163255,-0.0171561682404355,-7.1931722035911e-05,0.04811594130304
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,36679,0.00506334341556265,0.00256655887981422,3.28880111267723e-05,0.0100937988199985,0.0485382043561918
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD1,Leiomodin-1,36767,-0.00625711925415767,0.00317178631799242,-0.0124738204374228,-4.04180708925301e-05,0.0485461574322895
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",36792,-0.00535967006671868,0.00272180302743819,-0.0106944040004975,-2.49361329398359e-05,0.048955850305695
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,38994,-0.00463913078371913,0.00235611813287445,-0.00925712232415306,-2.11392432852026e-05,0.0489745158192772
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP12,Macrophage metalloelastase,39130,0.00893050187665521,0.00453992181458455,3.22551200695031e-05,0.0178287486332409,0.0491892094013828
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,36767,0.0152251990417367,0.00773992712566006,5.49418754429935e-05,0.0303954562080304,0.049193242168208
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,36743,-0.00854243522335002,0.00434320122502847,-0.0170551096244058,-2.97608222942138e-05,0.0492216729013089
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSM,Oncostatin-M,39019,0.0126319840798219,0.00644506028588065,-3.3408050412187e-07,0.025264302240148,0.0500201422804556
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,36747,0.0177635252925331,0.00906704668348908,-7.88620710543905e-06,0.0355349367921717,0.0501190663962264
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,36538,0.0148678540941969,0.00761132946424583,-5.03516557248916e-05,0.0297860598441188,0.0507959988405596
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNMT,Histamine N-methyltransferase,38909,-0.00818574619346011,0.00419764454343153,-0.0164131294985859,4.16371116656999e-05,0.0511850268076414
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",38741,0.00534236299062899,0.00274074440065193,-2.94960346487929e-05,0.0107142220159068,0.0512857765012901
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C3,Complement C3,36195,0.00812665297333564,0.004170107931593,-4.67585725866387e-05,0.0163000645192579,0.0513434828893391
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,36339,0.0117236493742564,0.00601592279260032,-6.75592992402021e-05,0.023514858047753,0.0513452868605865
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP5,Fatty acid-binding protein 5,39208,0.0119927190400168,0.00616560097081855,-9.18588627875517e-05,0.0240772969428212,0.0517810135006846
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,36731,-0.00513371794221513,0.00263958714629559,-0.0103073087489545,3.98728645242185e-05,0.051809453505455
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,39106,0.0225480943102672,0.0116154635764868,-0.000218214299646868,0.0453144029201813,0.0522507936261308
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABHD14B,Protein ABHD14B,38927,0.0100870873028797,0.00519859855004387,-0.000102165855206237,0.0202763404609657,0.0523561133100759
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP7,Caspase-7,36747,0.0148079070171856,0.00764199397232901,-0.000170401168579248,0.0297862152029505,0.0526814082649322
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,38789,0.00879682768871596,0.00454168294994979,-0.000104870893185623,0.0176985262706175,0.0527752815655835
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,36538,0.0114933196578973,0.00593997870018179,-0.000149038594458964,0.0231356779102536,0.0530236502545286
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,39068,0.00665221465782315,0.00343922606238328,-8.86684244480749e-05,0.0133930977400944,0.0531047969882322
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,39283,0.00594071546268793,0.00307143348296279,-7.92941639191306e-05,0.011960725089295,0.0531088601333866
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F9,Coagulation factor IX,39145,-0.0031859066414249,0.00164801571637216,-0.00641601744551433,4.42041626645333e-05,0.0532328008377711
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BID,BH3-interacting domain death agonist,39099,0.0115600085167058,0.00598159257721556,-0.000163912934636681,0.0232839299680483,0.0533043568906016
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39140,-0.0151846088416054,0.00786624033350373,-0.0306024398952727,0.000233222212061939,0.0535817827714341
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXJ3,Forkhead box protein J3,36430,-0.00786088598655936,0.00407440928216511,-0.015846728179603,0.000124956206484257,0.0537122088084864
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCP1,Plastin-2,36791,0.00817701246897396,0.00423911531835201,-0.000131653554995987,0.0164856784929439,0.0537597787722918
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REST,RE1-silencing transcription factor,36339,0.00625691105871437,0.00324404645889142,-0.000101420000712811,0.0126152421181416,0.0537862266229462
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",38939,0.00699274653299474,0.0036283198093457,-0.000118760293322829,0.0141042533593123,0.0539649388469448
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,36391,0.0100537686160332,0.00521869879538222,-0.00017488102291591,0.0202824182549824,0.0540658667821485
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN4,Nectin-4,39147,0.00513101630349261,0.00266391866600364,-9.02642818745233e-05,0.0103522968888597,0.0541084150796404
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDHB15,Protocadherin beta-15,36731,-0.00690486630272544,0.0035855602932322,-0.0139325644774605,0.000122831872009665,0.0541585207276606
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEF,Thyrotroph embryonic factor,36391,0.00737833642899295,0.00384107736596298,-0.000150175208294488,0.0149068480662804,0.0547666208624483
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAP,Prosaposin,36705,0.00487263401886882,0.00253699214026012,-9.98705760410111e-05,0.00984513861377864,0.0547999458453325
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUCL3,Mucin-like protein 3,36339,0.00778411994993168,0.00405339454750364,-0.000160533363175445,0.0157287732630388,0.0548307478984945
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM2,Myomesin-2,36391,-0.00899330089471207,0.00468335760212398,-0.0181726817948751,0.000186080005450931,0.0548467506899211
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,39106,-0.00442700474225537,0.0023096447845965,-0.00895390852006452,9.98990355537766e-05,0.0552887517255932
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL34,Interleukin-34,38713,-0.00619162024363704,0.00323062650009598,-0.0125236481838252,0.000140407696551072,0.055315749231425
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39171,0.0194847525492746,0.0101688610487799,-0.000446215106334052,0.0394157202048833,0.0553684914570149
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,38841,-0.00729189755997677,0.00381001517075278,-0.0147595272946522,0.000175732174698672,0.0556550031100645
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB2,Calretinin,38741,0.00505483552031499,0.00264205897995979,-0.000123600080406193,0.0102332711210362,0.0557392840247343
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPN3,Calpain-3,36731,-0.00652473405931681,0.00341204989186793,-0.0132123518473779,0.00016288372874432,0.0558647451772586
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2B,Alpha-amylase 2B,38106,0.00826867810531882,0.00433534716503337,-0.000228602338146583,0.0167659585487842,0.0565057082430935
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN2,Nectin-2,39086,-0.0048615388006856,0.00254936104002366,-0.00985828643913197,0.000135208837760764,0.0565440973321389
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL19,C-C motif chemokine 19,39241,0.0198746147989824,0.0104260609920903,-0.000560464745514543,0.0403096943434794,0.0566371924553475
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PITHD1,PITH domain-containing protein 1,36311,0.0136535874791494,0.0071711133961584,-0.000401794777321092,0.0277089697356198,0.0569370718131079
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST13,Hsc70-interacting protein,36500,-0.00951366473123852,0.00499684000704316,-0.0193074711450431,0.000280141682566078,0.0569411753696137
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39147,-0.00439429759385303,0.0023112828517044,-0.00892441198319366,0.0001358167954876,0.0572896988826352
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,36500,-0.0134130920902668,0.00705877234694605,-0.027248285890281,0.000422101709747505,0.0574293714697382
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,39099,0.00594934613559699,0.00313723558965802,-0.000199635620132716,0.0120983278913267,0.0579305919460652
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,39147,-0.0049067472945672,0.00258824973130549,-0.00997971676792596,0.000166222178791564,0.058008227607432
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,36747,0.00610769840648795,0.00322418764719034,-0.00021170938200512,0.012427106194981,0.0582026424204943
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,36629,-0.00511134323189161,0.0027008369402709,-0.0104049836348226,0.000182297171039364,0.0584465313897844
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,39291,0.00957236262203569,0.00505992163706397,-0.000345083786609681,0.0194898090306811,0.0585362636964227
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,39283,-0.00547539744935311,0.0028971666817756,-0.0111538441456333,0.00020304924692706,0.0587881245951473
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,38727,-0.00978308470853095,0.00517658060208424,-0.0199291826886161,0.000363013271554167,0.058794259071067
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPK2,SRSF protein kinase 2,39099,-0.0144315558093858,0.00763672915980864,-0.0293995449626107,0.000536433343839134,0.0588095445213477
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGA,Fibrinogen alpha chain,36517,0.00525131775300415,0.00278014694763776,-0.000197770264365868,0.0107004057703742,0.0589329794448907
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",39162,-0.00459701853342042,0.00243543174121464,-0.00937046474620112,0.000176427679360277,0.0591042267638575
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX7,Syntaxin-7,36430,0.00839360933152548,0.00445036849455818,-0.000329112917808558,0.0171163315808595,0.0593114985168424
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,36391,0.0121906207496614,0.00647177348662464,-0.000494055284122887,0.0248752967834457,0.0596341171088842
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASET2,Ribonuclease T2,39209,-0.00433586587758854,0.00230573760306136,-0.0088551115795888,0.000183379824411721,0.0600632365586521
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLU,Clusterin,36806,0.00536464610514869,0.00286526372599479,-0.000251270797801105,0.0109805630080985,0.0611870162598083
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,36430,0.00361344447741371,0.00193035809521954,-0.000170057389216594,0.00739694634404401,0.0612431295872188
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,38727,0.0143804042632389,0.00769223993919017,-0.000696386017573828,0.0294571945440516,0.0615772320855919
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNXB,Tenascin-X,39093,-0.00433516877259168,0.00232578660779729,-0.00889371052387437,0.000223372978691008,0.0623468124991931
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,36792,0.0152916282430639,0.00820711752594395,-0.000794322107786228,0.0313775785939141,0.062454610609468
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH4,Cadherin-4,36363,0.00791090992418638,0.00425112986799454,-0.000421304617082917,0.0162431244654557,0.0627823418229674
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",36731,0.00615137568988854,0.0033076842782268,-0.000331685495435993,0.0126344368752131,0.0629475602695672
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,36420,-0.00552277695637262,0.00297035464670435,-0.0113446720639131,0.000299118151167899,0.0630081584529891
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGT,Angiotensinogen,36796,-0.00373889149073339,0.00201140782591777,-0.00768125082953222,0.000203467848065441,0.0630720793431519
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATOX1,Copper transport protein ATOX1,39147,0.012190586446307,0.00657344707907934,-0.000693369828688548,0.0250745427213025,0.0636841021074839
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,36743,0.0109157008575093,0.0058949320984958,-0.000638366055542494,0.022469767770561,0.0640904362555224
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,36420,0.00951066005585582,0.00515083848547176,-0.000584983375668834,0.0196063034873805,0.0648533805882637
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,36339,0.00699436274641457,0.00379542139913719,-0.000444663195894328,0.0144333886887235,0.065375755871315
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,36363,-0.00726738799621782,0.0039492002825704,-0.0150078205500558,0.000473044557620162,0.0657599787377419
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN3,Calsyntenin-3,36747,-0.0050280515508561,0.00273284101563367,-0.0103844199414981,0.000328316839785903,0.065811419366366
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH4,Myosin-4,36391,0.00798244128099677,0.00434521786787048,-0.000534185740029376,0.0164990683020229,0.0662241846137653
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR1,Complement receptor type 1,36772,-0.00588819241514029,0.0032197655447805,-0.0121989328829101,0.000422548052629496,0.0674579734500931
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLON5,IgLON family member 5,36339,0.0152980007526436,0.00837174330978843,-0.00111061613454167,0.031706617639829,0.0676729048057027
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39093,-0.00770962688145954,0.00422395204193624,-0.0159885728836546,0.000569319120735504,0.067987939699672
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF7,Fibroblast growth factor 7,36339,0.0131773209372138,0.00722634342392404,-0.000986312173677268,0.027340954048105,0.068249853386523
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL3,Insulin-like 3,36747,0.0119860632574111,0.00658332099830973,-0.000917245899275995,0.0248893724140982,0.0686800256289333
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,36421,0.0171540303673971,0.00942316472910227,-0.0013153725016434,0.0356234332364375,0.0687202612427882
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRC1,Macrophage mannose receptor 1,36796,0.00452637656025791,0.00248721299738778,-0.000348560914622136,0.00940131403513796,0.0688036049662653
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LARP1,La-related protein 1,36731,-0.0105233341282766,0.00578338739334487,-0.0218587734192326,0.000812105162679329,0.0688462598555395
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,39099,0.0172001218986064,0.00945749318752797,-0.00133656474894838,0.0357368085461613,0.0689803975014537
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRP15,RRP15-like protein,36363,0.0149433423463335,0.00821694782968766,-0.0011618753998543,0.0310485600925213,0.068996372180933
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,36747,0.00647201319778112,0.00356550685142809,-0.000516380231017939,0.0134604066265802,0.0695205003047622
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAND5,DAN domain family member 5,36430,0.00886733771139498,0.00488602701944872,-0.000709275246724508,0.0184439506695145,0.0695729405096965
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NINJ1,Ninjurin-1,38727,0.00924100683565798,0.00509472110087239,-0.00074464652205191,0.0192266601933679,0.0697225764946924
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOSB,Protein fosB,38741,-0.00633984261485906,0.00349677383794892,-0.0131935193372389,0.00051383410752081,0.0698435073934459
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCC,Tubulin-specific chaperone C,38987,0.0132988419111664,0.00734940742657355,-0.0011059966449178,0.0277036804672505,0.0703913171584612
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,36743,-0.00824296272563691,0.00455857916032841,-0.0171777778798806,0.000691852428606773,0.0705939128323189
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,36548,-0.00682521678496506,0.00377491710601129,-0.0142240543127472,0.000573620742817069,0.0706232980445168
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,39099,-0.00706064048205627,0.00392300573278468,-0.0147497317183143,0.00062845075420171,0.0719114010777109
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,39165,-0.00451060213970446,0.00250692614151484,-0.00942417737707354,0.000402973097664622,0.0719978703008813
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSG1,Tryptase gamma,36430,0.00437166059709407,0.00242967731736449,-0.00039050694494033,0.00913382813912847,0.0719989739455157
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,36500,0.010879272027875,0.00605412231026219,-0.000986807700238906,0.0227453517559889,0.072359109665369
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,36743,-0.0136247859734039,0.00758592275692097,-0.028493194576969,0.00124362263016124,0.0725081128590648
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,39099,-0.0168663201874023,0.0093930348641455,-0.0352766685211274,0.0015440281463229,0.0725747950901219
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,36767,-0.0124625884189841,0.00694057309319742,-0.026066111681651,0.00114093484368284,0.0725793511414366
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,36731,0.00909560556387786,0.00506596754154338,-0.00083369081754717,0.0190249019453029,0.0726081796494805
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RUVBL1,RuvB-like 1,38727,-0.0164385808316325,0.0091638873178159,-0.0343997999745517,0.00152263831128665,0.0728584453995398
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT1,Deaminated glutathione amidase,36420,-0.00760632407642709,0.00424189904781838,-0.0159204462101511,0.000707798057296929,0.0729743956312986
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTDH,Protein LYRIC,36430,0.0150592730504129,0.00840901538220811,-0.00142239709871498,0.0315409431995408,0.0733416541407162
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,36391,0.00752851770524069,0.00422242063592532,-0.000747426741172947,0.0158044621516543,0.0746127497260064
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,36538,0.0102577787778676,0.00575643971424636,-0.00102484306205528,0.0215404006177905,0.0747787344482653
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39147,0.0055505089652804,0.00312048606432057,-0.000565643720787927,0.0116666616513487,0.0753035488171352
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL4,Delta-like protein 4,36420,-0.0140128644813059,0.007879255551591,-0.0294562053624243,0.00143047639981241,0.0753541093922605
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOP56,Nucleolar protein 56,36391,0.0176566814665349,0.00993401406450335,-0.00181398609989167,0.0371273490329615,0.0755272808007444
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXLNA,Alpha-taxilin,38987,-0.0143327090636219,0.00806646304685605,-0.0301429766354597,0.00147755850821599,0.075616804913257
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,36538,0.0100238265561712,0.00565353799747584,-0.00105710791888149,0.0211047610312238,0.0762496727372584
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CABP2,Calcium-binding protein 2,36421,0.0105798974957646,0.00596900668921499,-0.00111935561509676,0.022279150606626,0.0763404647897193
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLUL1,Clusterin-like protein 1,39079,0.00724204759864289,0.00408813043239458,-0.000770688048850484,0.0152547832461363,0.07650066731448
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,36792,0.0142862878625737,0.00806599215845079,-0.00152305676798989,0.0300956324931372,0.0765550672067178
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK11,Kallikrein-11,39017,-0.00466980741663419,0.00263788218721414,-0.00984005650357391,0.000500441670305532,0.0766995116900025
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD1,Glutamate decarboxylase 1,36339,0.00415945001732416,0.00235333076766038,-0.000453078287290181,0.0087719783219385,0.0771733803789501
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,39106,0.0106488846054225,0.00603746571769209,-0.00118454820125401,0.022482317412099,0.0777856110085141
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRD2,Protein ZNRD2,36743,-0.0108815266744785,0.00617017132910878,-0.0229750624795317,0.00121200913057475,0.0778281673228186
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCLRE1C,Protein artemis,36339,0.00496299068022826,0.00281712731151945,-0.00055857885034987,0.0104845602108064,0.0781410304952253
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],38841,0.00869148567460657,0.00493546169902692,-0.000982019255486195,0.0183649906046993,0.0782540820535403
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,36791,-0.00940004476937371,0.00534941166907344,-0.0198848916407577,0.00108480210201023,0.0789055215299665
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",39093,0.0123549319284785,0.00703520832803072,-0.00143407639446167,0.0261439402514188,0.0790816597403662
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,36743,-0.00471005318469463,0.00268385304389873,-0.00997040515073613,0.000550298781346873,0.0792900168642036
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,36363,0.0117023177916086,0.00666971128269283,-0.00137031632246939,0.0247749519056865,0.0793614234284456
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,36363,0.00998279141133506,0.00569001022136325,-0.0011696286225369,0.021135211445207,0.0793793395377213
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR2,Complement factor H-related protein 2,36723,0.0089803402146105,0.0051199259510416,-0.00105471464943103,0.019015395078652,0.0794546508589573
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,36767,0.00615629444643283,0.00351046811742891,-0.000724223063727829,0.0130368119565935,0.0795063178237679
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,39099,-0.0168713863326891,0.00962071408877792,-0.0357279859466939,0.00198521328131558,0.0795102242054418
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTBDN,Retbindin,39023,0.00466226363469506,0.00265882748786276,-0.000549038241515954,0.00987356551090607,0.0795358015878965
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN3,Perilipin-3,39106,-0.00682934057138905,0.00389537125870924,-0.0144642682384592,0.000805587095681064,0.0795888498420416
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,36747,-0.0173548343046655,0.00990970047215407,-0.0367778472300875,0.00206817862075643,0.0799184555281563
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,36767,-0.00760336433989877,0.00434240241634727,-0.0161144730759394,0.000907744396141881,0.079976895590848
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1A,Protein phosphatase 1A,38727,0.00482032199621067,0.00275983578549307,-0.000588956143355742,0.0102296001357771,0.0807278501749265
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLMH,Bleomycin hydrolase,39283,0.00505500924549483,0.002894412526087,-0.000618039305635692,0.0107280577966254,0.0807489468738227
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,38841,-0.0111399267795959,0.00638224422159261,-0.0236491254539174,0.0013692718947256,0.0809260177255876
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,38502,-0.00463672625744961,0.00265709985404618,-0.00984464197138012,0.000571189456480901,0.0810001473454249
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,36500,0.0130363557219736,0.00750360162446161,-0.00167070346197118,0.0277434149059183,0.0823503932683556
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6,Interleukin-6,39023,-0.0111251835530114,0.00640807945892824,-0.0236850192925107,0.001434652186488,0.082563244297809
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASHC3,WASH complex subunit 3,36747,-0.0119071931788538,0.00687377944268709,-0.0253798008865205,0.00156541452881291,0.0832506891629214
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",36750,-0.00632412561342012,0.00365321715916884,-0.013484431245391,0.000836180018550818,0.0834558389965645
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17F,Interleukin-17F,38841,0.0120438336767948,0.00695800460119602,-0.00159385534154941,0.025681522695139,0.083484461530535
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSB,Arylsulfatase B,39023,0.00867432619249289,0.00501284882355689,-0.00115085750167861,0.0184995098866644,0.0835758821366817
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",36430,0.00554060824194622,0.00320648369201608,-0.000744099794405297,0.0118253162782977,0.0840237205731023
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARC,SPARC,39147,0.0109894159918799,0.00636250915296747,-0.00148110194793636,0.0234599339316961,0.0841494054138448
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,36500,0.00392037525611479,0.00227140947972924,-0.000531587324154524,0.0083723378363841,0.0843779894701297
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,36363,0.00924204627468322,0.00535482011374884,-0.0012534011482645,0.0197374936976309,0.0843846589939239
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,36747,-0.010879035158058,0.00630382427283603,-0.0232345307328166,0.00147646041670062,0.0844103616112276
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,39023,0.011368080835006,0.00659851190203355,-0.00156500249297973,0.0243011641629918,0.0849405774814975
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX4,Syntaxin-4,39023,-0.00923456086116923,0.00536126856197052,-0.0197426472426315,0.00127352552029299,0.0850069444574903
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,36421,-0.0104563281598214,0.00607986491091637,-0.0223728633852175,0.00146020706557465,0.0854881572919453
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC79,Protein unc-79 homolog,36339,-0.00887196320744055,0.00515929725457487,-0.0189841858264073,0.0012402594115262,0.0855287155654211
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,36743,0.0045097032754698,0.00262939894142774,-0.000643918649728567,0.00966332520066816,0.0863494671005957
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOH,Beta-2-glycoprotein 1,39093,0.00549567885382773,0.00320523387210819,-0.000786579535504328,0.0117779372431598,0.0864397958136891
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA3,Annexin A3,39218,0.0108186799846569,0.00631312994951421,-0.00155505471639092,0.0231924146857048,0.0866078238643714
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,36420,-0.00484621722409742,0.00282935965418945,-0.0103917621463087,0.000699327698113897,0.0867681660738683
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,35842,-0.00802884022483715,0.00469381569590594,-0.0172287189888128,0.0011710385391385,0.0871966442832765
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN9,Septin-9,39023,0.00438132405580078,0.00256223527992946,-0.000640657092860949,0.00940330520446252,0.0872934242271226
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,36743,-0.00778182896967619,0.00455206562674453,-0.0167038775980955,0.00114021965874309,0.08737949459132
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,39162,-0.00402719420154944,0.00235971730477303,-0.00865224011890459,0.000597851715805707,0.0879087817638327
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",36743,0.0227613564394607,0.0133524672051935,-0.00340947928271869,0.04893219216164,0.0882828080098201
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,36791,-0.00505647183525277,0.00296756941996625,-0.0108729078983866,0.000759964227881067,0.088421889123663
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,36391,-0.0149948355157974,0.00880679372409912,-0.0322561512150317,0.00226648018343691,0.0886594893850985
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN2,Neuroligin-2,36363,0.00730133584437337,0.00429500368097283,-0.00111687137033339,0.0157195430590801,0.0891632610101147
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,38812,0.006286610423086,0.00370061400595762,-0.000966593028590938,0.0135398138747629,0.0893773032466522
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC9,Histone deacetylase 9,36363,0.00985307188536053,0.00580577998466895,-0.0015262568845906,0.0212324006553117,0.0896999532639535
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGB,Secretogranin-1,39185,0.00604978943337296,0.0035696977066931,-0.000946818071745505,0.0130463969384914,0.0901408206185263
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,39274,0.00768507792539886,0.00453585157986731,-0.00120519117114107,0.0165753470219388,0.0902291372050838
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",36421,-0.00747625043506841,0.00441344963270946,-0.0161266117151789,0.00117411084504214,0.0902958117775894
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",36391,0.00605824315201957,0.00358401468882963,-0.000966425638086503,0.0130829119421257,0.0909856767774112
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,36339,0.0221068470275099,0.013089718858007,-0.0035490019341838,0.0477626959892036,0.0912691304148132
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,39241,0.00890454248725955,0.00527351222193333,-0.00143154146772977,0.0192406264422489,0.0913276642127569
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,36420,-0.0113630632439374,0.00673444612167479,-0.0245625776424199,0.00183645115454524,0.0915695897090011
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36363,0.00863991001628443,0.00512124744115851,-0.00139773496838624,0.0186775550009551,0.0916145714239196
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORT1,Sortilin,39086,-0.00569792490562799,0.0033789182435159,-0.0123206046629192,0.00092475485166317,0.0917553806666553
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,36420,-0.00700289209571834,0.00415385965386021,-0.0151444570172843,0.00113867282584767,0.0918445330614749
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",38841,0.0185198580945664,0.0109880025015289,-0.00301662680843025,0.040056342997563,0.0919203417364142
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B2M,Beta-2-microglobulin,36806,0.0046549032766231,0.00276545339307384,-0.000765385373801632,0.0100751919270478,0.0923540454957309
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIT2,Slit homolog 2 protein,38741,-0.00783426089165948,0.00465770646933308,-0.0169633655715523,0.00129484378823336,0.0925898792119571
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSPN,Persephin,39099,-0.0143291495973164,0.00851990978082547,-0.0310281727677343,0.00236987357310152,0.0926198006570475
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,36743,0.00723896804040797,0.00430594120985289,-0.0012006767309037,0.0156786128117196,0.0927564448932269
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,36430,0.00620691680424134,0.00369390268334708,-0.00103313245511894,0.0134469660636016,0.0929210645068607
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1A,Lithostathine-1-alpha,39046,-0.00706135825860437,0.00420343087119718,-0.0153000827661509,0.0011773662489421,0.0929966604948976
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17D,Interleukin-17D,38841,0.00510077117890881,0.00304224321595262,-0.000862025524358324,0.011063567882176,0.0936321875546697
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI3,Elafin,38840,0.00799756476003908,0.00477052424703025,-0.0013526627641402,0.0173477922842184,0.0936701532027903
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,39241,-0.0071656323064423,0.00427613331173841,-0.0155468535974496,0.00121558898456499,0.0938119921035811
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,36743,-0.016427528451371,0.00981619114169793,-0.0356672630890989,0.00281220618635696,0.0942505270154042
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,38727,-0.00787308374061349,0.0047129113051405,-0.0171103898986889,0.0013642224174619,0.0948345909355355
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,39062,0.00339670255410932,0.00203533150322957,-0.000592547192220644,0.00738595230043928,0.095163848382516
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,39147,0.0126480706082963,0.00758416630718261,-0.00221689535378156,0.0275130365703743,0.0953969176614329
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,36363,0.00933454523616881,0.00559939688115344,-0.00164027265089194,0.0203093631232296,0.0955269994024553
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",36391,0.00769097333542895,0.00461634521417551,-0.00135706328435504,0.0167390099552129,0.0957322732002157
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRXN3,Neurexin-3,36421,0.00530250933384978,0.00318273616871141,-0.000935653556824592,0.0115406722245242,0.0957339136946904
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,39283,0.0034108493556425,0.00204762379234795,-0.000602493277359479,0.00742419198864448,0.0957815787367509
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,36430,0.0143361354895175,0.00862226041241631,-0.0025634949188185,0.0312357658978534,0.0963996847184886
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL8,Interleukin-8,38990,-0.00989152402130298,0.00596014634408621,-0.021573410855712,0.00179036281310598,0.0970134724715897
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMCH,Pro-MCH,36391,0.0124621678454046,0.00752039467045383,-0.00227780570868486,0.0272021413994941,0.0975210178575336
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK3,Dickkopf-related protein 3,39283,0.00431110400898476,0.00260337620700381,-0.000791513356742702,0.00941372137471223,0.0977489291769958
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F13B,Coagulation factor XIII B chain,36737,-0.00381400342414988,0.00230371370135917,-0.00832928227881386,0.000701275430514103,0.0978294147047884
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,36767,-0.0159822832576042,0.00965840989127987,-0.0349127666445128,0.0029482001293043,0.0979989143948802
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,36343,0.00834760245664939,0.00504573849105301,-0.00154204498581451,0.0182372498991133,0.0980741161270583
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,36500,0.0128897465245837,0.00779436894364898,-0.00238721660496834,0.0281667096541357,0.0982081347134392
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGLL,Monoglyceride lipase,39140,0.013056759521311,0.00790346437681365,-0.00243403065724374,0.0285475496998658,0.0985490012805106
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMD,Dystrophin,36420,-0.00773695598617344,0.00468798052324675,-0.0169253978117371,0.00145148583939019,0.0988899506389413
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39121,0.00349042562954608,0.00211790036513062,-0.000660659086109925,0.00764151034520209,0.099361065683901
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,38727,-0.00856041792322583,0.00519438572326015,-0.0187414139408157,0.00162057809436406,0.0993710271021492
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,38741,-0.0100437608903267,0.00609694958512781,-0.0219937820771772,0.00190626029652381,0.0995088909660342
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOST,Sclerostin,39086,0.00568508105845158,0.00345439932460773,-0.00108554161777957,0.0124557037346827,0.0998356793781678
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,36747,0.00720427884909596,0.00438325992477331,-0.00138691060345972,0.0157954683016516,0.100285472077119
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,39004,-0.0068987613477373,0.00420455319416337,-0.0151396856082975,0.0013421629128229,0.100863139285813
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA5,Annexin A5,38674,0.00447382881770343,0.00272780834446239,-0.000872675537442851,0.00982033317284971,0.10100939185113
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,36363,0.00426819281628789,0.002609140754793,-0.000845723063106385,0.00938210869568216,0.101893755257475
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,36792,0.00409072797990641,0.00250173205315987,-0.000812666844286944,0.00899412280409976,0.102040201083486
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,39106,-0.00652176495443341,0.0039895919222066,-0.0143413651219583,0.00129783521309152,0.102133699707838
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,36407,-0.0041312352308004,0.00252848471623748,-0.00908706527462587,0.000824594813025065,0.102309585619066
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,36767,0.0124772045798613,0.00766237534504154,-0.00254105109642016,0.0274954602561427,0.103470240480915
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,36500,0.0166362411760418,0.0102181434071126,-0.00339131990189894,0.0366638022539826,0.103526906999667
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,36391,0.00586530142953419,0.00360726776309369,-0.00120494338612944,0.0129355462451978,0.10398163944597
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,39106,-0.00408238736740701,0.00251206064992592,-0.00900602624126182,0.000841251506447807,0.104158733715467
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1,Methionine aminopeptidase 1,38741,-0.00446190100326734,0.00274797246488816,-0.00984792703444814,0.000924125027913463,0.104459624098921
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,36339,-0.00729146959431172,0.00449145094830317,-0.0160947134529859,0.00151177426436249,0.10452689386076
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,39106,0.0118675631676081,0.00731768816254371,-0.00247510563097753,0.0262102319661938,0.104874568968796
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,38727,-0.00497578248736932,0.00306979252142889,-0.01099257582937,0.00104101085463131,0.105063383177563
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,39283,-0.00393257941389629,0.00242775193614251,-0.00869097320873562,0.000825814380943033,0.105286236160705
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN6,Dynactin subunit 6,38741,0.0103999579805308,0.00642467025560991,-0.00219239572046459,0.0229923116815263,0.105521485406574
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHIT1,Chitotriosidase-1,39144,0.0220458224069704,0.0136396161168249,-0.00468782518200635,0.0487794699959471,0.10604834869113
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEO1,Neogenin,36767,-0.00316894714331439,0.00196305612090345,-0.00701653714028515,0.00067864285365638,0.106488399608358
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FN1,Fibronectin,36806,0.00388658598719875,0.00240868617896091,-0.000834438923564628,0.00860761089796213,0.106644899968928
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,39106,-0.00440092131031114,0.00272816646692093,-0.00974812758547617,0.000946284964853893,0.106734245998034
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,39099,-0.00800368806119317,0.00496545212284623,-0.0177359742219718,0.00172859809958544,0.107009855439673
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RYR1,Ryanodine receptor 1,36391,0.00490145442708796,0.00304083874016851,-0.00105858950364231,0.0108614983578182,0.107014149419478
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,39093,-0.00440876414532156,0.00273706249386742,-0.00977340663330169,0.000955878342658582,0.107251696944825
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,36791,0.00371813858152083,0.00230845092289346,-0.000806425227350358,0.00824270239039202,0.107277404148526
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,39093,-0.00341236644741439,0.00212399023309449,-0.0075753873042796,0.000750654409450823,0.108166616765731
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,36747,-0.00602609134193494,0.00375492649842138,-0.0133857472788408,0.00133356459497095,0.108551466414252
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASC3,Protein CASC3,36421,0.00614472020780443,0.00384160789004939,-0.00138483125669237,0.0136742716723012,0.109730746441928
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,39265,-0.00803085067025601,0.00502488701510517,-0.0178796292198621,0.00181792787935012,0.110015607131965
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO4,Roundabout homolog 4,36420,-0.00258096126474438,0.00161521866771897,-0.00574678985347355,0.000584867323984793,0.110089926806625
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_E,,39099,0.00395348792866171,0.00247548024462138,-0.000898453350796196,0.00880542920811962,0.110273297234588
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,36767,0.0098895079382052,0.00619280359286766,-0.00224838710381541,0.0220274029802258,0.110304564783841
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,36731,0.00903513122533561,0.00565941487696142,-0.00205732193350878,0.02012758438418,0.110406668236078
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SWAP70,Switch-associated protein 70,36743,-0.00516818432796181,0.00323782563539429,-0.0115143225733346,0.001177953917411,0.110470946513995
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,36394,0.0123553379802844,0.00774702578315962,-0.00282883255470849,0.0275395085152772,0.110771171448763
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON2,Spondin-2,39017,0.0048255359840552,0.00302977228742351,-0.00111281769929488,0.0107638896674053,0.111247051693165
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,36363,0.00617860036182049,0.00388196028656181,-0.00143004179984065,0.0137872425234816,0.111495699173597
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNU13,NHP2-like protein 1,36391,-0.0089603862084926,0.0056351281959425,-0.0200052374725399,0.0020844650555547,0.111838737639006
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,36731,-0.0110652022543939,0.00696060067889836,-0.0247079795850347,0.00257757507624691,0.111929098737734
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,36743,0.00772464323446878,0.00486027354449384,-0.00180149291273916,0.0172507793816767,0.112007444398533
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,36792,-0.00379829497764137,0.00239048726135844,-0.0084836500099039,0.000887060054621164,0.112102716098286
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",36731,-0.00727141029834704,0.00457933836078751,-0.0162469134854906,0.00170409288879648,0.112339496880975
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,36792,-0.00431468197712357,0.0027174833803959,-0.00964094940269953,0.0010115854484524,0.112367517450282
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,36779,0.00269353002121752,0.00170079120275867,-0.00064002073618947,0.0060270807786245,0.113288223250275
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGN,Mimecan,39093,0.00566304454019722,0.00357968572231145,-0.00135313947553322,0.0126792285559277,0.113671496545247
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,38727,-0.00847199457677516,0.00535529118419865,-0.0189683652978045,0.00202437614425419,0.113674085399071
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,39099,0.00533450985565498,0.00337221393311272,-0.00127502945324595,0.0119440491645559,0.113692839822747
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINH1,Serpin H1,36538,0.0184351907764767,0.0116774510056338,-0.00445261319456565,0.041322994747519,0.11442985520071
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36339,0.011991825813587,0.00759660020995801,-0.00289751059793069,0.0268811622251047,0.114458234938979
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,36500,0.00865860837974501,0.00548584359348504,-0.00209364506348567,0.0194108618229757,0.114509112621409
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,38832,0.00456768959672683,0.00289507908657334,-0.00110666541295692,0.0102420446064106,0.114645882550665
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,39241,-0.00934221689127247,0.00592258821422269,-0.0209504897911489,0.002266056008604,0.114726944257576
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,36747,-0.00842724790350353,0.00534360495530798,-0.0189007136159072,0.00204621780890011,0.114803583960119
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,36363,0.0150860703732247,0.00957184703010023,-0.0036747498057718,0.0338468905522211,0.115030893227574
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",36755,-0.00322330676049891,0.00204802916857308,-0.00723744393090214,0.000790830409904324,0.115544851784643
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300C,CMRF35-like molecule 6,39241,0.00473498113675548,0.00300958557910361,-0.00116380659828759,0.0106337688717985,0.115669926231622
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,36391,0.0088983724364872,0.00565733335215747,-0.00219000093374144,0.0199867458067158,0.11576915324217
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAX,Apoptosis regulator BAX,38713,0.0130381399674808,0.00830054288949551,-0.00323092409593042,0.029307204030892,0.116260289088425
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",36420,0.00368092096469339,0.00234352709440274,-0.00091239214033598,0.00827423406972276,0.116283195369353
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP2,Guanylate-binding protein 2,38841,0.00843132747282502,0.00537485811661544,-0.00210339443574124,0.0189660493813913,0.116748193551836
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM1,Myomesin-1,36363,0.00679467523686767,0.00433274493873189,-0.00169750484304684,0.0152868553167822,0.116856290725717
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,36538,0.00542409615784815,0.00346227860674108,-0.00136196991136437,0.0122101622270607,0.117227062526872
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,36363,0.0108282218789879,0.00691227360403599,-0.00271983438492259,0.0243762781428985,0.117251999146045
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,38841,-0.0080695111691387,0.00515353990327925,-0.018170449379566,0.00203142704128863,0.117412096764254
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTYMK,Thymidylate kinase,36792,-0.00971344292372673,0.00620440281085649,-0.0218740724330054,0.00244718658555198,0.117473181091689
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,36767,0.00941528983045595,0.00601959546005727,-0.0023831172712563,0.0212136969321682,0.117817019435159
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF75D,Zinc finger protein 75D,36538,0.00841596930964036,0.00538740494700175,-0.00214334438648307,0.0189752830057638,0.118276100138186
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCA,Alpha-synuclein,36500,0.0164327540575408,0.0105246127332998,-0.00419548689972678,0.0370609950148083,0.118462867013952
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOC,Myocilin,39093,-0.00647757959934677,0.0041576686567533,-0.0146266101665832,0.0016714509678897,0.119257908918317
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWF,von Willebrand factor,39283,0.0102808813559007,0.00660107307831788,-0.00265722187760232,0.0232189845894038,0.119382760250532
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXIN1,Axin-1,39099,-0.0134002235031954,0.00863822460162461,-0.0303311437223797,0.00353069671598879,0.120857625350959
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,36538,-0.0100172155138862,0.00646027509766478,-0.0226793547053091,0.00264492367753679,0.121025764243778
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,39023,0.0054539864754458,0.0035185339065349,-0.00144233998136261,0.0123503129322542,0.121144724741359
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39046,0.00376369366333791,0.00243023541288681,-0.00099956774592025,0.00852695507259606,0.121475871838095
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD82,CD82 antigen,36538,0.00591757179333602,0.00382134685623261,-0.0015722680448799,0.0134074116315519,0.121513312554564
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAN,Versican core protein,39241,0.00412961062786911,0.00266878658490764,-0.00110121107854986,0.00936043233428809,0.121793691995423
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,38741,-0.0119421446366064,0.00772771929565757,-0.0270884744560953,0.00320418518288241,0.122279337474808
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC1,Hamartin,36430,0.0106117177591854,0.00686860431067974,-0.00285074668974687,0.0240741822081177,0.12238115354027
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNPO1,Transportin-1,36538,-0.00491529789787307,0.00318239128650044,-0.0111527848194139,0.00132218902366779,0.122485018252257
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,36767,0.00496784702417868,0.00321928675788706,-0.00134195502127996,0.0112776490696373,0.122818550003542
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,39099,0.00651043339602305,0.00422251395096084,-0.0017656939478602,0.0147865607399063,0.123133675493593
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,36731,0.00719975987991276,0.0046704108130867,-0.00195424531373717,0.0163537650735627,0.1232029809076
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRELP,Prolargin,39095,0.00309505924571605,0.00200783362128658,-0.00084029465200564,0.00703041314343774,0.123217884054401
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN4,CCN family member 4,39255,-0.00556413505130021,0.00361536948492143,-0.0126502592417462,0.00152198913914578,0.123819350873468
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39218,0.00391336250204445,0.00254365717437421,-0.001072205559729,0.00889893056381791,0.123952202461979
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPL,Periplakin,36430,-0.00448052745851767,0.00291301434143327,-0.0101900355677269,0.00122898065069155,0.124047649505375
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO2,Gamma-enolase,39241,0.0092058894892293,0.00599064658653186,-0.00253577782037314,0.0209475567988317,0.124384789123952
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],38739,-0.00673651313426321,0.00438596305841374,-0.0153330007287541,0.00185997446022773,0.124577880955174
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",36430,0.00413242584338614,0.00269409463237321,-0.00114799963606535,0.00941285132283762,0.125083616494545
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED8,Protein TMED8,36743,0.0143659998024187,0.00938077888029366,-0.00402032680295687,0.0327523264077943,0.125687876490596
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,36420,-0.00756016284601434,0.00493760883425532,-0.0172378761611548,0.00211755046912609,0.125760358104797
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSV,Cathepsin L2,39195,-0.00565782365110263,0.00369592161554158,-0.0129018300175641,0.00158618271535887,0.125832310236432
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39099,0.0115541229668537,0.00755161326161387,-0.00324703902590948,0.0263552849596169,0.126032415522701
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B4,Protein ATP1B4,36339,0.0058059346492273,0.00379591071212703,-0.00163405034654168,0.0132459196449963,0.126160063793093
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZN,Kazrin,36743,-0.0144622937368192,0.00945635727289724,-0.0329967539916978,0.00407216651805942,0.126196651961799
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELP,P-selectin,39165,0.00794528339703555,0.00520440864777738,-0.00225535755260812,0.0181459243466792,0.126870024623516
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,36767,0.0159765002123617,0.0104659152898315,-0.00453669375570794,0.0364896941804314,0.126903223483361
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36339,-0.00782256463180015,0.00512775051289161,-0.0178729556370677,0.00222782637346741,0.127150967655566
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F3,Tissue factor,39160,-0.00373128165449441,0.00244614540401663,-0.00852572664636701,0.00106316333737819,0.127187013437412
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,36421,0.00673361417145069,0.00441448412709745,-0.00191877471766032,0.0153860030605617,0.127198083161543
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,38741,0.0117268171328997,0.00769523399883036,-0.0033558415048078,0.0268094757706072,0.127553318790205
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,36806,0.00239809691523945,0.00157440961050931,-0.000687745921358798,0.00548393975183771,0.12774006006991
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,36420,-0.00720548328148632,0.00473117613209004,-0.0164785885003828,0.00206762193741016,0.127789061685268
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG3,Secretogranin-3,39117,0.00448111094239131,0.0029430500159236,-0.00128726708881895,0.0102494889736016,0.127877579389532
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR1,Toll-like receptor 1,36430,0.00360338851589784,0.00236666067494952,-0.00103526640700323,0.0082420434387989,0.127893382183459
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,36391,0.0120370745375838,0.00793452613421112,-0.00351459668547005,0.0275887457606376,0.129279233165759
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,36507,0.00698959039285307,0.00460995630508204,-0.00204592396510772,0.0160251047508139,0.129495171308734
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,39028,0.00616182201793202,0.00406556360544058,-0.00180668264873153,0.0141303266845956,0.129638016020617
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39041,-0.0255721719500264,0.0168799367355957,-0.0586568479517939,0.00751250405174117,0.1298072096409
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,39255,0.00488689276252243,0.0032281296699528,-0.00144024139058505,0.0112140269156299,0.13008530748189
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2,Microtubule-associated protein 2,36747,0.00633202679853557,0.00418522516865,-0.00187101453201843,0.0145350681290896,0.130317465992907
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD226,CD226 antigen,36430,0.0057540072364611,0.00380831658690925,-0.00171029327388104,0.0132183077468032,0.130837615532844
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK12,Kallikrein-12,38727,0.0187896116216569,0.0124402428970238,-0.00559326445650971,0.0431724876998236,0.130965331643087
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,36363,0.00522008164926151,0.0034570140690334,-0.00155566592604396,0.011995829224567,0.131069402417974
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,36731,-0.0060863081570596,0.00404020368337478,-0.0140051073764742,0.00183249106235496,0.13197983341083
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,36538,0.00980787551479714,0.0065200927499427,-0.00297150627509054,0.0225872573046848,0.13254089182321
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,36767,-0.00898182399331789,0.00597163579593749,-0.0206862301533554,0.00272258216671959,0.132584977295639
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRND,Prion-like protein doppel,36747,-0.00690881610459526,0.00459642585072504,-0.0159178107720163,0.00210017856282581,0.132841778444734
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,36743,-0.00652800765917104,0.00434760924094471,-0.0150493217714227,0.00199330645308059,0.133246491738634
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKIV2L,Helicase SKI2W,36391,0.00550555628316929,0.00366686533124871,-0.00168149976607817,0.0126926123324168,0.133268541567908
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN1,Transcobalamin-1,36591,0.00463358570254326,0.00309232405011604,-0.00142736943568418,0.0106945408407707,0.134050174608451
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRG,Histidine-rich glycoprotein,36737,-0.00429466388991379,0.00286749124240476,-0.00991494672502712,0.00132561894519953,0.134233705392507
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTR,Methionine synthase,36391,0.00871822058537728,0.00582648961867553,-0.00270169906722676,0.0201381402379813,0.134598704956919
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,39255,-0.00446849297128165,0.00298869203497742,-0.0103263293598374,0.0013893434172741,0.134900154872023
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,38502,0.00632233062160889,0.00423660511602348,-0.00198141540579714,0.0146260766490149,0.135639290395308
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,36430,-0.0132386995048508,0.00887594268079829,-0.0306355471592155,0.00415814814951381,0.135848537966692
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR5,Cadherin-related family member 5,39106,0.00523279505786976,0.00350939332602805,-0.00164561586114522,0.0121112059768847,0.135960518777245
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,39283,0.00552425809645468,0.00370832104811592,-0.00174405115785253,0.0127925673507619,0.13632555280526
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,36733,-0.00800845146445572,0.00537589355472152,-0.0185452028317099,0.00252829990279846,0.136328473386384
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,36767,0.00374293563276989,0.00251546185018034,-0.00118736959358356,0.00867324085912335,0.136782830144247
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAGE2A,G antigen 2A,36339,0.00822777126946267,0.00553431398949156,-0.00261948414994078,0.0190750266888661,0.137123783178542
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36339,0.00454048239841376,0.00305413733859182,-0.00144562678522622,0.0105265915820537,0.137128288482933
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USO1,General vesicular transport factor p115,39023,0.012043993381406,0.00811411442577536,-0.00385967089311375,0.0279476576559257,0.137743164889505
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,39023,-0.0153216533048179,0.0103289418472599,-0.0355663793254473,0.00492307271581154,0.137996639090237
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB2A2,Mammaglobin-A,36391,0.00416256729961539,0.00281990470067144,-0.00136444591370064,0.00968958051293141,0.139932089394474
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNMBP,Dynamin-binding protein,38987,-0.00827735346713591,0.00560955772794573,-0.0192720866139096,0.00271737967963772,0.140077381989212
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,36743,0.0188145123694749,0.0127537606196298,-0.00618285844499958,0.0438118831839494,0.140179748168532
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,39291,0.00487789907649585,0.00331185235083004,-0.00161333153113104,0.0113691296841227,0.140808841861555
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEP,Leptin,39106,-0.00901382718147679,0.00612111176472644,-0.0210112062403406,0.00298355187738703,0.140884945221383
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,36339,0.00349554201386831,0.00237559842849998,-0.00116063090599166,0.00815171493372828,0.141198349792547
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VGF,Neurosecretory protein VGF,36767,0.00387704606329053,0.00264475751313457,-0.00130667866245323,0.00906077078903428,0.142690000080855
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,39147,0.0044969976569186,0.00306973130806681,-0.00151967570689235,0.0105136710207296,0.142955589024901
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD2,Polycystin-2,36391,0.00790879471756957,0.00540599065532999,-0.00268694696687722,0.0185045364020164,0.143501044623347
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRB1,Chymotrypsinogen B,39093,-0.00701773290910028,0.00480768050085912,-0.0164407866907842,0.0024053208725836,0.144395354619926
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS2,Protein MTSS 2,36731,-0.0131940053790144,0.0090446676126155,-0.0309215538997408,0.00453354314171194,0.144655393166055
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,39033,-0.00453370187421429,0.00310867782064917,-0.0106267104026867,0.00155930665425808,0.144750475097659
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,36743,0.00657780097079389,0.00451225911813638,-0.00226622690075341,0.0154218288423412,0.144930464196352
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,36391,-0.00551400186072455,0.00378581485599455,-0.0129341989784739,0.00190619525702476,0.145282238994033
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF9,Fibroblast growth factor 9,36311,0.0053777744689882,0.00369369985131876,-0.00186187723959657,0.012617426177573,0.145436732457181
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH5,Cadherin-5,39283,0.00400793140910446,0.00275799042131944,-0.00139772981668165,0.00941359263489057,0.146186592304985
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1,Integrin beta-1,39098,0.0028570697674861,0.00196870146295346,-0.00100158509990268,0.00671572463487488,0.14673200811438
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,38705,0.00627232486534664,0.00432329994127965,-0.00220134301956148,0.0147459927502548,0.146851450336194
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBI3_IL27,Interleukin-27,39237,0.00403310872548845,0.00278582270113592,-0.00142710376873796,0.00949332121971486,0.147714005312552
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHDC3L,KH domain-containing protein 3,36339,0.00879551200320154,0.00607599325486071,-0.00311343477632545,0.0207044587827285,0.14775848572347
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39086,-0.0149358807826085,0.0103195960450409,-0.0351622890308887,0.00529052746567167,0.147824570374884
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,36743,-0.0043271127527163,0.00299145680671867,-0.0101903680938849,0.00153614258845229,0.148064106040797
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,39145,0.00350227637159138,0.00242142438624376,-0.00124371542544639,0.00824826816862916,0.148093865902552
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYZL2,Lysozyme-like protein 2,36339,0.00475675324852784,0.00328985315218833,-0.00169135892976128,0.011204865426817,0.148234238463691
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,36363,0.00649023453668196,0.00449045860908216,-0.00231106433711908,0.015291533410483,0.148387777071429
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,36421,-0.0047707211710076,0.00330169489037094,-0.0112420431561346,0.00170060081411944,0.14850222366648
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,36792,-0.00422194960198049,0.00292273349067051,-0.00995050724369469,0.0015066080397337,0.148616733543613
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN5,Contactin-5,39135,0.00469124740238465,0.00325106424775878,-0.00168083852322255,0.0110633333279919,0.149044296031093
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC1,Sialoadhesin,39162,0.00544807407172598,0.0037756250333327,-0.00195215099360611,0.0128482991370581,0.149052345027805
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,36391,0.00875731366728319,0.00607112189713946,-0.00314208525111015,0.0206567125856765,0.149199351186508
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,38741,-0.00840791303246721,0.00583607463403975,-0.0198466193151851,0.0030307932502507,0.149696290878988
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT1,Angiopoietin-1,39031,0.0110142485857575,0.00764753984910574,-0.0039749295184897,0.0260034266900048,0.149821780239884
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,38841,0.00446753382089265,0.00310205860187946,-0.00161250103879109,0.0105475686805764,0.149836368169077
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEXIM1,Protein HEXIM1,39099,-0.0106391990563368,0.00738894126887825,-0.0251215239433381,0.0038431258306646,0.14992149976125
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,39162,0.0138632259512438,0.0096282493489024,-0.00500814277260485,0.0327345946750925,0.149930559648824
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,36403,-0.00749434133745869,0.00520698014649109,-0.0177000224245812,0.00271133974966386,0.150094042653499
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36363,0.00735690617750947,0.00511266462220349,-0.00266391648200937,0.0173777288370283,0.15018764833206
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,36747,-0.00425290238044171,0.00295932245251679,-0.0100531743873746,0.00154736962649119,0.1507080910211
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,36420,-0.00380563568513603,0.00265215485243557,-0.00900385919590974,0.00139258782563769,0.151334188370658
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,39283,0.00876890979542538,0.0061124707272641,-0.00321153283001227,0.020749352420863,0.151423289373562
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,39021,0.00346817293092388,0.00241803682085895,-0.00127117923795967,0.00820752509980743,0.151509333858832
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,36430,0.00885549289009424,0.00618573328851379,-0.00326854435539278,0.0209795301355813,0.152283325774944
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",36747,0.00715868601435594,0.00500439645470934,-0.00264993103687438,0.0169673030655862,0.152603720768843
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL7,C-C motif chemokine 7,39099,0.00753706729698048,0.00527341832173788,-0.00279883261362577,0.0178729672075867,0.152951028277264
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ING1,Inhibitor of growth protein 1,38705,-0.00583077489377801,0.00408543410298236,-0.0138382257356234,0.00217667594806741,0.153540230523922
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,36391,-0.0149887399312337,0.0105103902617808,-0.0355891048443241,0.00561162498185676,0.15386789424672
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN1,Nectin-1,36430,-0.00414947042286096,0.00291101200827431,-0.00985505395907861,0.00155611311335668,0.154055134103408
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP2B1,AP-2 complex subunit beta,36421,-0.00639160795558371,0.00448664853397128,-0.0151854390821674,0.002402223171,0.154302315666981
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39093,0.00326826743429273,0.00229502498682898,-0.00122998153989208,0.00776651640847753,0.154447802781415
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,36743,-0.011108458443784,0.00780522316260336,-0.0264066958424866,0.00418977895491854,0.15469999334963
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,36500,0.00929792875080392,0.00653555171140618,-0.00351175260355219,0.02210761010516,0.154856723204449
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PF4,Platelet factor 4,36743,0.0124244138021607,0.00873586616893434,-0.0046978838889506,0.029546711493272,0.154983607288664
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESR1,Estrogen receptor,36430,0.00759658952504287,0.00535303599983885,-0.00289536103464128,0.018088540084727,0.155889424247393
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAB2,Stabilin-2,36791,-0.00358553114215877,0.00253408691573334,-0.00855234149699611,0.00138127921267858,0.157115930922434
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39099,0.0129744671202185,0.00917340320062216,-0.00500540315300092,0.0309543373934379,0.157277536110937
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRAP,BRCA1-associated protein,36619,-0.0141176328394491,0.00998258424107159,-0.0336834979519494,0.00544823227305121,0.157319878639847
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE,Angiotensin-converting enzyme,36796,-0.00326590688274554,0.0023121103765453,-0.00779764322077434,0.00126582945528325,0.157820360547868
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,36363,-0.0109348084872286,0.00774217840108232,-0.02610947815335,0.00423986117889272,0.157866391063758
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,39106,0.00376865343611151,0.00266844070796871,-0.00146149035150716,0.00899879722373018,0.15788044433307
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MILR1,Allergin-1,38841,-0.0063080815715482,0.00447066643019049,-0.0150705877747216,0.00245442463162516,0.158267276395178
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,36391,-0.00961910992317098,0.00681846827702374,-0.0229833077461375,0.00374508789979554,0.158345078049127
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,36363,0.00962251799382455,0.00682159659750096,-0.00374781133727734,0.0229928473249264,0.15838860181481
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,36391,-0.00658222322854688,0.00467159294651156,-0.0157385454037095,0.00257409894661578,0.158863224216371
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,36391,0.00412059606089508,0.00293233569892902,-0.00162678190900579,0.00986797403079595,0.159978703177667
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39162,-0.00543417831639636,0.00386935732628062,-0.0130181186759064,0.00214976204311366,0.160215999890104
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIM,Vimentin,38832,-0.0148068247196563,0.0105602263567895,-0.0355048683789637,0.00589121893965122,0.160896751110352
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTD,Biotinidase,36806,-0.00259129949794349,0.00185243097004405,-0.00622206419922984,0.00103946520334285,0.161877644900344
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1B,Protein phosphatase 1B,36430,0.00801739028009122,0.00573917967551802,-0.0032314018839241,0.0192661824441065,0.162451002370916
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,36421,0.00542042856000621,0.00388274763224372,-0.00218975679919147,0.0130306139192039,0.162730413804396
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAG,S-arrestin,36363,-0.00674247252967071,0.00483398345697643,-0.0162170801053445,0.00273213504600309,0.16309891523583
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EP300,Histone acetyltransferase p300,36430,0.0037472582177363,0.00269131371628541,-0.00152771666618311,0.00902223310165571,0.163840216541284
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,39099,-0.00448373534632963,0.00322546414348295,-0.0108056450675562,0.00183817437489695,0.164517156365237
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC5,Glypican-5,38987,0.00702008314740779,0.00505674156925906,-0.00289113032833997,0.0169312966231556,0.165077663180259
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,36363,0.00425605987931087,0.00307215324440437,-0.00176536047972169,0.0102774802383434,0.165964974265551
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,38841,0.00777146098361138,0.00561539320300448,-0.00323470969427741,0.0187776316615002,0.166392334360998
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,36743,-0.00818307787108321,0.00591306451505897,-0.0197726843205988,0.00340652857843236,0.166413678481167
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD22,B-cell receptor CD22,39291,0.00500362682855168,0.00361598563798286,-0.00208370502189473,0.0120909586789981,0.166454465026536
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIF,Macrophage migration inhibitory factor,39064,0.00850417804238978,0.00615695599450924,-0.00356345570684834,0.0205718117916279,0.167228267009933
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,36391,0.0149382296382754,0.0108411538082276,-0.00631043182585065,0.0361868911024014,0.16825296470597
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,36421,-0.00829191376663005,0.00602098229107051,-0.0200930390571283,0.00350921152386815,0.168484359075195
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,38832,0.00748005400502056,0.00543161241905464,-0.00316590633632655,0.0181260143463677,0.16849164612725
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,39283,-0.00499191035796818,0.00362701600061616,-0.0121008617191759,0.0021170410032395,0.168744638714886
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,36731,0.0104515460556358,0.0075958260513816,-0.00443627300507211,0.0253393651163438,0.168858233662665
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,36792,0.00775354873973285,0.00563987118398446,-0.00330059878087669,0.0188076962603424,0.169225314317795
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHBP1,EH domain-binding protein 1,36792,-0.00935602928458246,0.006807902080133,-0.0226995173616431,0.00398745879247822,0.169375597610115
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYAP1,Synapse-associated protein 1,36500,0.00718755166019764,0.00523351791530952,-0.00307014345380903,0.0174452467742043,0.169661997455748
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,36421,0.00539058748441263,0.00392911647714604,-0.0023104808107936,0.0130916557796189,0.170100642060553
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TWF2,Twinfilin-2,36791,0.0105116456554319,0.00766607999285484,-0.00451387113056358,0.0255371624414274,0.17033979658475
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,38832,-0.00765724835523535,0.00559492575067785,-0.0186233028265639,0.00330880611609323,0.171143035368193
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,36538,-0.00667827723609452,0.00487990538370493,-0.0162428917881562,0.00288633731596714,0.171171748946328
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,36339,0.00740280658725395,0.00541762521938628,-0.00321573884274315,0.0180213520172511,0.171828602243805
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,38727,0.00599322537408689,0.00438716708382785,-0.0026056221102157,0.0145920728583895,0.171934220110474
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARCL1,SPARC-like protein 1,39108,0.00336376422631974,0.00246795302863342,-0.00147342370980177,0.00820095216244124,0.172909756861572
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,36538,0.0102573058981326,0.00753165984598051,-0.0045047473999892,0.0250193591962544,0.173256227542809
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JUN,Transcription factor AP-1,38841,0.0063541833730878,0.00466657834383339,-0.00279231018082564,0.0155006769270012,0.17333310863803
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",36391,0.00490509609536097,0.00360264787619815,-0.00215609374198741,0.0119662859327093,0.173372234488558
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARK7,Parkinson disease protein 7,39093,0.00646021103527584,0.00474576583041447,-0.00284148999233651,0.0157619120628882,0.173452350334545
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP10,Caspase-10,38741,-0.00877748238063297,0.00644815695840012,-0.0214158700190972,0.00386090525783127,0.173458801496798
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,36731,0.00544942966829453,0.00400651684449766,-0.00240334334692088,0.0133022026835099,0.173808984782358
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB1,Heat shock protein beta-1,38869,0.00851723792598445,0.00626734564753896,-0.0037667595431919,0.0208012353951608,0.174171297059604
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK6,Kallikrein-6,39123,0.00363510522220198,0.00267710608674414,-0.00161202270781653,0.0088822331522205,0.174531747120487
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",36538,-0.00566952539590401,0.00418053264378573,-0.013863369377724,0.00252431858591603,0.175068290304702
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA,Adenosine deaminase,39291,-0.00427024338938225,0.00314970664007736,-0.0104436684039339,0.00190318162516937,0.175195674039521
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,36391,0.00451634318097622,0.00333430403279839,-0.00201889272330862,0.0110515790852611,0.175598622492291
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX5,Sorting nexin-5,36420,0.00373811483753436,0.00276016991061873,-0.00167181818727834,0.00914804786234706,0.175663117062752
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD244,Natural killer cell receptor 2B4,39291,0.00325986004952394,0.00240716486722506,-0.00145818309023718,0.00797790318928506,0.17568215574632
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",36538,0.00860653814710416,0.00636322483239947,-0.00386538252439881,0.0210784588186071,0.176225647207697
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36363,0.00752870074043143,0.00556791643796375,-0.00338441547797753,0.0184418169588404,0.176349348708485
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36G,Interleukin-36 gamma,36397,-0.00817926976385198,0.00605377102974989,-0.0200446609821618,0.00368612145445781,0.176686739356508
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF16,Fibroblast growth factor 16,36430,-0.00583883580482801,0.00432437906836138,-0.0143146187788163,0.00263694716916029,0.176971759183139
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX2,Transcription factor SOX-2,36748,0.00290387640451309,0.00215383945257086,-0.0013176489225258,0.00712540173155198,0.177607300232643
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5,Interleukin-5,38841,0.0174930018838958,0.0129877960460378,-0.00796307836633822,0.0429490821341298,0.178039278944409
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,39207,0.00278988392254055,0.00207205005983068,-0.00127133419472758,0.00685110203980869,0.178181656874801
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHCY,Adenosylhomocysteinase,39106,0.00826208810724469,0.00614417974083572,-0.00378050418479331,0.0203046803992827,0.178741633684077
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,36391,0.00686610246988325,0.00510873621029278,-0.00314702050229059,0.0168792254420571,0.178975187562844
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,39136,-0.00404156675405633,0.00300773026288892,-0.00993671806931862,0.00185358456120595,0.179056814116373
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,36731,-0.00846282362504579,0.00630254616460632,-0.0208158141076742,0.00389016685758259,0.179372518291804
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP20,Centrosomal protein 20,38727,0.00899322755320835,0.00670429886677941,-0.00414719822567928,0.022133653332096,0.179807184519226
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,36747,-0.00929861683012022,0.00693902409940528,-0.0228991040649546,0.00430187040471412,0.180253766448162
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA12,Serpin A12,38664,-0.0142718546581718,0.0106507546565792,-0.0351473337850671,0.00660362446872347,0.180270691116954
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36339,0.00774241328009641,0.00577821842573046,-0.00358289483433529,0.0190677213945281,0.180292216501288
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,38987,0.0114587609943766,0.00856989005897337,-0.00533822352121118,0.0282557455099644,0.18121158864728
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,36430,0.00721624061445494,0.0054021923454793,-0.00337205638268449,0.0178045376115944,0.181639316652543
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMOD4,Tropomodulin-4,36339,-0.00495671542247718,0.00371150338975282,-0.0122312620663927,0.00231783122143834,0.181736880100788
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX1,Peroxiredoxin-1,38681,0.0109666593282482,0.00821232747020843,-0.00512950251336036,0.0270628211698567,0.181769270095494
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEC31A,Protein transport protein Sec31A,36420,0.0092648132590335,0.00695337379816459,-0.00436379938536911,0.0228934259034361,0.182746436452218
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,39043,0.00231896947498469,0.00174155894450433,-0.0010944860562438,0.00573242500621319,0.18302872481001
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,36421,0.00491787238141645,0.0036991578552002,-0.00233247701477595,0.0121682217776088,0.18372129096895
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,36743,0.00703558478472461,0.00529297100939388,-0.0033386383936874,0.0174098079631366,0.183795082167701
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,36731,0.00500809130207997,0.0037712795747896,-0.00238361666450764,0.0123997992686676,0.184216370052765
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAEP,Glycodelin,38987,0.0172783000690157,0.0130129761249349,-0.00822713313585675,0.0427837332738881,0.184272592807313
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,36363,-0.00924625552831089,0.00698130919722616,-0.0229296215548742,0.00443711049825239,0.185384476163986
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D1,DCN1-like protein 1,36363,0.0090104716945715,0.0068090423938026,-0.00433525139728159,0.0223561947864246,0.185756612476592
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,36377,-0.00480045666017227,0.00363013054232825,-0.0119155125231356,0.0023145992027911,0.186061715074899
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,38987,-0.00529864293557052,0.00400709264442467,-0.0131525445186429,0.00255525864750184,0.186082921447519
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",36767,-0.00563996638218528,0.00427357803386202,-0.0140161793285549,0.00273624656418428,0.186948802509608
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,39023,0.0067704774954341,0.00513601663063285,-0.00329611510060628,0.0168370700914745,0.187444865083704
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,36421,0.0061171159693245,0.00464060548909471,-0.00297847078930114,0.0152127027279501,0.187470131114765
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINK1,Misshapen-like kinase 1,36747,0.0110619913712908,0.00840318879337318,-0.00540825866372067,0.0275322414063022,0.188061891264094
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TUBB3,Tubulin beta-3 chain,36363,0.0033704248020881,0.00256175695201612,-0.00165061882386349,0.0083914684280397,0.18830920910055
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",36420,-0.0101234300715243,0.00769977986391691,-0.0252149986048014,0.00496813846175288,0.188611632927162
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,38727,0.00888562362352409,0.00675998200380308,-0.00436394110392995,0.0221351883509781,0.188716818919161
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,36791,-0.00471578455644032,0.0035932850235402,-0.0117586232025791,0.00232705408969846,0.189412508966792
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,36538,-0.00902785276876436,0.00688356959948074,-0.0225196491837466,0.00446394364621788,0.189710130554148
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARD3,Partitioning defective 3 homolog,36538,0.00880067327714815,0.00671545726978085,-0.00436162297162232,0.0219629695259186,0.190047135363807
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,36430,0.0129308699847009,0.0098800164947694,-0.00643396234504712,0.0322957023144489,0.190629312510611
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,36538,0.00875691837493116,0.00669277902774819,-0.00436092851945529,0.0218747652693176,0.190757020964308
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD177,CD177 antigen,39080,-0.0147690456005699,0.0112954149091531,-0.03690805882251,0.00736996762137011,0.191053973424451
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,36339,0.00472152597948209,0.00361497974028154,-0.00236383431146973,0.0118068862704339,0.191542538488973
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,36391,0.00728942704850422,0.00558330688089342,-0.00365385443804688,0.0182327085350553,0.191721024221991
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCL2,Phosducin-like protein 2,36339,0.00632357355780398,0.00484620968701055,-0.0031749974287367,0.0158221445443447,0.19196821233967
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP9,Fatty acid-binding protein 9,39099,0.00654187706983114,0.00501630189892913,-0.00329007465206994,0.0163738287917322,0.19221118302569
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,39023,-0.00390891962903772,0.00299813018462924,-0.00978525479091102,0.00196741553283558,0.192326410982058
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLM2,Protein GOLM2,39241,0.00260236934516441,0.00199659502431753,-0.00131095690249794,0.00651569559282675,0.192456482900875
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPAG1,Sperm-associated antigen 1,36767,-0.00687550878637827,0.00528174136741239,-0.0172277218665066,0.00347670429375002,0.193024966496243
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3,Galectin-3,39139,0.00346347179184653,0.00266217155372302,-0.0017543844534506,0.00868132803714365,0.193279796843967
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,36339,-0.00496032328955475,0.00381532042125088,-0.0124383513152065,0.00251770473609698,0.193588445322155
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL20,C-C motif chemokine 20,39291,0.00982930323065293,0.00757018404549244,-0.00500825749851225,0.0246668639598181,0.1941613264943
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300A,CMRF35-like molecule 8,36500,0.00338758103030543,0.00260939001588653,-0.00172682340083216,0.00850198546144303,0.19423296908585
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON1,Spondin-1,39117,-0.00373259084809812,0.00288013094346935,-0.00937764749729806,0.00191246580110181,0.195002129555147
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCLN,Nicalin,38841,0.00614998004594131,0.00474554926817652,-0.00315129651968466,0.0154512566115673,0.195013731572947
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO6,Unconventional myosin-VI,36767,0.00451315494978125,0.00348856339374192,-0.00232442930195291,0.0113507392015154,0.195792167301331
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRL,Prolactin,39241,-0.0088522630050262,0.00686248985686286,-0.0223027431244774,0.00459821711442501,0.197087705462492
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAP1,Antigen peptide transporter 1,36538,-0.00685469604115145,0.00531713789333985,-0.0172762863120976,0.00356689422979465,0.19736242196684
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,36430,0.00641582077999433,0.00497879302986159,-0.00334261355853438,0.016174255118523,0.197550554741163
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP3,Stromelysin-1,39093,0.00555756829351002,0.00431401833910097,-0.00289790765112788,0.0140130442381479,0.197675763038475
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB118,Beta-defensin 118,36363,0.0067908856800451,0.00527426272669885,-0.00354666926428464,0.0171284406243748,0.197925910804897
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLA2,Src-like-adapter 2,36767,0.0122762663969137,0.00954232702753642,-0.00642669457705771,0.030979227370885,0.198289402838818
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBN1,Drebrin,36430,0.00608865280336001,0.0047392638196395,-0.00320030428313341,0.0153776098898534,0.198911918509925
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP43,Centrosomal protein 43,38728,-0.00813604632911585,0.00634613697042991,-0.0205744747911585,0.00430238213292676,0.19984612373251
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,39241,-0.00536591933411874,0.00418715896545576,-0.013572750906412,0.00284091223817455,0.20003112106977
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,36664,-0.00352326332004725,0.00274947327422045,-0.00891223093751933,0.00186570429742483,0.200065139837615
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH6,Cadherin-6,39106,-0.00441364209627573,0.0034453415706743,-0.0111665115747974,0.0023392273822459,0.200196886698647
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,36430,-0.0068060214843889,0.00531962879822716,-0.0172324939289141,0.00362045096013633,0.200774000333764
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,39023,-0.00793519831558289,0.00621238336444288,-0.0201114697098909,0.00424107307872515,0.201509034928286
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLMP,CXADR-like membrane protein,39255,-0.00236315523657258,0.00185292283119058,-0.00599488398570611,0.00126857351256095,0.20219888454358
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,36421,0.00423117944179679,0.00332269329386929,-0.00228129941418702,0.0107436582977806,0.20289310518376
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,36743,-0.00464931345425039,0.00365408474024971,-0.0118113195451398,0.00251269263663904,0.203267989884877
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,36767,0.00517718235980017,0.00407566791892968,-0.00281112676130199,0.0131654914809023,0.204012794797128
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",36403,-0.00915979376804342,0.00721503279837749,-0.0233012580528633,0.00498167051677646,0.204271048577097
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE3,Eosinophil cationic protein,39030,-0.0123505876462145,0.00973304047512037,-0.0314273469774504,0.00672617168502144,0.204484012898929
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",36747,0.0112231735539608,0.00887478192090622,-0.0061713990110154,0.028617746118937,0.206032597624044
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39093,0.00474817564218158,0.00376678237599001,-0.00263471781475884,0.012131069099122,0.207494338648643
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,36538,0.00778912986928004,0.00618106909861709,-0.00432576556400946,0.0199040253025695,0.207635203309918
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNB2,Ephrin-B2,36421,0.00693357892095406,0.00550640609319587,-0.00385897702170984,0.017726134863618,0.207987247120022
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL4,C-C motif chemokine 4,39114,-0.00712299517367707,0.00565760291577451,-0.0182118968885951,0.00396590654124098,0.20804493100615
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,39006,0.0032442131769689,0.00257680054156705,-0.00180631588450252,0.00829474223844031,0.208046750397861
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,38960,-0.00375962805246865,0.00298815781494737,-0.00961641736976549,0.0020971612648282,0.208347614663851
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GKN1,Gastrokine-1,38391,-0.00318705430091962,0.0025346294635904,-0.00815492804955681,0.00178081944771757,0.208627436211223
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,36421,0.00768185528519623,0.00611023913329913,-0.00429421341607008,0.0196579239864625,0.208700886766756
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17A,Interleukin-17A,38813,-0.00481868429903416,0.00383419731083621,-0.0123337110282731,0.00269634243020481,0.208858439327194
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM3,Paralemmin-3,36391,0.00860056162094064,0.00684457609687111,-0.00481480752892674,0.022015930770808,0.208939548631654
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP1,Retinol-binding protein 1,36421,0.00801805483569071,0.00638522203979765,-0.00449698036231269,0.0205330900336941,0.209240645800724
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,39291,0.00518991518535509,0.00413365344331035,-0.00291204556353319,0.0132918759342434,0.209306376809226
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,36363,0.00505242465102226,0.0040256399372781,-0.00283782962604282,0.0129426789280873,0.20947998723673
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,39197,-0.00337644678664018,0.00269175845122615,-0.00865229335104344,0.00189939977776307,0.209728592643024
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,36391,-0.0098557582586626,0.00785945910805124,-0.025260298110443,0.00554878159311784,0.209865557886514
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,36363,0.00708964466944578,0.00566424772368311,-0.00401228086897311,0.0181915702078647,0.210721550348229
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,38727,0.00867859812716372,0.00693521477186379,-0.00491442282568931,0.0222716190800167,0.21081508381606
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,38713,0.00580864306356037,0.00464231635124474,-0.00329029698487932,0.0149075831120001,0.210867330770696
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,38909,0.00430108180024426,0.00343895529671575,-0.0024392705813186,0.0110414341818071,0.21106547435177
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,36743,-0.0115986846146623,0.00929968677074421,-0.0298260706853209,0.00662870145599636,0.212342301370327
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX2,Sorting nexin-2,36731,0.0090675507945758,0.00727127931199499,-0.00518415665693437,0.023319258246086,0.212406801218203
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES2,Cocaine esterase,39023,-0.00612224089681036,0.00491607378183614,-0.0157577455092092,0.00351326371558847,0.213021739332556
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAP,Cartilage-associated protein,36421,0.00556840159934005,0.00447827767157471,-0.00320902263694637,0.0143458258356265,0.213734536031707
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,38960,-0.0100488616104417,0.0080827353387298,-0.0258910228743521,0.00579329965346872,0.213794984551073
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,36373,-0.00573808862046502,0.00462562755170438,-0.0148043186218056,0.00332814138087557,0.214813961335306
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,36743,-0.00289871415145402,0.00233960090846369,-0.00748433193204286,0.00168690362913482,0.215376202219155
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36339,0.00640687530388711,0.00517110543019884,-0.00372849133930261,0.0165422419470768,0.215377704574198
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRX,Cone-rod homeobox protein,38832,0.0120376811846656,0.0097612619030067,-0.00709439214522755,0.0311697545145587,0.217516962561857
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,36391,0.00568919274098369,0.00461674267821391,-0.00335962290831558,0.014738008390283,0.217861718455981
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBD,Thrombomodulin,39106,0.00301849241989953,0.00245848327220407,-0.00180013479362045,0.00783711963341951,0.219546103393964
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKAP12,A-kinase anchor protein 12,36500,0.00234903489431886,0.00191524665587525,-0.00140484855119663,0.00610291833983435,0.220036392703836
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3A,Uroplakin-3a,36363,0.00535430843586023,0.00436707022629084,-0.00320514920766983,0.0139137660793903,0.220197610225604
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,39095,0.00310217508645358,0.00253101864058523,-0.00185862144909348,0.00806297162200062,0.22034458652978
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLINT1,Clathrin interactor 1,36339,0.00549991395677488,0.0044875516963623,-0.00329568736809524,0.014295515281645,0.220374834157736
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,38998,-0.0026693800504792,0.00218309219500729,-0.00694824075269349,0.00160948065173509,0.221442467305363
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,39241,0.010630512778776,0.00870979830869082,-0.00644069190625802,0.02770171746381,0.222285229677441
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,39099,0.0054865001464257,0.00449739884114611,-0.00332840158222067,0.0143014018750721,0.222511270621449
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRAS,GTPase Hras,36531,0.0108522597603028,0.00889846906143225,-0.00658873960010439,0.02829325912071,0.222652592111525
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,36430,0.0100615223619243,0.00826358879368522,-0.00613511167369877,0.0262581563975473,0.22340914676549
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL33,Interleukin-33,38841,0.00431535117019543,0.00354510681566516,-0.0026330581885083,0.0112637605288991,0.22352078649575
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,39106,0.00310290719937782,0.00254930280919288,-0.00189372630664022,0.00809954070539586,0.223562515066255
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,38832,-0.00353514746979455,0.00291066378502985,-0.00924004848845305,0.00216975354886396,0.224556823006838
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",39093,0.00412182786146708,0.00339775147906139,-0.00253776503749324,0.0107814207604274,0.225108652213311
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ULBP2,UL16-binding protein 2,38987,-0.00399716115298388,0.00330153435686974,-0.0104681684924486,0.00247384618648081,0.226030071971356
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",36421,0.00928653097838014,0.00767077451512814,-0.00574818707127102,0.0243212490280313,0.226056959559849
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF3,Trefoil factor 3,39077,0.0052279123369073,0.00432024171802244,-0.00323976143041667,0.0136955861042313,0.22626040056478
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCC1,Regulator of chromosome condensation,36731,-0.00555534284463645,0.00459165528290454,-0.0145549871991294,0.00344430150985645,0.226347919068441
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCA,Tubulin-specific chaperone A,36500,0.00945320287411113,0.00782155101771357,-0.00587703712060747,0.0247834428688297,0.226835415105329
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,38945,-0.00302361048698005,0.00250252258782635,-0.00792855475911969,0.00188133378515959,0.226979647661732
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX16,Syntaxin-16,38727,-0.00637276421965919,0.00527448236300652,-0.016710749651152,0.0039652212118336,0.226979744167021
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",36391,-0.00443995527419769,0.0036762908859057,-0.0116454854105729,0.00276557486217749,0.227175133520113
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,38832,-0.0103188248771187,0.00854572502632592,-0.0270684459287175,0.00643079617448009,0.227264939059337
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,39093,0.0030247621983746,0.00250566476182968,-0.00188634073481158,0.00793586513156077,0.227385599460564
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,38987,0.00391020411583853,0.00324737689177524,-0.00245465459204095,0.010275062823718,0.228565295775814
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGA,Protein O-GlcNAcase,36743,-0.00778291232667578,0.0064670027673889,-0.020458237750758,0.00489241309740646,0.228812510549798
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",36500,0.0113642822479037,0.00945227494506064,-0.00716217664441515,0.0298907411402226,0.22927753910795
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOB,Elongin-B,36391,0.00427939990070162,0.00356157809130048,-0.00270129315824731,0.0112600929596506,0.229562182861969
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,36538,0.00774182083466895,0.00644822058197373,-0.00489669150599956,0.0203803331753375,0.229923584408228
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QDPR,Dihydropteridine reductase,39032,-0.00471661187332235,0.00393301395862374,-0.0124253192322249,0.00299209548558019,0.230454926663665
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN10,Ataxin-10,38741,0.00791137180329827,0.00660894218043294,-0.00504215487035029,0.0208648984769468,0.231298023351213
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNG,Interferon gamma,38841,-0.0123500693403148,0.0103400151190866,-0.0326164989737245,0.00791636029309494,0.2323421379636
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,38727,0.0130187549551157,0.0109116655203456,-0.00836810946476167,0.034405619374993,0.232847570932769
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,36430,0.00319588405869239,0.00268768636566189,-0.00207198121800491,0.00846374933538969,0.234429192001655
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK15,Kallikrein-15,36714,-0.00540394620967837,0.00454670838018453,-0.01431549463484,0.0035076022154833,0.23464256431477
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,36363,-0.00803272238642419,0.00676606192627961,-0.0212942037619322,0.00522875898908384,0.235168167950376
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTKN2,Rhotekin-2,36391,0.00555233646026207,0.00467831157673996,-0.00361715423014825,0.0147218271506724,0.235319211671621
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,36430,0.00402909351817026,0.00339611831031226,-0.00262729837004177,0.0106854854063823,0.23549391312229
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LG,CMRF35-like molecule 9,39093,0.00391509106452738,0.00330056355110834,-0.00255401349564497,0.0103841956246997,0.235566303249732
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBNL,Drebrin-like protein,39162,0.00996134396937879,0.00841488458851994,-0.00653182982412028,0.0264545177628779,0.236519872543303
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,39064,-0.00694103078980762,0.00586602735987872,-0.0184384444151699,0.00455638283555468,0.236724941767171
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICOSLG,ICOS ligand,39023,0.00201789380912519,0.0017056055354916,-0.00132509304043835,0.00536088065868874,0.23678994884098
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTO1,Protein LTO1 homolog,38841,-0.00429565568533346,0.00364603554629287,-0.0114418853560675,0.00285057398540056,0.238746899753588
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEK,Angiopoietin-1 receptor,39147,-0.00230590234724347,0.0019590010379335,-0.00614554438159313,0.0015337396871062,0.239181617048491
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11R,Junctional adhesion molecule A,39093,-0.00601276836869376,0.00512294780222925,-0.0160537460610631,0.00402820932367558,0.240536334430489
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,36499,-0.00557665330866098,0.00475926909361659,-0.0149048207321495,0.00375151411482755,0.241321238698246
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA11,Integrin alpha-11,39099,0.00360018958207885,0.0030743254388022,-0.00242548827797346,0.00962586744213115,0.241596888918776
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC3B,Tetranectin,36506,-0.00223063555248247,0.00190650498456325,-0.00596738532222644,0.00150611421726149,0.242017800467263
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK7,Kallikrein-7,36203,-0.0041409758975665,0.00354498790270131,-0.0110891521868611,0.00280720039172807,0.242780399492063
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,39088,0.0082952112868568,0.00710210164016524,-0.00562490792786708,0.0222153305015807,0.24282751759949
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFH,Complement factor H,36141,0.00247916118767755,0.00212416045599759,-0.00168419330607772,0.00664251568143282,0.243182474928889
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,39089,-0.00598656246416356,0.00513203020563131,-0.0160453416672009,0.00407221673887381,0.243426739035499
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,39255,0.00265963332466357,0.0022801595212428,-0.00180947933697231,0.00712874598629945,0.243461033396736
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,36420,-0.00811836358954876,0.00696300920567415,-0.0217658616326701,0.00552913445357257,0.243665917588371
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD5,Programmed cell death protein 5,39241,-0.00611266650877697,0.00524813653843475,-0.0163990141241091,0.00417368110655514,0.244146023185465
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,36731,-0.00581526263098283,0.00499419907871271,-0.0156038928252597,0.00397336756329407,0.244282132610524
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK2,Protein AHNAK2,36420,-0.00307348160333145,0.00264455966961024,-0.00825681855576752,0.00210985534910461,0.245180255606905
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36363,-0.00337180112387216,0.00290170583193081,-0.00905914455445656,0.00231554230671223,0.245254993330298
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,36391,0.00486180554531636,0.00418480243918953,-0.00334040723549511,0.0130640183261278,0.245348349525176
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,36430,-0.00448163467172171,0.00387406758157569,-0.0120748071316101,0.00311153778816665,0.247364114918151
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,38721,-0.00618317229984241,0.00534702792597525,-0.0166633470347539,0.00429700243506907,0.247546171201085
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX1B,Syntaxin-1B,36421,0.00446950285975426,0.00386556372000138,-0.00310700203144844,0.012046007750957,0.247606742148192
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,36731,0.00877343689286135,0.00759193498421541,-0.00610675567620085,0.0236536294619235,0.247855650327513
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLN,Mesothelin,39001,0.00552047856631343,0.0047792017160058,-0.00384675679705794,0.0148877139296848,0.248065765256718
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171A2,Protein FAM171A2,36767,0.0164622574224947,0.0142540344070588,-0.0114756500153406,0.0444001648603301,0.248144914129593
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,36430,0.00501852113715413,0.00435169650227204,-0.00351080400729907,0.0135478462816073,0.248836584204941
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR2,GMP reductase 2,36500,-0.00698984179339892,0.00606739489164774,-0.0188819357810285,0.00490225219423066,0.24932912169256
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A4,Protein S100-A4,39147,-0.00591508222405849,0.005137669202899,-0.0159849138617405,0.00415474941362355,0.249620146199241
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS2,Podocin,36430,0.0106666554499156,0.00926775745747305,-0.00749814916673161,0.0288314600665628,0.249777806247673
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,38727,0.0071244846503802,0.00619190479548194,-0.00501164874876441,0.0192606180495248,0.249910088301254
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,36731,0.00431355221281897,0.00375146196281546,-0.00303931323429933,0.0116664176599373,0.250234304680756
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCN,Decorin,38832,-0.00226031338929929,0.00196615585097767,-0.00611397885721553,0.00159335207861694,0.250322699302574
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX1,Heme oxygenase 1,38941,-0.00497562102216752,0.00432876441302619,-0.0134599992716989,0.00350875722736381,0.25039605421361
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,36421,-0.004557317436371,0.00397129068189619,-0.0123410471728875,0.00322641230014553,0.251169703900259
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDNRB,Endothelin receptor type B,36430,0.00475949096326244,0.00414875509844942,-0.00337206902969841,0.0128910509562233,0.251316910735373
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL26,C-C motif chemokine 26,39099,0.00890498385890308,0.00776355331495566,-0.00631158063841002,0.0241215483562162,0.251389610089133
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,38727,0.00485081042749865,0.0042307395740728,-0.00344143913768404,0.0131430599926813,0.25158063371775
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,36531,0.0102943131503679,0.00898018848943541,-0.00730685628892548,0.0278954825896613,0.251677809183001
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD3,Bromodomain-containing protein 3,36391,0.00482682819356124,0.00421229402200758,-0.00342926808957362,0.0130829244766961,0.251862296360963
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,36391,0.00486690419206729,0.00425695413716572,-0.00347672591677753,0.0132105343009121,0.25294286461647
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",36420,0.00474536585967891,0.00415963938541993,-0.00340752733574414,0.012898259055102,0.253969984130498
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,36430,0.00919949370304999,0.00810215942831772,-0.00668073877645275,0.0250797261825527,0.25621380427829
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAMBP,STAM-binding protein,38951,-0.0066074852304941,0.00582012019260939,-0.0180149208080085,0.00479995034702032,0.256274669496643
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,39069,0.00455151325625385,0.00401190672904118,-0.00331182393266686,0.0124148504451745,0.256602223899918
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,38987,-0.00593182554480493,0.00523020106315701,-0.0161830196285927,0.00431936853898282,0.256750166247551
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39095,0.00382859706588464,0.00337817910027381,-0.00279263397065203,0.0104498281024213,0.25709286785427
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,39283,0.00320208859138171,0.0028270547548782,-0.00233893872817956,0.00874311591094299,0.257375152092502
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI16,Peptidase inhibitor 16,36796,0.00244771054573676,0.0021622307628814,-0.0017902617495108,0.00668568284098431,0.257642716935952
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",36339,0.004995384060917,0.00441289939344523,-0.00365389875023565,0.0136446668720697,0.257657905547353
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,38741,0.00501744456176317,0.00443401057571628,-0.00367321616664075,0.0137081052901671,0.257828635006658
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD109,CD109 antigen,39093,-0.00344254068224836,0.00304694319713548,-0.0094145493486339,0.00252946798413718,0.258563877246721
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,36421,0.00393655357908799,0.0034864427413475,-0.00289687419395311,0.0107699813521291,0.25887587351682
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,36731,0.00498416676374228,0.004420967448144,-0.00368092943461996,0.0136492629621045,0.259597468358683
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFC,Platelet-derived growth factor C,38727,-0.00297262133483646,0.00263740157071558,-0.00814192841343899,0.00219668574376607,0.259717428491583
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LXN,Latexin,38923,-0.00682267782474938,0.00605624443287432,-0.0186929169131831,0.00504756126368429,0.25994964220114
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE1,Ribonuclease pancreatic,36796,0.00227943990511985,0.00202644342600183,-0.00169238920984373,0.00625126902008343,0.260674515315126
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD93,Complement component C1q receptor,38500,0.00313919600625105,0.00279403709801826,-0.00233711670586474,0.00861550871836685,0.261229141962995
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH7,Protocadherin-7,36743,-0.00340028901136945,0.00303278434846986,-0.00934454633437037,0.00254396831163147,0.262233292028838
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,39050,0.00903102448836488,0.0080948506775854,-0.00683488283970251,0.0248969318164323,0.264589400641593
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,36767,0.00733188147009118,0.00657697373666389,-0.00555898705377004,0.0202227499939524,0.264965290454453
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRNN,Cornulin,38645,0.00653341786638446,0.00586440839379385,-0.00496082258545148,0.0180276583182204,0.265263141785443
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXOSC10,Exosome component 10,36391,0.00614086692841194,0.00553449674092176,-0.00470674668379471,0.0169884805406186,0.267209132975736
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,36430,-0.00575091546163213,0.00518863110218762,-0.0159206324219199,0.0044188014986556,0.267723893762594
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,36321,-0.00623133895036856,0.005628177559297,-0.0172625669665907,0.00479988906585355,0.268242605719879
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBN2,Fibrillin-2,36421,0.00605550265317873,0.00547945321513263,-0.00468422564848123,0.0167952309548387,0.269124863421015
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,39147,0.00233948173102777,0.00211731016375998,-0.0018104461899418,0.00648940965199733,0.269206859280618
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,38741,0.00622363624983434,0.00563481627381375,-0.00482060364684062,0.0172678761465093,0.269395571759116
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3G,Semaphorin-3G,36500,0.00436487990595835,0.00395530991988489,-0.00338752753701605,0.0121172873489327,0.269809657841643
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,36363,0.00696894430538787,0.00631872559302872,-0.00541575785694843,0.0193536464677242,0.270090320250372
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGRN,Neugrin,36747,0.00211313136639553,0.00191715920184455,-0.00164450066921978,0.00587076340201085,0.270386588871612
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CERT,Ceramide transfer protein,38741,0.0061553043215902,0.00558755235367994,-0.00479629829162248,0.0171069069348029,0.270649015957644
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,36767,-0.00777003423707832,0.0070558375479656,-0.0215994758310909,0.00605940735693425,0.270821158108047
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTF,Ciliary neurotrophic factor,36363,0.00340944070400358,0.00309647080238317,-0.00265964206866744,0.0094785234766746,0.270886040371801
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH1,Neurexophilin-1,38741,0.00371129959617527,0.00338081442248649,-0.00291509667189826,0.0103376958642488,0.27233006714946
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",38741,0.004919371949796,0.00448529693528631,-0.00387181004336516,0.0137105539429572,0.272756495012779
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,36391,0.00342205837472317,0.00312176898249481,-0.00269660883096665,0.009540725580413,0.273015799352677
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA4,Ephrin-A4,38960,-0.0027337031053806,0.00249863421781395,-0.00763102617229595,0.00216361996153474,0.273937805146177
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",38741,-0.00499325911011329,0.00457688421170203,-0.0139639521650493,0.0039774339448227,0.275302234002854
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,36538,0.00339335501025026,0.00311092243907196,-0.00270405297033077,0.0094907629908313,0.275387170557691
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,36391,0.0098905079817655,0.00907011100126874,-0.00788690958072123,0.0276679255442522,0.275535670430848
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN1,Contactin-1,39283,0.00262329270559495,0.00240693310981662,-0.00209429618964562,0.00734088160083551,0.275778560926534
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,38727,-0.00435241868407184,0.00399757781110391,-0.0121876711938355,0.00348283382569183,0.276275632889408
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICALL2,MICAL-like protein 2,36421,-0.00672738850438218,0.00618885756012866,-0.0188575493222344,0.00540277231346998,0.277050502983386
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRAS,Ras-related protein R-Ras,36421,0.0130718472841821,0.0120269044088938,-0.0105008853572497,0.0366445799256139,0.27710903290226
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTTG1,Securin,36538,0.00412222009814893,0.00380022753011847,-0.00332622586088327,0.0115706660571811,0.278061965959538
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,39180,0.00235713769733211,0.00217388179416647,-0.00190367061923417,0.00661794601389839,0.278249344055259
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMD,Osteomodulin,39162,0.00425087433064335,0.00392699001208973,-0.00344602609305251,0.0119477747543392,0.27905791757774
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMTN,Smoothelin,36702,-0.00943404698814294,0.00871609084242195,-0.02651758503929,0.00764949106300409,0.279107877606457
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,36363,0.00696250005039108,0.0064720501636126,-0.00572271827028961,0.0196477183710718,0.282046560357828
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D23,TBC1 domain family member 23,39023,0.00877223414343971,0.00816047728804663,-0.00722230134113169,0.0247667696280111,0.282407137019399
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB1,Lamin-B1,36712,-0.00563583437814591,0.00524916123324371,-0.0159241903953036,0.00465252163901176,0.282993551036777
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,36421,0.00598966228921671,0.00557986911085939,-0.0049468811680677,0.0169262057465011,0.283093756510836
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHISA5,Protein shisa-5,36791,0.00221659602818408,0.00206517463224088,-0.00183114625100804,0.0062643383073762,0.283146987244748
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX15,Sorting nexin-15,36500,-0.00523039495930152,0.0048742452484439,-0.0147839156462516,0.00432312572764852,0.28326124392416
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",36767,0.00630381119629146,0.00588239442724958,-0.00522568188111771,0.0178333042737006,0.28390164178284
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MITD1,MIT domain-containing protein 1,38987,0.00939563009619352,0.0087738321724062,-0.00780108096172264,0.0265923411541097,0.284245154630665
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,36430,0.0088604711972917,0.00827953275857774,-0.00736741300952067,0.0250883554041041,0.284565320816883
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,38969,-0.009148422588,0.00858728887355675,-0.0259795087801712,0.00768266360417123,0.286737001083345
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR1B,Cornifin-B,36538,0.0084941994110301,0.0079831336493135,-0.00715274254162435,0.0241411413636846,0.287340724530819
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,36747,-0.00343694516596727,0.00323506717817845,-0.00977767683519704,0.0029037865032625,0.288072667808191
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,38987,-0.00332174373894612,0.00313054402256609,-0.00945761002317567,0.00281412254528342,0.288672506024593
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,36363,0.00395713359994867,0.00373000624698613,-0.00335367864414414,0.0112679458440415,0.288759500450385
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,36538,0.00376840193894417,0.00355396372419879,-0.00319736696048545,0.0107341708383738,0.289011165521124
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,36421,-0.00682530591569358,0.0064468429328257,-0.0194611180640319,0.00581050623264478,0.28975443289001
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIAPIN1,Anamorsin,39147,0.00601841441717927,0.0057134201289579,-0.00517988903557822,0.0172167178699368,0.292182559865575
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",38727,0.0077250103108459,0.00734056672825539,-0.00666250047653466,0.0221125210982265,0.292645799981032
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,36421,0.00479449363705372,0.0045561962053392,-0.00413565092541111,0.0137246381995186,0.292681331686098
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36311,-0.00838658415108195,0.00797250113945103,-0.024012686384406,0.00723951808224207,0.292847993761257
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171B,Protein FAM171B,36731,-0.00262613438782302,0.00249799110509393,-0.00752219695380713,0.00226992817816109,0.293141237257606
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,36430,-0.00372878517278315,0.0035483268736117,-0.0106835058450621,0.00322593549949579,0.293344339355452
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,36421,0.00506292103073747,0.00482091525741978,-0.00438607287380529,0.0145119149352802,0.293646771773993
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB2,Lysosome membrane protein 2,38733,-0.00271230304560341,0.00258872321384856,-0.00778620054474659,0.00236159445353978,0.294776473863457
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,36731,0.00268583614326484,0.00256462604782034,-0.00234083091046302,0.0077125031969927,0.294998289627141
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,38841,-0.00356928772506757,0.00340860941271327,-0.0102501621739856,0.00311158672385043,0.295052385298256
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN3,Matrilin-3,38960,0.00295105888886112,0.00281898692578225,-0.0025741554856721,0.00847627326339433,0.295185124973323
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAD,Chondroadherin,36500,0.00474018508451722,0.00452993513031854,-0.00413848777090713,0.0136188579399416,0.295390191339435
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,36420,-0.00390029756604131,0.00373510605824643,-0.0112211054402043,0.00342051030812169,0.296400602042642
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,36767,0.00717031936998555,0.00686669062870051,-0.00628839426226745,0.0206290330022385,0.296404271421495
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,36806,0.00160994240987127,0.00154408199174983,-0.00141645829395839,0.00463634311370092,0.297128295966867
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,36731,0.00481774729834138,0.00462697934739514,-0.00425113222255308,0.0138866268192359,0.297788614493544
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,39162,0.00246626029999745,0.00237064904797035,-0.00218021183402443,0.00711273243401933,0.298202464882065
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3,Interleukin-3,36339,0.00559157739019392,0.0053895635838889,-0.00497196723422833,0.0161551220146162,0.299531193780841
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN1,Cerebellin-1,36363,0.00905453650191615,0.00872902162533057,-0.00805434588373178,0.0261634188875641,0.299620269377501
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,39099,-0.00324802000743327,0.00313385876671046,-0.00939038319018577,0.00289434317531924,0.300018804915396
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA4,Carboxypeptidase A4,36251,-0.00409081495629319,0.0039485998439751,-0.0118300706504844,0.003648440737898,0.30021461922347
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FYB1,FYN-binding protein 1,39071,-0.00858631559301792,0.00830468444998832,-0.024863497114995,0.00769086592895919,0.301193590695392
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,38828,-0.00279037749309814,0.00270808514970262,-0.00809822438651528,0.002517469400319,0.302844717440203
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,39136,-0.00666113073938474,0.00647631444730976,-0.0193547070561119,0.00603244557734239,0.303713456605548
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITM2A,Integral membrane protein 2A,39099,0.00550756349058816,0.00535677220480665,-0.00499171003083288,0.0160068370120092,0.303895755084007
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD2,Glutamate decarboxylase 2,36430,0.00431539860310266,0.00419885822778423,-0.00391436352335443,0.0125451607295597,0.304084745572646
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRUNE2,Protein prune homolog 2,36538,-0.00265185051947853,0.00258184197628396,-0.00771226079299509,0.00240855975403803,0.304385565910049
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF2,Fibroblast growth factor 2,39099,0.00619990288724887,0.00604147284608819,-0.00564138389108398,0.0180411896655817,0.304802420352906
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP1,Caspase-1,38741,0.00619299514660358,0.00604548222808667,-0.00565615002044629,0.0180421403136535,0.305662787659351
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,36500,0.0048794557619078,0.00476572669701401,-0.00446136856423967,0.0142202800880553,0.305919133697336
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRTN,Neurturin,38841,-0.00457008627922918,0.00446945731804158,-0.0133302226225907,0.0041900500641323,0.306553820001484
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,36363,0.00924568389559837,0.00904927735243293,-0.00849089971517017,0.0269822675063669,0.306940731553275
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,36538,0.00618339211893793,0.00606227659497473,-0.00569867000721255,0.0180654542450884,0.307758094519393
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAP3,Cytosol aminopeptidase,38841,0.00446635095790387,0.00438093202065905,-0.00412027580258786,0.0130529777183956,0.307983116998473
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MN1,Transcriptional activator MN1,36421,0.00541176208061227,0.00533559504874033,-0.00504600421491879,0.0158695283761433,0.310470959705837
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABO,Histo-blood group ABO system transferase,36796,0.0131290560037574,0.0129725697512225,-0.0122971807086387,0.0385552927161534,0.311526929439176
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,36792,-0.00584923540088032,0.00579036917537969,-0.0171983589846245,0.00549988818286388,0.312434555392139
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,39023,-0.00421984785896083,0.00418709046298481,-0.012426545166411,0.00398684944848939,0.313555319302773
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCG22,Protein PBMUCL2,36391,0.00497690510678734,0.00493914660821086,-0.00470382224530595,0.0146576324588806,0.313644498190877
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,38832,-0.00439782851322626,0.00436530392212147,-0.0129538242005843,0.00415816717413183,0.313734516597352
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36363,-0.00537453451568636,0.00533526362277772,-0.0158316512163307,0.00508258218495797,0.313780998812273
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTN,Neuroplastin,38727,-0.0076111762259886,0.00755751962664258,-0.0224239146942081,0.00720156224223086,0.313903225580013
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDHD2,Phospholipase DDHD2,36767,-0.00609063485455731,0.00604946917252014,-0.0179475944326968,0.00576632472358216,0.314047441348389
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,36391,-0.0056005148853796,0.00556744374202359,-0.0165127046197458,0.00531167484898664,0.314463811360702
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA7A,Semaphorin-7A,39234,-0.00244605997332736,0.00243515600204214,-0.00721896573732996,0.00232684579067524,0.3151642092067
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,36517,0.00477872009852056,0.00476186044458357,-0.00455452637286324,0.0141119665699044,0.31561930195396
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,36500,-0.0029680883851456,0.00296825916873161,-0.00878587635585956,0.00284969958556835,0.317357494790407
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,39054,0.00230186219675926,0.00230329723049052,-0.00221260037500216,0.00681632476852069,0.317628029253454
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,36363,0.00655914987364899,0.00656593901177465,-0.00631009058942931,0.0194283903367273,0.317830491472585
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,36430,0.00799389274357091,0.00802535491701871,-0.00773580289378577,0.0237235883809276,0.319230618844752
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLHL41,Kelch-like protein 41,36767,-0.00464339304754613,0.00466208837888019,-0.0137810862701513,0.00449430017505904,0.319273712735308
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,39023,0.00201981204307142,0.002031127765323,-0.00196119837696166,0.0060008224631045,0.320029998156947
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBLN2,Fibulin-2,36791,0.00271486465449097,0.00273062769364453,-0.00263716562505231,0.00806689493403425,0.320130813969873
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,36747,-0.00229156750806212,0.00230515766509017,-0.00680967653163884,0.00222654151551461,0.320190680865847
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,36767,-0.00843296900612443,0.0084941952152299,-0.025081591627975,0.00821565361572618,0.320829943516527
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,39291,-0.00308411411709601,0.00311001136483532,-0.00917973639217324,0.00301150815798122,0.321372644291602
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRING1,SREBP regulating gene protein,36339,0.00538874735695195,0.00543809081292052,-0.00526991063637226,0.0160474053502762,0.321740768830655
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB37,Ras-related protein Rab-37,38841,0.00747918237013827,0.00755167265391657,-0.0073220960315382,0.0222804607718147,0.321994267694393
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,36420,-0.00310219760191213,0.00313265866851923,-0.00924220859220981,0.00303781338838556,0.322058169191567
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,36703,0.00402165725758038,0.00406386193302376,-0.00394351213114619,0.0119868266463069,0.322381155878363
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,39226,0.00227277963870546,0.00229822838364794,-0.0022317479932445,0.00677730727065541,0.32271452922174
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,36538,0.00658601663911934,0.00666506156574998,-0.00647750402975063,0.0196495373079893,0.323102747360133
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSPN,Claspin,38705,0.00307076408763323,0.00312329194065016,-0.00305088811604107,0.00919241629130754,0.325533947175783
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,36767,0.00297240078386223,0.00303096088443922,-0.00296828254963864,0.00891308411736309,0.326769266002149
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,36420,0.00245132605440285,0.00250476498782239,-0.00245801332172903,0.00736066543053472,0.327764335683442
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164,Sialomucin core protein 24,39093,0.00228222354928954,0.00233296410646091,-0.00229038609937384,0.00685483319795291,0.327965928551394
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,39291,-0.00287540145111835,0.00293952109797284,-0.00863686280314512,0.00288605990090842,0.327997158446222
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,38741,0.00475289484052622,0.00485889956498757,-0.00477054830684942,0.0142763379879019,0.32799953240206
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,36796,0.00303437570625339,0.00310496877444668,-0.00305136309166209,0.00912011450416888,0.328456506218802
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",36391,0.00548453696320692,0.0056234492239233,-0.00553742351568275,0.0165064974420966,0.329431449298573
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,36339,-0.00569285088441039,0.00584153248307631,-0.01714225455124,0.00575655278241918,0.329803656101912
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36363,0.00425686075131215,0.00437950464199095,-0.00432696834699011,0.0128406898496144,0.331071369461
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTN,Titin,36391,-0.00601266651113719,0.00620051878596644,-0.0181656833316314,0.00614035030935703,0.332212881142022
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,36420,0.0080913669749253,0.00835618397483337,-0.00828675361574811,0.0244694875655987,0.332908786446981
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,39147,-0.00357849078858257,0.00369950017719775,-0.0108295111358902,0.00367252955872502,0.33341421327955
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,39283,0.00198679939419656,0.00205403148998864,-0.00203910232618118,0.0060127011145743,0.333425130813132
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,36711,-0.00354065573084483,0.00366744343283512,-0.0107288448592017,0.00364753339751201,0.33434821923371
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX3,Syntaxin-3,36747,-0.00329498419764719,0.00342421691584639,-0.0100064493527061,0.00341648095741173,0.335937477656371
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC16,Mucin-16,39023,-0.0161782217470671,0.016819727304966,-0.0491448872648004,0.0167884437706663,0.336135306468143
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFB,Complement factor B,36584,0.00285577147576297,0.00297270625285989,-0.00297073277984242,0.00868227573136836,0.336739460644067
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO1,Roundabout homolog 1,39117,-0.00205799229559725,0.00214486562110957,-0.00626192891297199,0.0021459443217775,0.337323595862929
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,39291,0.00371729757749915,0.00388394210165982,-0.0038952289417541,0.0113298240967524,0.338534819508399
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL24,C-C motif chemokine 24,39140,-0.00712599750445698,0.00744993464223163,-0.021727869403231,0.00747587439431702,0.338825665308536
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,38841,0.00311633286329155,0.0032586524112003,-0.00327062586266104,0.00950329158924413,0.338923169957068
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP6,Guanylate-binding protein 6,36391,0.00399523693229374,0.00417921543163745,-0.00419602531371566,0.0121864991783031,0.339101921486841
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN1,Prorelaxin H1,36767,-0.00693124832925987,0.00726023911322291,-0.0211613169911768,0.00729882033265703,0.33975441264465
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,36538,0.00449925634978407,0.00471558572074238,-0.00474329166287099,0.0137418043624391,0.340038765254351
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,38727,0.00628278288246601,0.00658866624298409,-0.0066310029537828,0.0191965687187148,0.340314666978572
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,36743,0.00662442538489643,0.00695652782827668,-0.00701036915852587,0.0202592199283187,0.340982843681767
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,36500,-0.00210826784708844,0.0022142964957497,-0.00644828897875786,0.00223175328458098,0.341056195173853
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYGD,Gamma-crystallin D,36747,0.00829482981617405,0.00871246092630269,-0.00878159359937921,0.0253712532317273,0.341081832762573
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39099,-0.00317863084046177,0.00334194154371892,-0.00972883626615084,0.00337157458522731,0.341551956096011
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL21,C-C motif chemokine 21,39162,0.00337910638291578,0.00355604224203619,-0.00359073641147516,0.0103489491773067,0.342003496920201
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP7,Matrilysin,38810,-0.00426836698070197,0.00450445472688669,-0.0130970982453999,0.00456036428399593,0.343354583612667
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,39237,0.00558533873046384,0.00592824860818182,-0.00603402854157254,0.0172047060025002,0.346127255848695
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPN1,Epsin-1,36538,0.00368530566712966,0.0039177814694953,-0.00399354601308114,0.0113641573473405,0.346896345639205
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39023,-0.00655275726109178,0.00696736541861083,-0.020208793481569,0.00710327895938544,0.346979804849627
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12A_IL12B,Interleukin-12,39023,0.00627189682839829,0.0066789215518217,-0.00681878941317224,0.0193625830699688,0.347715762052443
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC8,Histone deacetylase 8,36430,0.00535339670733105,0.0057049707576791,-0.00582834597771998,0.0165351393923821,0.348070229367597
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,36401,0.0031055042958154,0.00331085172604914,-0.0033837650872409,0.00959477367887171,0.348274056483316
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD48,CD48 antigen,39140,0.0024552315929071,0.00262505420346392,-0.00268987464588219,0.00760033783169638,0.349644885567328
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,36363,0.00780600773755593,0.00834596598408915,-0.00855208559125881,0.0241641010663707,0.349650189172647
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHH,Sonic hedgehog protein,36430,-0.00370633122169374,0.00396417202850368,-0.011476108397561,0.00406344595417348,0.349828311840766
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,38841,0.00255336154965464,0.00273464949735552,-0.00280655146516218,0.00791327456447145,0.350470069344533
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,36391,0.00347276113666257,0.00372055212046348,-0.00381952101944585,0.010765043292771,0.3506317717201
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSD1,Tryptase delta,36767,-0.00305934764637354,0.0032895507511029,-0.00950686711853523,0.00338817182578815,0.352378176777502
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPP,Lipoma-preferred partner,36391,0.00565429558473778,0.00610123483370953,-0.00630412468933289,0.0176127158588085,0.35407622445146
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP350,Centrosome-associated protein 350,36339,0.00303892363661146,0.00328098439941988,-0.00339180578625151,0.00946965305947443,0.354347946881597
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKCQ,Protein kinase C theta type,38841,-0.00361422005711768,0.00390290945339439,-0.0112639225857707,0.00403548247153532,0.354444133113661
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,36731,0.00376809912512518,0.00407766403036087,-0.00422412237438213,0.0117603206246325,0.35546054008557
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,36500,-0.0048804311488606,0.00528319286357357,-0.0152354891614648,0.0054746268637436,0.355626069430685
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,36430,-0.00372604402185538,0.00403391137163526,-0.0116325103102605,0.00418042226654974,0.35567057923267
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,38841,0.00297496199462894,0.00322128182334151,-0.00333875037912041,0.0092886743683783,0.355744073625673
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GJA8,Gap junction alpha-8 protein,36339,0.00502282630535484,0.00544649461653426,-0.00565230314305231,0.015697955753762,0.356435488145733
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,39234,0.00175632639721136,0.0019077507231788,-0.00198286502021908,0.0054955178146418,0.357259763022475
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKZF2,Zinc finger protein Helios,38727,0.0077965298912362,0.00847740769303996,-0.00881918918712213,0.0244122489695945,0.357753227625459
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,39099,0.00701265186964274,0.00763714193064214,-0.00795614631441586,0.0219814500537013,0.358513064448388
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,36421,-0.0057379491091099,0.00624943111974191,-0.017986834103804,0.00651093588558424,0.358555128710162
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,36538,0.00608892289958899,0.00663407746161659,-0.00691386892517953,0.0190917147243575,0.358727892044941
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSC2,Desmocollin-2,38923,0.0027525465901853,0.00300095139177396,-0.00312931813769166,0.00863441131806226,0.359039617421369
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,36538,0.00718312980285867,0.00783822401629396,-0.00817978926907749,0.0225460488747948,0.359462438495184
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,39241,-0.00224229563131288,0.00244755886478506,-0.00703951100629159,0.00255491974366583,0.359610179043817
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GL3,Endophilin-A3,36456,0.00687948962908857,0.00750991872163046,-0.00783995106530713,0.0215989303234843,0.359656211652468
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36311,0.00437573108433284,0.0047802021676056,-0.00499346516417414,0.0137449273328398,0.3600066493579
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST2,Bone marrow stromal antigen 2,39241,-0.00442692588313314,0.00483659929459316,-0.0139066605005357,0.00505280873426945,0.360049967781036
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR4,Proline-rich protein 4,36408,0.00576186079280809,0.00630089088420616,-0.00658788534023598,0.0181116069258522,0.360497083132519
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36363,0.0026902926101327,0.00295483954991253,-0.00310119290769586,0.00848177812796126,0.362592275438895
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLGAP5,Disks large-associated protein 5,36767,-0.00429033717598577,0.00472770044632507,-0.0135566300507829,0.00497595569881136,0.364165091540466
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,38727,0.00379762357660945,0.00419225667416148,-0.00441919950474705,0.0120144466579659,0.365021362623941
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK8,Kallikrein-8,38575,-0.00283948522078936,0.00313483263584013,-0.00898375718703601,0.00330478674545728,0.365064350389084
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL2,Interferon lambda-2,36363,0.00512764553377996,0.00566458463116905,-0.00597494034331138,0.0162302314108713,0.365370944191146
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,36421,0.00823174393294284,0.00910121150422342,-0.00960663061533507,0.0260701184812207,0.365765260747163
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD302,CD302 antigen,39023,0.00236995522442135,0.00262085317113087,-0.00276691699099517,0.00750682743983786,0.365867359540989
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,38832,0.00281229357333486,0.0031160652679864,-0.00329519435191849,0.00891978149858821,0.366798229031499
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGN,Cingulin,36421,-0.00318647948041743,0.00354249648186415,-0.0101297725848712,0.0037568136240363,0.368403053644422
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,36421,0.00344045301957962,0.00382571336202144,-0.0040579451699824,0.0109388512091416,0.368511658420242
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,39182,-0.00164018306194226,0.00182541581809657,-0.00521799806541154,0.00193763194152701,0.368919458981957
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,39095,-0.0238647686,0.026666018609401,-0.076130165074426,0.028400627874426,0.370827649769511
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,36391,0.00522754361015705,0.00584997504095827,-0.00623840747012116,0.0166934946904353,0.371552566568094
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,39033,-0.00210077606145094,0.00235164285473847,-0.00670999605673835,0.00250844393383646,0.371698526700311
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DXO,Decapping and exoribonuclease protein,36747,0.00367523144515636,0.00411962060572425,-0.00439922494206317,0.0117496878323759,0.372340653499597
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,36767,-0.00216240860090389,0.00243074824235621,-0.00692667515592207,0.00260185795411429,0.373693979479966
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,38987,-0.00234271260339379,0.00263621600352612,-0.00750969597030498,0.0028242707635174,0.37419733649505
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",36420,0.0050767493912657,0.00571821793224185,-0.00613095775592833,0.0162844565384597,0.374654475809372
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,36743,-0.00348452237168058,0.00392500507947988,-0.0111775323274612,0.0042084875841,0.374678231535329
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMP,Olfactory marker protein,36363,-0.00393923261349619,0.00443972986873349,-0.0126411031562138,0.00476263792922146,0.374951408722894
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,36767,-0.00394459626461448,0.00445046964316854,-0.0126675167652248,0.00477832423599585,0.375454848290479
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,36538,0.00470734196444999,0.00531402746310344,-0.00570815186323275,0.0151228357921327,0.375724216709855
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESPL1,Separin,36339,0.004296875313373,0.0048511384251025,-0.0052113559998279,0.0138051066265739,0.375771608717988
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,36430,0.00309918968500208,0.00350063796820617,-0.00376206073268201,0.00996044010268618,0.376000249549039
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,36430,-0.00329835250935026,0.00372601695147065,-0.0106013457342327,0.00400464071553222,0.376053793901251
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,36743,-0.0042775669680368,0.00483668085500444,-0.0137574614438455,0.0052023275077719,0.376496111413006
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX8,Syntaxin-8,39099,0.00389362084742885,0.00440289237787066,-0.00473604821319765,0.0125232899080553,0.376530698001894
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRKL,Crk-like protein,39114,0.00855740402331775,0.00968192125488664,-0.0104191616362601,0.0275339696828956,0.37678900645754
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF3,Fibroblast growth factor 3,36430,0.00247099192288576,0.00279605680095084,-0.00300927940697789,0.00795126325274942,0.376852579202266
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",36538,0.00399401660343775,0.0045200110160894,-0.00486520498809748,0.012853238194973,0.376912821774156
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,39165,0.00261426386868402,0.00296003058645222,-0.00318739608076234,0.00841592381813037,0.377148507611332
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,36767,0.00618104759205277,0.00700037817689051,-0.00753969363465263,0.0199017888187582,0.377274816388365
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,36731,-0.00311013521195379,0.00352282305840018,-0.0100148684064182,0.00379459798251057,0.377332141758832
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK2,Docking protein 2,39106,0.00979465733686134,0.0111086321835431,-0.0119782617428832,0.0315675764166058,0.377944374667231
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,39241,0.00364777513819752,0.00413862202092539,-0.00446392402281624,0.0117594742992113,0.378115955527568
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM,Paralemmin-1,36667,0.00226515460986612,0.00257550904437323,-0.0027828431171054,0.00731315233683765,0.379147912075766
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL6B,Myosin light chain 6B,36421,-0.00738621090856208,0.00840117937483241,-0.0238525224832336,0.00908010066610945,0.379316502603826
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,36538,0.00221057249074693,0.0025150662283046,-0.00271895731673009,0.00714010229822396,0.379454739844047
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,36792,-0.0026292881712254,0.00299148918381863,-0.00849260697150992,0.00323403062905911,0.379459443839717
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK1,Docking protein 1,36747,0.0108529649672631,0.0124114110814043,-0.0134734007522894,0.0351793306868155,0.38189801860047
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,39162,-0.00159618758845375,0.00182540538312955,-0.00517398213938766,0.00198160696248017,0.38189833858879
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,36767,0.0020227410406839,0.00231767207774915,-0.00251989623170443,0.00656537831307223,0.38281730255756
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,36421,-0.00512247833461389,0.00586947051754982,-0.0166266405490115,0.00638168387978376,0.38282552028385
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,39283,0.00275174179756734,0.00315405219262877,-0.00343020049998506,0.00893368409511974,0.382978424007647
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,39099,0.00890321163071199,0.0102336209884312,-0.0111546855066133,0.0289611087680372,0.384316170282928
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,36398,0.00304956815378218,0.00352149706328022,-0.00385256609024705,0.0099517023978114,0.386514254188822
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRN,"Attractin, Isoform 2",36806,-0.00127639172020999,0.0014753992748727,-0.00416817429896048,0.00161539085854051,0.386991079133606
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,36731,0.0036045076564792,0.0041695615530272,-0.00456783298745412,0.0117768483004125,0.387339703314177
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,36391,0.00532673653333406,0.00616513609487639,-0.00675693021262366,0.0174104032792918,0.387599175767635
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAV,Integrin alpha-V,39255,0.00129115443061491,0.00149534664250148,-0.00163972498868799,0.00422203384991782,0.387904516112266
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEXN,Nexilin,36796,-0.00538695509840357,0.00624241106968282,-0.0176220807949819,0.00684817059817477,0.38817510221506
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",36430,-0.00217551961987846,0.00252183207109732,-0.0071183104792292,0.00276727123947228,0.38833304561897
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,36430,0.00170423911578153,0.00197814290656641,-0.00217292098108864,0.0055813992126517,0.388959951952477
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,36538,-0.00315955208541115,0.00366797431423444,-0.0103487817413106,0.00402967757048835,0.389040219542832
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,39095,0.00401759075417629,0.00468252729719648,-0.0051601627483288,0.0131953442566814,0.39090804421306
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR2,Complement receptor type 2,39165,-0.00351916747981206,0.00410315922241102,-0.0115613595557377,0.00452302459611355,0.391086671552249
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,38832,0.00590316917537382,0.00689978481157355,-0.00762040905531034,0.019426747406058,0.392255753843615
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MB,Myoglobin,39283,-0.00400800608244076,0.00470592714877033,-0.0132316232940306,0.00521561112914909,0.394397627884707
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,39274,-0.00295339847986155,0.00346817029180954,-0.00975101225180824,0.00384421529208514,0.394464632212748
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,36538,0.00661149151981871,0.00777239273598439,-0.0086223982427107,0.0218453812823481,0.3949866165861
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,36420,-0.0197749444628533,0.0233149576982194,-0.0654722615513634,0.0259223726256567,0.396361930088377
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,36363,0.00232687318617804,0.00275025313644526,-0.00306362296125467,0.00771736933361075,0.397536678665633
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,38741,0.00568612749038827,0.00673235130788326,-0.00750928107306291,0.0188815360538395,0.398349149611409
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,36430,0.00614294494408976,0.00730311505169462,-0.00817116055723171,0.0204570504454112,0.400285298393542
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,39095,0.00186432334919183,0.00221719750154502,-0.00248138375383641,0.00621003045222008,0.400446980584472
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,36743,-0.00205548845825017,0.00244477479200374,-0.00684724705057751,0.00273627013407717,0.400493510892459
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,36420,-0.00313205261715459,0.00373222840715973,-0.0104472202951876,0.00418311506087848,0.401378089369949
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,36747,0.00291951950581967,0.00348355581228523,-0.00390824988625938,0.00974728889789873,0.401997924465666
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,36767,-0.00180947011585539,0.00215998527386505,-0.00604304125263088,0.0024241010209201,0.402201603793156
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,39023,0.00409072445256038,0.00489384624226673,-0.00550121418228241,0.0136826630874032,0.403229118905855
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,36791,0.00195185865077695,0.00233544769652098,-0.00262561883440417,0.00652933613595808,0.403309017499197
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XCL1,Lymphotactin,39255,0.00414626080332781,0.00496577922154663,-0.00558666647090359,0.0138791880775592,0.403749356506271
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN3,CCN family member 3,39273,-0.00243596217745704,0.0029315870473531,-0.00818187279026911,0.00330994843535503,0.406022471113163
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,36430,0.0069747144610028,0.00839484452342941,-0.00947918080491884,0.0234286097269244,0.406083717404407
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEB,Nebulin,36391,-0.00281378736114402,0.00339021207726711,-0.00945860303258755,0.00383102831029951,0.406569381278857
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,36391,0.00250770604903462,0.00302162439929775,-0.00341467777358896,0.00843008987165821,0.406599914569541
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,39241,-0.00392221012916304,0.00472724659289578,-0.0131876134512388,0.00534319319291269,0.406719667422376
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,36806,-0.00143722864058029,0.00173246684965661,-0.00483286366590724,0.00195840638474667,0.406788714472142
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36363,0.00351167029004966,0.00423604743539302,-0.00479098268332065,0.01181432326342,0.407121973753297
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,39023,-0.00231167586118921,0.00279063630779861,-0.00778132302447448,0.00315797130209606,0.407474746656884
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,36391,-0.00208604736677074,0.0025212335091312,-0.00702766504466789,0.00285557031112641,0.408030909266681
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,36339,0.00407843464504319,0.00493618552371798,-0.00559648898144406,0.0137533582715304,0.408688271419808
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,36785,0.00359686725088865,0.00436194468066079,-0.0049525443232065,0.0121462788249838,0.409612940329967
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA8,Carbonic anhydrase-related protein,36430,-0.00194706774538152,0.00236153025464256,-0.00657566704448093,0.00268153155371789,0.409674515418565
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX33,Testis-expressed protein 33,36538,0.00299072215548996,0.00362832544720786,-0.00412079572103744,0.0101022400320174,0.409801301037372
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,38841,-0.00418341460555191,0.00508054167035292,-0.0141412762794436,0.00577444706833981,0.410282862369012
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39165,-0.00316732661746307,0.00384672706512264,-0.0107069116651034,0.00437225843017731,0.410303508016143
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39099,-0.0110622844515989,0.0134484619213259,-0.0374212698173977,0.0152967009141999,0.410766148803269
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD36,Platelet glycoprotein 4,36430,-0.00340995212774629,0.00414614816256155,-0.0115364025263669,0.00471649827087435,0.410842941088342
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAT,Tissue-type plasminogen activator,39234,-0.00366956915039997,0.00447732310382574,-0.0124451224338984,0.00510598413309848,0.412462593341635
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,38741,-0.00589697452384002,0.00720925923301975,-0.0200271226205587,0.00823317357287869,0.413386087972321
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENG,Endoglin,39283,-0.00125146857640122,0.00153036893198974,-0.00425099168310111,0.00174805453029867,0.413509085160951
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,36767,0.00473716158169006,0.00581330656966347,-0.00665691929485033,0.0161312424582305,0.415154627071965
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,38727,-0.00220514854399431,0.00270707879483042,-0.00751102298186193,0.00310072589387331,0.415322362548957
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,36430,0.00231430168222535,0.00284138829526231,-0.00325481937648878,0.00788342274093949,0.415375833109332
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRN,Agrin,39162,-0.00240535940355803,0.00295379487672365,-0.00819479736193639,0.00338407855482033,0.415469449137718
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,36391,0.00726239594573587,0.00892403399954132,-0.0102287106933651,0.0247535025848368,0.415773901809417
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,36731,0.00440335116729927,0.00541920809319413,-0.00621829669536124,0.0150249990299598,0.416493927559147
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTB,Lymphotoxin-beta,36731,0.00250110282146573,0.00307901616248817,-0.00353376885701109,0.00853597449994254,0.41663118152158
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,38727,-0.00259713992986138,0.00322387552598387,-0.00891593596078975,0.003721656101067,0.420488949296365
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,39106,0.0019521119742092,0.00242378347969293,-0.00279850364598895,0.00670272759440735,0.420602223444597
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,36743,0.00308997947861374,0.00384092512819916,-0.00443823377265662,0.0106181927298841,0.421129846057561
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,39216,-0.00451771806073109,0.00562058074316657,-0.0155340563173376,0.00649862019587538,0.421535695913087
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,36339,-0.00449188296905321,0.00559313855795183,-0.0154544345426388,0.00647066860453237,0.421928782924503
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX6,Syntaxin-6,38727,0.00493316382655133,0.00614362057327732,-0.00710833249707221,0.0169746601501749,0.422002952721839
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTF2,Transcription termination factor 2,36421,-0.00359545810730966,0.0044780765879388,-0.0123724882196697,0.0051815720050504,0.422046383191971
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL21R,Interleukin-21 receptor,36430,-0.00396043847055531,0.00493347904634771,-0.0136300574013968,0.00570918046028621,0.42212409344016
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,36538,0.00474370397024897,0.00592112164728975,-0.00686169445843895,0.0163491023989369,0.423060084856602
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,38841,0.0030326024601841,0.00378649681738426,-0.00438893130188906,0.0104541362222573,0.423202675820151
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",36430,-0.00434017539798149,0.00542081631763731,-0.0149649753805506,0.00628462458458763,0.423349554947407
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,36796,-0.00286248641424441,0.00357837865041857,-0.00987610856906481,0.00415113574057599,0.423760542087679
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39095,-0.00215863009177824,0.00269943380171829,-0.0074495203431461,0.00313226015958961,0.423920097572815
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS27,Serine protease 27,39057,0.00290056954576675,0.00363080643444524,-0.00421581106574591,0.0100169501572794,0.42437393486844
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL3,Fc receptor-like protein 3,38841,0.00375874803375728,0.00471256432533722,-0.00547787804390367,0.0129953741114182,0.425114463978909
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELENOP,Selenoprotein P,36806,0.00160136995606546,0.00201052407093003,-0.00233925722295739,0.00554199713508831,0.425759683714833
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,36339,0.00333133939365313,0.00418505545309239,-0.00487136929440795,0.0115340480817142,0.426042281013397
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSHB,Follitropin subunit beta,36420,-0.00467172274455347,0.00587588369451073,-0.0161884547857945,0.00684500929668757,0.426589402327253
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,36430,0.00230445179412616,0.00290473217913855,-0.0033888232769854,0.00799772686523773,0.427592412934331
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WNT9A,Protein Wnt-9a,38841,0.00201512416997056,0.00254200341987881,-0.0029672025329919,0.00699745087293302,0.42794728881725
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLTP,Phospholipid transfer protein,39210,0.0025773582190549,0.00325244603523268,-0.00379743601000115,0.00895215244811095,0.428118223491209
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,38741,0.004637710598605,0.00585265749300555,-0.00683349808768587,0.0161089192848959,0.428133657593462
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS1,Nephrin,36430,0.00245411430449014,0.00310322927367455,-0.00362821507191198,0.00853644368089226,0.429060472467382
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",36363,0.00594371713830672,0.00751984224462733,-0.00879517366116285,0.0206826079377763,0.429306566904212
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH1,Protocadherin-1,39252,-0.00148246473457637,0.00188052339992883,-0.00516829059843688,0.00220336112928415,0.430518418754315
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,39216,0.00286903694840938,0.00364240421325616,-0.0042700753095727,0.0100081492063915,0.430897992615914
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERVV_1,,36391,0.00338987237252656,0.00432051110647432,-0.00507832939616311,0.0118580741412162,0.432703048937251
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,36430,0.00639733095612562,0.00815514463874472,-0.00958675253581403,0.0223814144480653,0.432788896668478
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB2,Beta-crystallin B2,36747,-0.0039879418456332,0.00509818344244178,-0.0139803813928191,0.00600449770155269,0.434094963073173
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",36747,-0.00423930787542019,0.00542436508271715,-0.0148710634375458,0.00639244768670542,0.43450478130263
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXDNL,Peroxidasin-like protein,36731,-0.00417009506070147,0.00535392079654802,-0.0146637798219356,0.00632358970053265,0.436061069166799
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17C,Interleukin-17C,38841,-0.00465109580200596,0.00597507158411606,-0.0163622361068734,0.00706004450286151,0.436335661558307
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36230,0.00229962863641483,0.00295632351110021,-0.00349476544534159,0.00809402271817124,0.436661875476099
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,36420,-0.00564829567038876,0.00728504120787828,-0.0199269764378302,0.00863038509705268,0.438160526631576
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TADA3,Transcriptional adapter 3,36731,-0.00277979915916034,0.00358882779114656,-0.00981390162980761,0.00425430331148692,0.438607883773776
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK3,NT-3 growth factor receptor,39241,0.00148980730381616,0.00192427549401608,-0.00228177266445535,0.00526138727208768,0.438814222178072
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,36767,0.0068662462806195,0.00887038176346938,-0.0105197019757805,0.0242521945370195,0.438906916938658
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1,Allograft inflammatory factor 1,38727,0.00368919778227125,0.00478468510596774,-0.00568878502542552,0.013067180589968,0.4406937198035
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN4,Contactin-4,39093,-0.00166330796931827,0.00215884058611345,-0.00589463551810062,0.00256801957946409,0.441036920958627
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALCAM,CD166 antigen,39283,0.00134798989480054,0.00175563104539816,-0.00209304695417987,0.00478902674378094,0.442612226094823
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFAP1,Actin filament-associated protein 1,36500,0.00590437801206315,0.00769191092579892,-0.00917176740250273,0.020980523426629,0.442734010073953
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,36391,0.00317837717640087,0.00414630104357162,-0.00494837286899951,0.0113051272218012,0.44335923414951
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,36686,-0.00423505064607465,0.00554171637493859,-0.0150968147409543,0.00662671344880498,0.444754492141188
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",38832,-0.00298758084038856,0.00390988697533511,-0.0106509593120454,0.00467579763126825,0.44481417651146
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,36420,-0.00216546433229234,0.00283554162808152,-0.00772312592333212,0.00339219725874745,0.445068543736149
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSCA,Prostate stem cell antigen,36743,0.0175575569204939,0.0229909955167752,-0.0275047942923855,0.0626199081333733,0.445077301690071
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36339,0.00377450135943339,0.00494261584790756,-0.00591302570246542,0.0134620284213322,0.44508150616214
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,38741,-0.00466348644649638,0.00611096590906733,-0.0166409796282684,0.00731400673527559,0.445395524867906
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS8,Galectin-8,39241,0.00423016474037433,0.00554467780061507,-0.0066374037488312,0.0150977332295799,0.445520748002931
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,36339,-0.00250823207379266,0.00329876469878335,-0.00897381088340804,0.00395734673582271,0.447056808117762
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,39283,0.00480139873069268,0.00632248161819631,-0.00759066524097209,0.0171934627023574,0.447614876179511
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,36731,0.00359557485211294,0.0047411764139994,-0.00569713091932588,0.0128882806235518,0.448242275223113
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP4,Guanylate-binding protein 4,38741,-0.00336671938140244,0.00444065104750911,-0.0120703954345203,0.00533695667171541,0.448367832775139
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,39099,-0.00316581556893337,0.00418104794581457,-0.0113606695427299,0.00502903840486319,0.448952349871305
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,36339,0.00331652279636115,0.00438702360455635,-0.00528204346856929,0.0119150890612916,0.449672629007118
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL24,Interleukin-24,38841,0.00322784165722667,0.00427191499496719,-0.00514511173290901,0.0116007950473624,0.449903366185968
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,38605,-0.00581499281999934,0.00770485894474118,-0.0209165163516921,0.00928653071169338,0.450430484387319
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,36391,0.00230715770490445,0.00306283048970666,-0.0036959900549206,0.00831030546472949,0.451298032472967
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36339,-0.00348039519179265,0.00462621242630558,-0.0125477715473516,0.00558698116376628,0.451872435650668
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTNNA1,Catenin alpha-1,36363,0.00235212310662237,0.00313160741944238,-0.00378582743548469,0.00849007364872943,0.452611843575355
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM25,RNA-binding protein 25,36339,-0.0031261259007561,0.00416403134537671,-0.0112876273376945,0.00503537553618225,0.452820263724793
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",36420,-0.00473538299037698,0.00632132342341498,-0.0171251769002704,0.00765441091951639,0.45380337352942
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,36538,0.00249571792192043,0.00334178714153175,-0.0040541848754818,0.00904562071932266,0.455185266744313
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,H2AP,Huntingtin-interacting protein M,36339,-0.00337252987815228,0.00454026217351536,-0.0122714437382424,0.00552638398193781,0.457613672293533
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,38741,-0.00388549293345468,0.00523727779690538,-0.0141505574153892,0.00637957154847986,0.458164663117306
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDM1,Nuclear protein MDM1,36421,0.00211900468014744,0.00285640263660057,-0.00347954448758968,0.00771755384788456,0.458195829828068
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFI,Complement factor I,36806,-0.00133395365293244,0.00179914559388981,-0.00486027901695647,0.00219237171109159,0.45844178410612
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAM,Signal transducing adapter molecule 1,36731,0.00244084111329405,0.00329664339615984,-0.00402057994317924,0.00890226216976735,0.459069657367969
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,38741,0.00468428811402289,0.00634729830122123,-0.00775641655637073,0.0171249927844165,0.460527812931536
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,36743,0.00470215818646116,0.00637524662120433,-0.00779332519109934,0.0171976415640217,0.460792319767147
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,36792,-0.00508733252013139,0.00691080872669458,-0.0186325176244528,0.00845785258418998,0.461657992752096
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,36796,-0.00171129783640872,0.00232662113299515,-0.00627147525707921,0.00284887958426177,0.462030583934468
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO2,Roundabout homolog 2,39241,-0.00150946449915648,0.00205657536340833,-0.00554035221143682,0.00252142321312386,0.462978245801036
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,39165,-0.00181722186517288,0.00247590056673683,-0.00666998697597706,0.00303554324563131,0.462981927012904
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP10,Bone morphogenetic protein 10,36500,-0.00187589162010339,0.00255677290884638,-0.0068871665214423,0.00313538328123552,0.463148225704763
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA,Lymphotoxin-alpha,39099,-0.00262555068917387,0.00358043784094178,-0.00964320885741975,0.00439210747907202,0.4633840949366
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSL,Cathepsin L1,39106,-0.00158044273701832,0.00216070749248737,-0.00581542942229356,0.00265454394825692,0.464517486058564
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36363,0.00479588938114419,0.00656419208332197,-0.00806992710216687,0.0176617058644553,0.465028764909706
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36363,0.00212916810355195,0.00291723453929118,-0.00358861159345876,0.00784694780056266,0.465490422495905
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,36339,0.00366219928931247,0.00502430895738077,-0.00618544626715384,0.0135098448457788,0.466078889064438
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH9,Protocadherin-9,36743,-0.00219452722273324,0.00301185025088077,-0.00809775371445954,0.00370869926899307,0.466240702958153
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,39093,-0.00258355553381086,0.00355356558333676,-0.00954854407715091,0.00438143300952919,0.467217587482979
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,39266,-0.00174458480691039,0.00239994719911766,-0.00644848131718101,0.00295931170336022,0.467282132503125
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO9B,Unconventional myosin-IXb,38841,-0.00433825495739459,0.00598557501268589,-0.0160699819822589,0.00739347206746976,0.468595261901251
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,38987,0.00618920407668653,0.00855373527856091,-0.0105761170692929,0.0229545252226659,0.469342544095302
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,39106,-0.00431243128376671,0.00596562952210282,-0.0160050651470882,0.00738020257955481,0.46976500824879
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",36420,-0.00210870467602469,0.0029315431402357,-0.00785452923088668,0.00363711987883729,0.471959876872832
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,36747,-0.0023358082450898,0.00324754439093694,-0.0087009952513262,0.0040293787611466,0.471997673898131
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,38727,0.00306198332901666,0.00426541987073249,-0.00529823961761902,0.0114222062756523,0.472853589118052
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBR1,T-box brain protein 1,36421,-0.0031491765116321,0.00439182310525175,-0.0117571497979255,0.00545879677466133,0.473353803330418
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD9,Enhancer of filamentation 1,36430,0.00215630460756814,0.00301594195710304,-0.00375494162835382,0.0080675508434901,0.474641558551628
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,38987,-0.0050639333813058,0.00710873552474345,-0.018997055009803,0.00886918824719135,0.476256823898476
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROCR,Endothelial protein C receptor,36391,0.00235182992507853,0.00331470939247331,-0.00414500048416916,0.00884866033432623,0.478019290945457
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP4,Caspase-4,36538,0.0106054833626476,0.0149714398705319,-0.018738538783595,0.0399495055088901,0.47872171963062
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP73,Tumor protein p73,36421,-0.00223017100917305,0.0031486826443158,-0.00840158899203203,0.00394124697368592,0.478780186562309
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL2,Fc receptor-like protein 2,39224,0.00296474296052973,0.00418593007741706,-0.00523967999120772,0.0111691659122672,0.478792165474772
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",36792,0.00475197572507687,0.00670980184487976,-0.00839923589088746,0.0179031873410412,0.47882512669533
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5E,5'-nucleotidase,39147,-0.00353714082277976,0.00499898005452738,-0.0133351417296534,0.00626086008409391,0.479221561063711
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,36339,0.00208212131162033,0.00294325620229483,-0.00368666084487753,0.00785090346811819,0.479318087160229
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,36538,0.00438318718764842,0.00620644060508786,-0.00778143639832378,0.0165478107736206,0.480056828333369
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,39023,0.00879353066271665,0.01246327211754,-0.0156344826876617,0.033221544013095,0.480475421325468
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,36339,-0.00357062497118949,0.0050672700009058,-0.0135024741729649,0.00636122423058587,0.481044520924091
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNG,Uracil-DNA glycosylase,36731,0.00219805582149233,0.00312027716751027,-0.00391768742682781,0.00831379906981246,0.481169997422261
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,39099,0.00385328160561985,0.00547380386457444,-0.00687537396894606,0.0145819371801858,0.481474966686017
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDC,Nuclear migration protein nudC,39291,0.00407693000211359,0.00580189678187604,-0.00729478769036345,0.0154486476945906,0.482260081792879
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,39291,-0.00485099667601432,0.00693507880503296,-0.0184437511338789,0.00874175778185027,0.48425834949956
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,36731,-0.00229529943164513,0.00328383518607356,-0.00873161639634932,0.00414101753305905,0.484583951251834
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39165,-0.00269056234318429,0.00384955489975674,-0.0102356899467075,0.00485456526033891,0.484607545245669
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,38741,-0.00297322382627076,0.00425867328551171,-0.0113202234658737,0.00537377581333218,0.485089738415756
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTPBP2,GTP-binding protein 2,36421,0.00515281597402418,0.00738259908751559,-0.00931707823750638,0.0196227101855547,0.485210291169459
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,38832,0.0046222248354011,0.00664606090097916,-0.00840405453051805,0.0176485042013203,0.486763223486554
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,36767,-0.00186699210110725,0.00269009210935108,-0.00713957263543536,0.00340558843322086,0.487678805877821
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP1,Dipeptidase 1,38951,0.00295807612309605,0.00426629060638604,-0.00540385346542058,0.0113200057116127,0.488094201335342
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLNK,B-cell linker protein,36430,0.00246218201050102,0.003561433806729,-0.00451822825068783,0.00944259227168986,0.489361075582908
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,36743,-0.00475173854425078,0.00687392519040491,-0.0182246319174444,0.00872115482894283,0.489408311375668
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,38741,0.00494468791023227,0.00716743902598322,-0.00910349258069484,0.0189928684011594,0.490279089429117
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG4,Desmoglein-4,38960,0.00306201119754897,0.00444817261756912,-0.0056564071328865,0.0117804295279844,0.491227185294827
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,38832,-0.00329990975077545,0.00480010163086518,-0.0127081089472712,0.0061082894457203,0.491799363585684
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM3,Dynamin-3,36767,0.00341266942339719,0.00497922700676249,-0.00634661550985729,0.0131719543566517,0.493115606383894
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,36743,-0.00904488141976529,0.0132574220256279,-0.0350294285899959,0.0169396657504653,0.495092899285294
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,38922,0.00196779205369968,0.00288661298015186,-0.00368996938739796,0.00762555349479732,0.495441781423336
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36363,0.00407600619039033,0.00598487022010229,-0.00765433944101016,0.0158063518217908,0.49585137420556
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FST,Follistatin,39140,0.00315913322624639,0.00464754403676578,-0.00595005308581455,0.0122683195383073,0.496677814623956
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TG,Thyroglobulin,36731,-0.00665225142863447,0.00982056668380766,-0.0259005621288975,0.0125960592716285,0.498177319824511
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC1,Glypican-1,39255,0.00177962374391203,0.00262832245409812,-0.00337188826612028,0.00693113575394434,0.498355914844079
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,36421,-0.00447018704912416,0.00663517145857111,-0.0174751231079235,0.00853474900967521,0.500507554416347
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,36421,0.00478013878000866,0.00712067952977428,-0.00917639309834892,0.0187366706583662,0.502039398856916
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOT,Angiomotin,36500,0.00250079722691528,0.00373209004245741,-0.00481409925630124,0.00981569371013181,0.502819319803186
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH23,Cadherin-23,36747,-0.00162665858370868,0.00243048408918418,-0.00639040739850967,0.0031370902310923,0.503333020041871
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDHB,Succinate dehydrogenase,36743,0.00426422448059898,0.00638764049970481,-0.00825555089882245,0.0167839998600204,0.504417340441809
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,36767,0.00547600665249976,0.00820972851226696,-0.0106150612315435,0.021567074536543,0.504774896930018
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,38741,0.00503079909032793,0.00761387501953012,-0.00989239594795109,0.019953994128607,0.508788679347008
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM2,Isthmin-2,36791,0.0026599831621549,0.00402670009454745,-0.0052323490231581,0.0105523153474679,0.508889385575828
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,36430,0.00120463584867759,0.0018250078773986,-0.00237237959102367,0.00478165128837885,0.50921998443257
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBN,Ameloblastin,38841,0.0017150178400156,0.00259841062888692,-0.00337786699260276,0.00680790267263397,0.509247472871054
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHC1,SHC-transforming protein 1,36339,0.00692555819763298,0.0105173214969138,-0.0136883919363181,0.0275395083315841,0.510235031407508
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,36538,-0.00308399832899071,0.00471425538028499,-0.0123239388743493,0.00615594221636787,0.513004056866788
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,36339,0.00219945348280949,0.00336818915388767,-0.00440219725881035,0.00880110422442933,0.513763338621687
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,38741,-0.00206207291027549,0.00316133481932225,-0.0082582891561471,0.00413414333559612,0.51423115814254
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39147,0.00559093247442892,0.00858192583952218,-0.0112296421710346,0.0224115071198924,0.51474802364691
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGF,Beta-nerve growth factor,38987,0.000724441208349575,0.00111417866580134,-0.00145934897662105,0.0029082313933202,0.51557161686748
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,36421,0.00312326227290976,0.00481022039405766,-0.00630476969944325,0.0125512942452628,0.516158215536391
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,36421,0.00370031117335412,0.0057001375848154,-0.00747195849288406,0.0148725808395923,0.516245714446518
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,38832,-0.00186920634105515,0.00288620152446621,-0.00752616132900892,0.00378774864689861,0.517230711797148
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBX2,Chromobox protein homolog 2,36391,0.00235579578456947,0.00364380994148245,-0.00478607170073612,0.00949766326987507,0.517954528551495
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,36500,-0.00161039617278497,0.00249799071706849,-0.00650645797823922,0.00328566563266928,0.519148480176171
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GC,Vitamin D-binding protein,36806,0.00150889021913578,0.00234104239301846,-0.0030795528711804,0.00609733330945197,0.519238200313563
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A3,Protein S100-A3,36731,0.00260798219905606,0.00404778843129933,-0.00532568312629063,0.0105416475244028,0.519393660463608
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,39093,0.00164708753189831,0.00255741244085002,-0.00336544085216772,0.00665961591596434,0.51955624564317
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,39241,-0.00196730051638726,0.00305744586123674,-0.00795989440441126,0.00402529337163675,0.519944504637622
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,38741,-0.00358694775799002,0.00557950600658644,-0.0145227795308994,0.00734888401491941,0.520312461849055
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL9,Interleukin-9,36538,0.00333937737030896,0.005203402833854,-0.00685929218404488,0.0135380469246628,0.521035440006679
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRN1,Secernin-1,39099,0.00325548403979658,0.00508677942938423,-0.00671460364179651,0.0132255717213897,0.522189224069374
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,38741,-0.00229211571310588,0.00358486734956006,-0.0093184557182436,0.00473422429203184,0.522581384672005
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,36420,0.00269826511977436,0.00423579174371673,-0.00560388669791043,0.0110004169374592,0.52412633845668
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,36430,-0.00496949805694735,0.00781074946811384,-0.0202785670144505,0.0103395709005558,0.524632689792671
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PER3,Period circadian protein homolog 3,36430,0.00677169979722987,0.0106931463443897,-0.014186867037774,0.0277302666322337,0.526565747026301
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,36767,-0.00356433598212522,0.00564879320074543,-0.0146359706555863,0.00750729869133583,0.528057777533384
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,38841,-0.00163187150940232,0.00259291852388863,-0.00671399181622403,0.00345024879741939,0.529124937717564
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_A,,36767,0.00182071084578414,0.00292903876981682,-0.00392020514305684,0.00756162683462511,0.534211330845583
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL,Podocalyxin,39023,0.00084396894069638,0.00136040113357007,-0.00182241728110095,0.00351035516249372,0.535015370617374
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,36320,0.00267090882478913,0.00433036191626635,-0.00581660053109291,0.0111584181806712,0.537386818527529
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2L,Ataxin-2-like protein,36767,0.00267691537338273,0.0043591284251475,-0.00586697633990637,0.0112208070866718,0.539163920751892
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPT,Microtubule-associated protein tau,38741,-0.00292978167346135,0.00477234453425375,-0.0122835769605987,0.006424013613676,0.539285343659566
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGM2,Phosphoglucomutase-2,36421,-0.00340067933369745,0.00554021211673084,-0.0142594950824899,0.007458136415095,0.539347025620209
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFP,Alpha-fetoprotein,38939,0.00371752944564961,0.00607925664771173,-0.00819781358386537,0.0156328724751646,0.540870869166814
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAG,Myelin-associated glycoprotein,36421,0.00255730064279254,0.00418917033224468,-0.00565347320840704,0.0107680744939921,0.541571382950215
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,38841,-0.00332976040738501,0.00549435750201437,-0.0140987011113332,0.00743918029656314,0.544502209603207
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,39110,0.00214566100623574,0.00355900134743735,-0.00482998163474146,0.00912130364721295,0.546595566432458
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HK2,Hexokinase-2,38832,-0.00148994530731013,0.00247375118460096,-0.00633849762912802,0.00335860701450776,0.546982245367441
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH3,Neurexophilin-3,36430,-0.00162212074013305,0.00269365640585966,-0.00690168729561798,0.00365744581535188,0.547051667176038
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT2,Omega-amidase NIT2,36737,-0.00410150743326138,0.00682784478000613,-0.0174840832020734,0.00928106833555064,0.548048335292553
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LF,CMRF35-like molecule 1,39255,0.0032355940396894,0.00539663596092758,-0.00734181244372865,0.0138130005231075,0.548809943240696
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,36421,0.00659437897494828,0.0110150698097206,-0.0149951578521041,0.0281839158020007,0.549404541032766
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPO,Myeloperoxidase,39093,0.002451399636909,0.00409650525605208,-0.00557775066495309,0.0104805499387711,0.549573675796723
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,38727,0.00183433292257905,0.00308694506428154,-0.00421607940341276,0.00788474524857087,0.552372193958529
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,38727,0.00323374644143269,0.00546411959642689,-0.00747592796756401,0.0139434208504294,0.553983660112614
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,36363,0.00517518269715036,0.00875955820928639,-0.011993551393051,0.0223439167873517,0.554662382534609
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,36430,-0.00293579767659098,0.00498662920444634,-0.0127095909173058,0.00683799556412384,0.556050369690535
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFIC,Nuclear factor 1 C-type,36767,0.00223819830889242,0.00381000643629733,-0.00522941430625035,0.00970581092403519,0.556910030802443
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR4,Toll-like receptor 4,36430,0.00145657324675775,0.00248149132821338,-0.00340714975654047,0.00632029625005598,0.557231072952835
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,39093,0.00227279310612532,0.00388011403051706,-0.00533223039368812,0.00987781660593876,0.55804938060377
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,36747,0.00479658555247849,0.00820931326312531,-0.0112936684432471,0.0208868395482041,0.559038240173906
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH22,Cadherin-22,36538,0.00154284965005598,0.00264787829801283,-0.00364699181404917,0.00673269111416113,0.560123190034295
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,36698,0.00253856961502366,0.00436427728068152,-0.00601541385511212,0.0110925530851594,0.560799126140646
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,36391,0.0020779902284682,0.00359521259529987,-0.00496862645831954,0.00912460691525594,0.563282514653459
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBH,Dopamine beta-hydroxylase,36782,-0.00565605931733111,0.00986238580953701,-0.0249863355040237,0.0136742168693614,0.56631747976127
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,36731,-0.00316222007329627,0.00551626596084778,-0.0139741013565579,0.00764966120996539,0.566482919876938
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",36320,0.00131911117128198,0.00230485640853088,-0.00319840738943855,0.00583662973200251,0.5671167768481
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,36363,0.00207476535865221,0.00362977162213069,-0.00503958702072394,0.00918911773802837,0.567605529493932
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRLB,Fc receptor-like B,38727,0.00299710541130944,0.00524483762863096,-0.00728277634080725,0.0132769871634261,0.567710654349695
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,36430,0.00235941420797698,0.00412974335272209,-0.00573488276335831,0.0104537111793123,0.567791445746984
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",36391,0.00333517321183429,0.00584153451975705,-0.00811423444688953,0.0147845808705581,0.568049684070267
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,39023,-0.00437268103665153,0.00766305428124845,-0.0193922674278985,0.0106469053545954,0.568266686915654
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF12,Fibroblast growth factor 12,36430,-0.00241307040076119,0.00423036127238868,-0.010704578494643,0.00587843769312061,0.568405031216893
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLKB1,Plasma kallikrein,36549,-0.00129054558558773,0.0022643579155151,-0.00572868709999733,0.00314759592882188,0.568729252162137
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,38992,-0.00137882225812217,0.00242010337026382,-0.00612222486383926,0.00336458034759491,0.568864597807757
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12B,Interleukin-12 subunit beta,39291,0.00269082632574371,0.00472875043991443,-0.00657752453648857,0.011959177187976,0.569340408803814
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN15,Lipocalin-15,36767,-0.003146994000063,0.00554551098070238,-0.0140161955222397,0.00772220752211366,0.570394621461918
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,36421,0.00297865433771301,0.00526861851004072,-0.00734783794196679,0.0133051466173928,0.571840549431382
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,36743,0.00109248526433161,0.00193378195949109,-0.00269772737627093,0.00488269790493415,0.572119317623793
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,36339,0.00325388170440008,0.0057822086282444,-0.00807924720695895,0.0145870106157591,0.573621860491556
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,38741,-0.0026647867549225,0.0047391495442599,-0.0119535198616719,0.0066239463518269,0.573925431218424
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIAE,Sialate O-acetylesterase,39111,0.00240056252832517,0.0042753327629398,-0.00597908968703682,0.0107802147436872,0.574470849792617
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF22,Kinesin-like protein KIF22,36391,-0.00616527114775327,0.0110017652100224,-0.0277287309593972,0.0153981886638906,0.575223968820667
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,39099,0.0018551570170523,0.0033224805826567,-0.00465690492495484,0.00836721895905944,0.576603340947878
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,39283,-0.0011796318088342,0.00212009319777658,-0.0053350144764763,0.00297575085880791,0.577941657849492
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2,Interleukin-2,38841,-0.0015570494580543,0.00280856932460558,-0.00706184533428125,0.00394774641817264,0.57931860928159
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APLP1,Amyloid-like protein 1,39106,0.00257797537830956,0.00465198903289481,-0.00653992312616426,0.0116958738827834,0.579473192658962
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,36767,0.00598076146145676,0.0108199247536657,-0.0152262910557279,0.0271878139786415,0.580441141365313
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",36767,-0.00385912679437549,0.00702396589584138,-0.0176260999502246,0.00990784636147361,0.582724857263594
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,36420,0.00233742411880374,0.00426617351216832,-0.00602427596504617,0.0106991242026536,0.583772293000508
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39113,0.00281980470388916,0.00515897995516036,-0.00729179600822515,0.0129314054160035,0.584674050292298
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,39093,-0.00141383846742809,0.00258778976667408,-0.0064859064101093,0.00365822947525311,0.584833499691028
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,36421,0.00389260718357217,0.00714550800764194,-0.010112588511406,0.0178978028785504,0.585926315320686
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1A,Interleukin-1 alpha,38841,0.00264213384795955,0.00485643129838039,-0.00687647149686601,0.0121607391927851,0.586416239604367
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,36421,0.00304666188475234,0.00560789640298639,-0.00794481506510098,0.0140381388346057,0.586946190982
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COCH,Cochlin,36792,-0.00224019378869291,0.0041244812078679,-0.010324176956114,0.00584378937872817,0.587038924988138
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMS,Spermine synthase,36363,0.0031782202166579,0.00585889660383163,-0.00830521712685209,0.0146616575601679,0.587510952206422
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,36538,-0.00289415662884873,0.00534117727392652,-0.0133628640857447,0.00757455082804725,0.587926242451893
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,36538,0.00214813712362862,0.0039710049292642,-0.00563503253772921,0.00993130678498645,0.588547730592377
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX2,Heme oxygenase 2,38741,-0.00231590112988595,0.00430406985700024,-0.0107518780496064,0.00612007578983453,0.590535124128427
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,36430,-0.00420325518872173,0.0078121131262452,-0.0195149969161623,0.0111084865387189,0.590556676031666
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDAN1,Codanin-1,36747,0.00109170534465608,0.00203034510008738,-0.00288777105151519,0.00507118174082735,0.590797278281028
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,36421,-0.00333046908551624,0.00620251652878201,-0.015487401481929,0.00882646331089649,0.591308562572606
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,36339,-0.00193098337302603,0.00359623085697152,-0.00897959585269021,0.00511762910663816,0.591314180786474
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,39283,0.0013283491932538,0.00247470521581443,-0.00352207302974248,0.00617877141625008,0.59143377174269
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPLAH,5-oxoprolinase,36420,-0.00335469410958056,0.00626418057387239,-0.0156324880343704,0.00892309981520932,0.592288763771508
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX2,Neuronal pentraxin-2,36791,-0.00162972940083694,0.00305015271901522,-0.00760802873010678,0.0043485699284329,0.593135738447368
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39106,-0.00447368873685564,0.00839389187166935,-0.0209257168053276,0.0119783393316163,0.594062430201003
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,38844,-0.00109390040463781,0.00205741348165866,-0.00512643082868878,0.00293863001941317,0.59495054364491
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRAXIN,Draxin,38987,0.00200839628588193,0.00378123180007677,-0.00540281804226853,0.00941961061403239,0.595323550003898
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,36420,0.00196062645214474,0.00369547764364861,-0.00528250972940654,0.00920376263369601,0.59574175956608
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,38832,-0.00159615793268891,0.00302459898163681,-0.00752437193669706,0.00433205607131924,0.59769770989836
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,36538,-0.0037721096075848,0.00715358449935855,-0.0177931352263276,0.010248916011158,0.597992123069041
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNA4,Plexin-A4,39099,0.00385482619675981,0.00733970547155809,-0.010530996527494,0.0182406489210137,0.599450585738422
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEBP1,Heme-binding protein 1,38832,0.002538822768924,0.00484629799535537,-0.00695992130197252,0.0120375668398205,0.600377772953095
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YWHAQ,14-3-3 protein theta,36500,0.0035135474498678,0.00672609780361603,-0.00966960424521962,0.0166966991449552,0.601418195275233
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,36391,-0.003193435759138,0.0061142251079966,-0.0151773169708113,0.00879044545253534,0.60147343612883
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA5,Integrin alpha-5,39093,0.00116800155188552,0.00224439643991756,-0.0032310154703529,0.00556701857412394,0.60278689510575
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,38754,0.00371501484603569,0.00716945499345904,-0.010337116941144,0.0177671466332154,0.604345575305639
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,38727,0.00228603021464409,0.00443857672310103,-0.00641358016263393,0.0109856405919221,0.606534983574679
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUMB,Protein numb homolog,36430,-0.0039469065772968,0.00766656250611356,-0.0189733690892794,0.0110795559346858,0.606687234181816
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,36391,0.00291447879080271,0.00568546890170137,-0.00822904025653197,0.0140579978381374,0.608226968165969
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F12,Coagulation factor XII,36806,-0.00189429889803749,0.00374905505155008,-0.00924244679907566,0.00545384900300067,0.613375217469899
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACYP1,Acylphosphatase-1,36452,-0.00300272698054633,0.00594611340406759,-0.0146571092525188,0.00865165529142615,0.613574794992403
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,39023,0.00119225714666742,0.00236932697346027,-0.00345162372131472,0.00583613801464955,0.614827468913242
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,36791,-0.00161115800795181,0.00320397580258961,-0.00789095058102745,0.00466863456512382,0.615069791730163
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTN3,Myeloblastin,38677,0.00208813393484592,0.00416466967660583,-0.00607461863130151,0.0102508865009934,0.616102400887572
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL4,Early placenta insulin-like peptide,36731,-0.00240100255276257,0.00481587507606517,-0.0118401177018503,0.00703811259632517,0.618097928192471
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,36421,0.00162683539970819,0.00326679860684725,-0.00477608986971241,0.00802976066912879,0.618499299358139
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36339,-0.00306658988749103,0.00616081498136798,-0.0151417872509723,0.00900860747599022,0.618663971614942
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC2,Mucin-2,36791,-0.00406049560083922,0.00816983786898756,-0.0200733778240548,0.0119523866223764,0.619190062386171
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39197,0.00154436475800098,0.00311320012227656,-0.00455750748166107,0.00764623699766303,0.619852229746886
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,36731,0.00301146199708835,0.00609628417175406,-0.00893725497954961,0.0149601789737263,0.62132647007229
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,36420,-0.000931966141269031,0.001888950337425,-0.00463430880262203,0.00277037652008397,0.621754299460519
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR5,Proline-rich protein 5,36430,0.00210824955628881,0.00428681374037211,-0.00629390537484052,0.0105104044874181,0.62287022171004
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,36430,0.00130237975641629,0.00264851107266187,-0.00388870194600098,0.00649346145883355,0.622911497753198
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL11,Interleukin-11,38841,0.00276954042144693,0.00564538832810569,-0.00829542070164022,0.0138345015445341,0.623727485188815
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36066,0.00216326562169529,0.00441785267865975,-0.00649572562847782,0.0108222568718684,0.624380126510755
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10,Interleukin-10,38841,-0.00347619490562336,0.00710083498082789,-0.017393831468046,0.0104414416567993,0.624461412746906
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,38741,0.00171670984932561,0.00350890244694367,-0.00516073894668398,0.00859415864533519,0.624676096321031
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",36792,0.00239198306319584,0.00489039303315423,-0.00719318728178644,0.0119771534081781,0.624765903282068
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,36500,-0.00163645715533285,0.00335935880697108,-0.00822080041699617,0.00494788610633047,0.626171976262356
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",36792,0.00386765358784754,0.00795056181137603,-0.0117154475624495,0.0194507547381446,0.626647226238974
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,36421,0.00225779083253974,0.00465907620389306,-0.00687399852709066,0.0113895801921701,0.627968182240105
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPG,Macrophage-capping protein,38972,-0.00255037102175883,0.00526313778274405,-0.0128661210759372,0.00776537903241951,0.627986757202681
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK1,Kallikrein-1,38961,-0.00550851887110779,0.0113820064906723,-0.0278172515928255,0.01680021385061,0.628416099347171
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPJ,Centromere protein J,36538,0.00316272512063386,0.00654045016778363,-0.00965655720822206,0.0159820074494898,0.628703802377565
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39093,0.00164272851558411,0.00340764104098846,-0.00503624792475328,0.0083217049559215,0.629761687500862
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR3,Folate receptor gamma,39093,0.00824122033221858,0.017123471776921,-0.0253207843505465,0.0418032250149837,0.63032293547478
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",36767,0.00204522207759092,0.00425004152451299,-0.00628485931045454,0.0103753034656364,0.630365447140206
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,39153,-0.00143467998786902,0.0029944315722494,-0.00730376586947784,0.00443440589373979,0.631862979582309
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,36767,-0.00152610821347695,0.00318703768795537,-0.00777270208186949,0.00472048565491558,0.632054522947758
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGLAP,Osteocalcin,36791,-0.00373136291233435,0.00779414475110767,-0.0190078866245054,0.0115451607998367,0.632132243079965
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,36430,0.00280368803055389,0.00585708456988464,-0.00867619772642,0.0142835737875278,0.632172339525837
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",36430,0.0021536641146901,0.00450522760172721,-0.00667658198469523,0.0109839102140754,0.632632400502544
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_DRA,,39035,0.0015298618643367,0.00320366711375282,-0.00474932567861882,0.00780904940729222,0.632988373003356
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,36747,0.0046894706285628,0.0098259641835157,-0.014569419171128,0.0239483604282536,0.633190086530496
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAL,Integrin alpha-L,36430,0.00184122370858887,0.00386430092947543,-0.00573280611318298,0.00941525353036072,0.633747811992286
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,36792,0.00171855449924732,0.00362395194426207,-0.00538439131150635,0.00882150031000098,0.635350250777593
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLTA,Clathrin light chain A,38832,-0.00199988091868142,0.00421773987554171,-0.0102666510747432,0.00626688923738032,0.635393172837926
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",36391,0.00272776028101828,0.00576186745641203,-0.00856549993354931,0.0140210204955859,0.635924659282417
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCR,Breakpoint cluster region protein,39099,-0.00391273265671694,0.00832069742072798,-0.0202212996013438,0.0123958342879099,0.638189610202604
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,38977,-0.00203255878652873,0.00432624054676348,-0.0105119902581852,0.0064468726851277,0.638489665607551
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,36391,-0.0018210324514898,0.00389343921306144,-0.00945217330909022,0.00581010840611062,0.639994244798945
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,39106,0.00143657941007969,0.00308804951287425,-0.00461599763515384,0.00748915645531322,0.641790529164053
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,36430,0.000952890678893633,0.00205113658684738,-0.00306733703132722,0.00497311838911449,0.642249507536127
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,39291,0.0028481503848584,0.00613447650805418,-0.00917542357092778,0.0148717243406446,0.64244954014321
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,36430,-0.00182421120661073,0.00393692717532375,-0.00954058847024529,0.00589216605702382,0.643114980874688
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSP90B1,Endoplasmin,38667,0.00281363043968673,0.00608587202978823,-0.0091146787386982,0.0147419396180717,0.643857464444348
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,36747,-0.0016017256160279,0.00348100172764136,-0.00842448900220497,0.00522103777014917,0.645428140656602
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,36792,-0.0029543125781687,0.00642840546650455,-0.0155539872925176,0.00964536213618022,0.645831474175809
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN1,Neuroligin-1,36421,0.00279622454680769,0.00613754274279481,-0.00923335922907013,0.0148258083226855,0.648690197267688
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,39266,-0.000953004442779624,0.00210121896636935,-0.00507139361686355,0.0031653847313043,0.65016030780375
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM13A,Protein FAM13A,36743,0.00278765768852665,0.00614948088028011,-0.00926532483682235,0.0148406402138757,0.65032889327591
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASQ2,Calsequestrin-2,36391,-0.00201102272060962,0.00443838124657793,-0.0107102499639024,0.00668820452268311,0.650485849426456
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH3,Cadherin-3,39241,0.00141431240610703,0.00313644819684029,-0.00473312605969993,0.00756175087191399,0.652047777514934
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,39255,-0.00131918057968449,0.0029307621644374,-0.00706347442198179,0.0044251132626128,0.652633719705086
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD1,COMM domain-containing protein 1,36420,-0.0025163350205602,0.00559995636512148,-0.0134922494961983,0.0084595794550779,0.65318763955964
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,36339,0.00134965256600103,0.00300555502534232,-0.00454123528366993,0.00724054041567198,0.653401446402091
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39162,-0.0010688046571246,0.00238092356870276,-0.00573541485178201,0.0035978055375328,0.653507708749967
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO6,Coronin-6,36363,-0.00154567171510021,0.00345280567250652,-0.008313170833213,0.00522182740301257,0.654408705944542
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RP2,Protein XRP2,39023,-0.00169746040982596,0.0037993054179587,-0.00914409902902502,0.0057491782093731,0.655039013961927
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,36430,0.00272369122029996,0.00611252844627039,-0.00925686453439,0.0147042469749899,0.655899966345912
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL6,Fc receptor-like protein 6,39099,0.00265557327716177,0.00598724580902657,-0.0090794285085303,0.0143905750628538,0.657382665407418
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",36721,-0.00438911079237815,0.0099134838903005,-0.0238195392173671,0.0150413176326108,0.657960162633606
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AAMDC,Mth938 domain-containing protein,36420,0.00214095389445994,0.00484257488761548,-0.0073504928852664,0.0116324006741863,0.658416755745929
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,38727,-0.00312635055187753,0.00707209243443549,-0.0169876517233711,0.010734950619616,0.658445939527829
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,36731,-0.00317454950475834,0.00724516004664738,-0.0173750631961872,0.0110259641866705,0.661276637433675
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICA1,Islet cell autoantigen 1,38841,0.00318603640709599,0.00728066050843996,-0.0110840581894463,0.0174561310036383,0.66168065089456
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,38727,0.00436527554393411,0.0099864582189769,-0.0152081825652606,0.0239387336531288,0.662031040830589
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,39057,-0.00160143045339759,0.00367775291536211,-0.00880982616750732,0.00560696526071214,0.663251293247193
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPS,Calcyphosin,36747,0.00341613540020235,0.00785819704428801,-0.0119859308066021,0.0188182016070068,0.663771112623728
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,36792,-0.00283587798067715,0.0065518126833513,-0.0156774308400457,0.0100056748786914,0.665139185893375
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP1,Interstitial collagenase,38571,0.00359080261572653,0.00830528622268431,-0.0126875583807347,0.0198691636121878,0.665492329311757
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIN2,Bridging integrator 2,39093,-0.00349085803443257,0.00812187375746831,-0.0194097305990705,0.0124280145302053,0.667340342911736
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBIN,Erbin,39023,0.00399121411574002,0.00930277764042608,-0.0142422300594951,0.0222246582909751,0.667904090885519
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,36792,-0.0041759526845688,0.00974149142980832,-0.0232692758869931,0.0149173705178555,0.668165488538495
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,38841,0.00175598628778123,0.00412509600038118,-0.00632920187296587,0.00984117444852834,0.67034442786788
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHB,Lutropin subunit beta,38727,0.00339420946257665,0.00797686060419442,-0.0122404373216444,0.0190288562467977,0.670473330265242
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,38960,-0.00151558477566,0.00357183471066281,-0.0085163808085591,0.0054852112572391,0.671341792903106
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",36430,0.0017389990079704,0.00410276865367194,-0.0063024275532266,0.00978042556916741,0.671675261474431
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD55,Complement decay-accelerating factor,38575,-0.000972732282251469,0.00229934626464697,-0.00547945096095953,0.00353398639645659,0.672266916548141
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,36414,0.00229226375501275,0.0054280833772783,-0.00834677966445272,0.0129313071744782,0.672815421872359
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",38999,0.00399302895881127,0.00946834962123074,-0.014564936298801,0.0225509942164235,0.673232573944136
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,39099,0.00156004861769305,0.00371173076228321,-0.00571494367638205,0.00883504091176815,0.674270626604416
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN7,Tetraspanin-7,36363,0.00360288938981391,0.00857316439291179,-0.0132005128202932,0.020406291599921,0.674308600871721
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,36339,-0.00162772757421306,0.0038979312305891,-0.00926767278616769,0.00601221763774157,0.676255881258908
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,38992,-0.000870716437893115,0.00208673467575697,-0.00496071640237677,0.00321928352659054,0.676492225244608
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,36339,-0.00280669879980196,0.0067317005211161,-0.0160008318211895,0.0103874342215856,0.676731250304562
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39106,0.00115591253998155,0.00277922296787883,-0.00429136447706096,0.00660318955702405,0.677480158182402
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A11,Protein S100-A11,38949,-0.00168970685187452,0.00411560535863432,-0.00975629335479778,0.00637687965104874,0.681400331105677
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM3,Junctional adhesion molecule C,36500,0.00187177156380753,0.00458961941207655,-0.00712388248386251,0.0108674256114776,0.683407461330983
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,38841,0.00242134171291093,0.00595980793126871,-0.00925988183237573,0.0141025652581976,0.684543798097606
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLG4,Disks large homolog 4,36747,0.00262067664548107,0.00650323337340528,-0.0101256607663933,0.0153670140573554,0.686969208459225
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,38832,0.00120535770802318,0.00299570758522228,-0.0046662291590125,0.00707694457505886,0.687423667624388
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA1,BolA-like protein 1,36363,-0.00201405070867274,0.0050058005949348,-0.011825419874745,0.00779731845739947,0.687438214632688
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEG1,Protein LEG1 homolog,36102,-0.00254318110966703,0.00632093827775329,-0.0149322201340635,0.00984585791472942,0.687439121859106
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,39241,0.00097355086800406,0.00242236532550785,-0.00377428516999132,0.00572138690599944,0.687762525286437
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,38951,0.00406684487866078,0.010127741591085,-0.0157835286398658,0.0239172183971874,0.688017268084302
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,36500,0.00246892911312197,0.00616027170920249,-0.00960520343691491,0.0145430616631588,0.688587036316454
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LUZP2,Leucine zipper protein 2,36731,-0.00158328856328713,0.00395179482580441,-0.00932880642186378,0.00616222929528951,0.688684111522052
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2,T-cell surface antigen CD2,36391,0.00139710500982295,0.00348831980332344,-0.00544000180469099,0.00823421182433689,0.688788159983646
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,36363,-0.00190871280402402,0.0047906195238227,-0.0112983270707165,0.00748090146266846,0.690322163829099
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,36469,-0.00175705646653298,0.00441505085896954,-0.0104105561501133,0.00689644321704732,0.690659258328791
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1B,Meprin A subunit beta,39106,-0.00414675880416406,0.0104222940111708,-0.0245744550660588,0.0162809374577307,0.690728707935658
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,39062,0.00100348411556927,0.00257813812954377,-0.00404966661833651,0.00605663484947506,0.697112781361447
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,39147,-0.00276161801847432,0.00710992351445829,-0.0166970681068126,0.0111738320698639,0.697712577404981
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXTL1,Exostosin-like 1,36391,-0.0016746243868621,0.00431921989820101,-0.0101402953873361,0.00679104661361188,0.698233874579705
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,39093,0.00182394361732253,0.00470953526195047,-0.00740674549610038,0.0110546327307455,0.698548870893513
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,36391,0.00177454496053258,0.00459532342520053,-0.00723228895286045,0.0107813788739256,0.699382336103671
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,39147,0.00318998622390852,0.00826512837472306,-0.0130096653905487,0.0193896378383657,0.699533700352369
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,38741,-0.00223292179808218,0.00580402447310785,-0.0136088097653736,0.00914296616920922,0.700450692422344
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPHN1,Oligophrenin-1,36747,-0.00375333468256113,0.00978798264032985,-0.0229377806576076,0.0154311112924854,0.701382408488961
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,38705,-0.00230106900035487,0.00600096571790679,-0.0140629618074522,0.00946082380674244,0.701391788561176
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,38727,0.00139872558081115,0.00365163535232678,-0.00575847970974933,0.00855593087137163,0.701694937598175
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,36748,-0.000684341686209059,0.00179405664588657,-0.00420069271214674,0.00283200933972862,0.70287615904483
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,36421,-0.00162752693412136,0.0042743440285328,-0.0100052412300456,0.00675018736180293,0.703382972414922
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,39283,0.00108060351427724,0.00284193422072938,-0.00448958755835235,0.00665079458690683,0.703776045455042
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FETUB,Fetuin-B,39145,-0.00115512060376283,0.00304607212818828,-0.00712542197501185,0.00481518076748619,0.704532418098244
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,36420,0.00264177419092217,0.00697397673185792,-0.0110272202035193,0.0163107685853637,0.704839403410517
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,36391,0.00192096581938995,0.00511168711351034,-0.00809794092309031,0.0119398725618702,0.707072850627032
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAM,Basal cell adhesion molecule,39093,-0.000802161342144489,0.00213686850425066,-0.00499042361047578,0.0033861009261868,0.707374876178612
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX18,Sorting nexin-18,36743,-0.00154354090241048,0.00411229586803172,-0.00960364080375265,0.00651655899893168,0.707408055533982
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPB,Natriuretic peptides B,38832,-0.00428016706252541,0.0114238175562714,-0.0266708494728174,0.0181105153477666,0.707910865139805
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",36767,-0.00272080419894846,0.00729145437520926,-0.0170120547743586,0.0115704463764617,0.709043139252491
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,36391,-0.0023744390702501,0.00638449197286759,-0.0148880433370706,0.0101391651965704,0.709968170145432
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,36339,0.000864566863468088,0.00232940098316982,-0.00370105906354476,0.00543019279048094,0.710529014654523
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCT,Secretin,36421,-0.001493133715143,0.00403082710473265,-0.00939355484041899,0.00640728741013298,0.711069399662105
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COLEC12,Collectin-12,39095,0.000832450657956155,0.00224901081966415,-0.00357561054858557,0.00524051186449788,0.711282730849296
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,36430,-0.00305494256563542,0.00826512813601058,-0.0192545937122162,0.0131447085809453,0.711673144412318
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,36430,0.00263935050647098,0.00715148982132966,-0.0113775695433351,0.0166562705562771,0.71208696025005
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YY1,Transcriptional repressor protein YY1,36430,0.000924310116109579,0.00250792671931336,-0.0039912262537446,0.00583984648596376,0.712465297277623
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,36796,0.000881890360154881,0.00240216735692318,-0.00382635765941456,0.00559013837972432,0.713533440524625
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPLX2,Complexin-2,36339,0.00100174078630683,0.00272977547909655,-0.00434861915272241,0.00635210072533607,0.713648962796931
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,36538,0.00145799549734006,0.0039973399975773,-0.00637679089791144,0.00929278189259156,0.715310514776557
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39023,0.000991415348236011,0.00272202288073257,-0.00434374949799983,0.00632658019447186,0.715698764083214
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4,Interleukin-4,38841,-0.00297919648377977,0.00818136040608194,-0.0190146628797004,0.0130562699121408,0.715755330678978
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",36767,-0.00129836434531092,0.0035659658699549,-0.00828765745042251,0.00569092875980068,0.715790102522983
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,36391,0.00146099587819786,0.00403821323055214,-0.00645390205368434,0.00937589381008005,0.717513083056346
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,36391,0.00228388485039081,0.00631336642799618,-0.0100903133484817,0.0146580830492633,0.717542053260296
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPB2,Coatomer subunit beta',36391,0.00140184489294395,0.00388104875494168,-0.00620501066674174,0.00900870045262964,0.717954089500431
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",36420,0.00316385554840258,0.00878383105575546,-0.0140524533208781,0.0203801644176833,0.718710475515865
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,39093,0.00187740632774343,0.00521271902180034,-0.00833952295498523,0.0120943356104721,0.718733419252795
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,38727,-0.00114851485993222,0.00318892199773626,-0.00739880197549528,0.00510177225563085,0.71873431050216
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSND,Barttin,36339,0.0010966532126345,0.00304782563758062,-0.00487708503702352,0.00707039146229251,0.718991615443321
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,36391,-0.00118232576677705,0.00330790077899465,-0.00766581129360655,0.00530115976005246,0.720779834591364
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39023,0.00109644324148029,0.0030872223550809,-0.00495451257447828,0.00714739905743885,0.722478223852717
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,38727,-0.00204796431530378,0.00578370071869986,-0.0133840177239555,0.00928808909334794,0.723274678960604
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBXN1,UBX domain-containing protein 1,36500,0.00222168543305021,0.00628988578454553,-0.010106490704659,0.0145498615707594,0.723932745380653
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAX,Integrin alpha-X,36538,0.00168200016458378,0.00476863268464702,-0.00766451989732438,0.0110285202264919,0.724302962909165
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,39162,0.000796546493971341,0.00225992835942911,-0.00363291309050972,0.0052260060784524,0.724494136376086
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH7B,Myosin-7B,36339,0.00141207602770649,0.00401438385859897,-0.00645611633514749,0.00928026839056047,0.725028614687933
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,38741,0.00121507751089742,0.00347436361881372,-0.00559467518197748,0.00802483020377232,0.726548808748396
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,36538,-0.00142614936018478,0.00408813775562435,-0.00943889936120849,0.00658660064083894,0.727207257219491
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2BP,LRP2-binding protein,36421,0.00250833778163955,0.00724247820028786,-0.0116869194909247,0.0167035950542038,0.729095306746821
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,36792,-0.0014671431935928,0.00424154316001246,-0.00978056778721722,0.00684628140003163,0.729424662271252
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,36430,0.0012789182790472,0.00372629213719844,-0.00602461430986173,0.00858245086795614,0.731442678021368
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,36500,-0.00255668977154308,0.00748699816111447,-0.0172312061673274,0.0121178266242413,0.732744955423903
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,38741,-0.00199528581434526,0.00586107287438189,-0.0134829886481338,0.00949241701944325,0.73353743538291
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39093,0.000845111037381272,0.0024828064607544,-0.00402118962569736,0.0057114117004599,0.733571015754128
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP7,Retinoid-binding protein 7,36743,-0.00184782395910603,0.00544869384986131,-0.0125272639048342,0.00883161598662214,0.734516163718647
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,39241,-0.00143801430209122,0.00425160886071408,-0.00977116766909083,0.00689513906490838,0.735195791263667
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,36420,-0.0031479867394905,0.00930880229092726,-0.0213932392297079,0.0150972657507269,0.735238381097248
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RWDD1,RWD domain-containing protein 1,39241,0.0019506368086071,0.00576997612857365,-0.00935851640339726,0.0132597900206115,0.735317535606352
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN1,Calsyntenin-1,38741,-0.00153127468440821,0.00453860561850051,-0.0104269416966692,0.0073643923278528,0.73582858823002
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESYT2,Extended synaptotagmin-2,36747,-0.0025081960551204,0.00746419836524228,-0.0171380248509953,0.0121216327407545,0.736853565154753
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,39051,0.00120175299052604,0.00358516985283183,-0.00582517992102435,0.00822868590207644,0.737477997223667
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31,Interleukin-31,36430,0.00172034523212406,0.0052021969493114,-0.00847596078852629,0.0119166512527744,0.740879707005011
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,36726,0.00110411419981307,0.00334489352059868,-0.00545187710056034,0.00766010550018648,0.741337717826602
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT1,Diamine acetyltransferase 1,36391,0.00148577501873612,0.00450959044136265,-0.00735302224633467,0.0103245722838069,0.741805929612452
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,38832,0.00117862152886372,0.00358343730428989,-0.00584491558754446,0.0082021586452719,0.742229757636051
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,36421,-0.00105271227611241,0.00320791029686484,-0.00734021645796749,0.00523479190574268,0.742795114999076
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPK2,Death-associated protein kinase 2,36430,-0.00157646898434751,0.00483141069435554,-0.0110460339452844,0.00789309597658936,0.744206002967322
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,38987,-0.00323550260614218,0.00996606554477181,-0.0227689910738949,0.0162979858616106,0.74544899439345
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP6,Bone morphogenetic protein 6,38816,0.00121992464833139,0.00376998279961417,-0.00616924163891238,0.00860909093557516,0.746253804870667
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,36538,0.00134254678880006,0.0041516984034874,-0.00679478208203525,0.00947987565963536,0.746418177560537
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO1,Forkhead box protein O1,39099,0.002506603748685,0.00778019036617156,-0.0127425693690113,0.0177557768663813,0.747322505464269
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,39161,0.00233683987456092,0.00727845539872326,-0.0119289327069367,0.0166026124560585,0.748167330693726
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXN,Thioredoxin,36652,-0.00125430912956655,0.00391120668840164,-0.00892027423883376,0.00641165597970066,0.748445864456801
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,38832,0.000769319498231365,0.00243809570191766,-0.00400934807752724,0.00554798707398997,0.752355217668548
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCIN,Adseverin,36363,-0.00212281151152478,0.00673445834396228,-0.0153223498656908,0.0110767268426413,0.752602637969751
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGL1,Fibrinogen-like protein 1,36796,0.00174651148706724,0.0055816870671491,-0.009193595164545,0.0126866181386795,0.75436146341451
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,36420,-0.000749674274796031,0.00240300533078546,-0.00545956472313552,0.00396021617354346,0.75506574929487
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,38832,-0.00148676839350165,0.00478038349878899,-0.0108563200511281,0.00788278326412477,0.755793958600675
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBQLN3,Ubiquilin-3,36391,0.00132744636005653,0.00427320099691098,-0.00704802759388898,0.00970292031400205,0.756076065014039
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORN4,MORN repeat-containing protein 4,36339,0.0022439065824681,0.0072909866600336,-0.0120464272711977,0.016534240436134,0.758266701816756
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC2,Stanniocalcin-2,39068,-0.000729853348811517,0.00238160524888506,-0.00539779963662623,0.0039380929390032,0.759262908208456
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,39023,0.000578224629017388,0.00189268987047671,-0.00313144751711697,0.00428789677515175,0.759986395768441
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,39255,0.00148670738428111,0.00487951535603961,-0.00807714271355652,0.0110505574821187,0.760611403627809
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO3,Forkhead box protein O3,38727,-0.0026869285977963,0.00882031793587052,-0.0199747517521025,0.0146008945565099,0.760652651891203
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB1,Calbindin,39023,-0.00115780937920013,0.00381348787956311,-0.00863224562314381,0.00631662686474356,0.761429932228132
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13,Interleukin-13,38841,0.00133858196437898,0.00443567109785346,-0.0073553333874138,0.0100324973161718,0.762826520984651
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHPK,Sedoheptulokinase,36538,0.00115238484088473,0.00382142654596631,-0.00633761118920924,0.0086423808709787,0.762993357912581
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,36430,0.0016406840320123,0.00547277532633391,-0.00908595560760216,0.0123673236716268,0.764342200608374
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,39023,0.000551992037127058,0.00184129993218216,-0.00305695582994998,0.0041609399042041,0.764346121577547
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,39162,0.00111175332545261,0.00371090637239147,-0.00616162316443467,0.00838512981533988,0.764493388771982
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YJU2,Splicing factor YJU2,36731,-0.000879034938754244,0.00294951730193014,-0.00666008885053732,0.00490201897302883,0.765687587947007
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST3,Cystatin-C,39132,0.000714847651512539,0.00240069461654305,-0.00399051379691183,0.00542020909993691,0.76588504762478
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18,Interleukin-18,39030,-0.00122421406418112,0.00411468838556958,-0.0092890032998975,0.00684057517153526,0.766071393484701
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",36391,-0.00104529571601362,0.00351430884506249,-0.00793334105233609,0.00584274962030885,0.766135606328955
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XRCC4,DNA repair protein XRCC4,38741,0.00100179533970576,0.00337029882572071,-0.00560399035870683,0.00760758103811835,0.766285686547386
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEFTY2,Left-right determination factor 2,39237,0.00142917425422459,0.00480923514058663,-0.00799692662132521,0.0108552751297744,0.766338540346538
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE6,Ribonuclease K6,36740,-0.000733009418819312,0.00247088474666135,-0.00557594352227556,0.00410992468463694,0.766731886043095
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,39283,0.0010470414247178,0.00352979221151614,-0.00587135130985383,0.00796543415928943,0.766753180260991
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB5,Integrin beta-5,39147,-0.00102242424289081,0.00344818200386098,-0.00778086097045833,0.00573601248467671,0.766843818557392
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36339,-0.00116888697958935,0.00394726800809499,-0.00890553227545553,0.00656775831627683,0.767139116588396
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,36806,0.000804173705371915,0.00272810928361225,-0.00454292049050808,0.00615126790125192,0.768171810572407
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,36420,-0.00162311443995827,0.00551150851644176,-0.0124256711321841,0.00917944225226758,0.768384170689461
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPGN,Epigen,36731,0.00131755594825139,0.00447965775314185,-0.00746257324790663,0.0100976851444094,0.76867112034518
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,36363,-0.000919320067435896,0.00313105565840777,-0.00705618915791512,0.00521754902304332,0.769058167066579
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,36420,-0.00133992966329453,0.00456856134577361,-0.0102943099010108,0.00761445057442174,0.769302614254028
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDK2,Protein sidekick-2,36500,-0.000975183455910046,0.00336269934363638,-0.00756607416943734,0.00561570725761725,0.771820847585346
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,36420,0.00111928247395973,0.0038599063540374,-0.00644613397995356,0.00868469892787303,0.771838935531834
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,36391,0.00157263541853962,0.00544631894805904,-0.0091021497196561,0.0122474205567353,0.772775952677156
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,38841,-0.0015307915193602,0.00531062042523665,-0.011939607552824,0.00887802451410363,0.773158618594964
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,39023,-0.000685198141928872,0.00240039270399098,-0.00538996784175119,0.00401957155789345,0.775301375685502
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA2,Integrin alpha-2,36500,0.000868443863458569,0.00304620279153572,-0.00510211360795144,0.00683900133486857,0.775579381762015
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,39229,0.00145816886125498,0.00513058289502536,-0.00859777361299472,0.0115141113355047,0.776252400552149
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36339,-0.000675890730329325,0.0023804178375287,-0.00534150969188557,0.00398972823122692,0.77646271787709
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,38832,0.00156157767474612,0.00554749562940482,-0.00931151375888733,0.0124346691083796,0.778336672097746
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPE,Coatomer subunit epsilon,38741,0.00119719295051517,0.00428211118172923,-0.00719574496567412,0.00959013086670446,0.779803583858878
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY75,Lymphocyte antigen 75,39099,0.00097499970301562,0.00349675177234693,-0.00587863377078437,0.00782863317681561,0.780378984774233
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,38832,0.00198029969518336,0.00710415851322677,-0.0119438509907411,0.0159044503811078,0.780438862495259
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,38741,0.00172967938109208,0.0062481804515434,-0.010516754303933,0.0139761130661171,0.781915031647528
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,36421,-0.00162424017006759,0.00587597402710307,-0.0131411492631896,0.00989266892305442,0.782229596765266
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPART,Spartin,36500,0.00194379568477111,0.0070597919866416,-0.0118933966090464,0.0157809879785886,0.783064698801624
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBZ,Hemoglobin subunit zeta,36792,0.00261914076813257,0.00952636847626987,-0.0160525414453564,0.0212908229816215,0.783369871227176
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,39140,0.0019156865061581,0.00698146481719126,-0.0117679845355368,0.015599357547853,0.783783972555843
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL1,Interferon lambda-1,38741,0.00110598477331534,0.00403524377316424,-0.00680309302208657,0.00901506256871726,0.784025964811779
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,38741,0.00116470171965232,0.00427381340154084,-0.00721197254736772,0.00954137598667236,0.7852256202043
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,39093,-0.00214670199222895,0.00792538407772608,-0.0176804547845721,0.0133870508001142,0.786499230375331
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,36421,-0.00126577293871792,0.0046889735092981,-0.0104561610169422,0.00792461513950637,0.787205691310863
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB116,Beta-defensin 116,36363,0.00188700910506384,0.00701358424567079,-0.0118596160164509,0.0156336342265786,0.787895177917469
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36339,0.000742984767865302,0.002761661839581,-0.00466987243771346,0.00615584197344406,0.787906897358398
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,39291,-0.0023922383056671,0.00897860181415033,-0.0199902978614018,0.0152058212500676,0.789905668979857
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD9,COMM domain-containing protein 9,36731,-0.000940770260900545,0.00356365829550663,-0.00792554052009355,0.00604399999829246,0.791791827563162
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLASP1,CLIP-associating protein 1,36339,-0.00174438793498293,0.0066104752403149,-0.0147009194060001,0.0112121435360343,0.791874911119049
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALB,Ras-related protein Ral-B,36430,-0.00069256798094715,0.00263921063799986,-0.00586542083142687,0.00448028486953257,0.79300594953492
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,36796,0.00112917250871395,0.00430789602996913,-0.00731430371002555,0.00957264872745344,0.793235463558194
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,39066,0.000841660611754393,0.00323611430070468,-0.00550112341762679,0.00718444464113557,0.794802724934614
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,36430,-0.00087852999704517,0.00338053584122028,-0.00750438024583692,0.00574732025174658,0.794961429875827
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY2,Protein canopy homolog 2,38832,0.00140764342396525,0.00543144897660692,-0.00923799657018433,0.0120532834181148,0.795511220720271
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,36363,0.00113865660255029,0.00441877893401047,-0.00752215010811024,0.00979946331321081,0.796653643783601
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,38705,0.000966876210637975,0.00377009470159131,-0.006422509404481,0.00835626182575695,0.797599683206143
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,39147,0.00058324055222325,0.00230007352729536,-0.00392490356127565,0.00509138466572215,0.799827521657158
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,39106,0.00198851019814434,0.00785692417354363,-0.0134110611820012,0.0173880815782898,0.800201954716245
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,38741,0.00110665331984215,0.00437405618136829,-0.0074664967956397,0.009679803435324,0.800268685897018
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,39260,-0.000814277967981471,0.00322038973513229,-0.00712624184884077,0.00549768591287782,0.800386921623075
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,38727,0.00125327419810478,0.00496804954244941,-0.00848410290509607,0.0109906513013056,0.800838298476265
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,36538,-0.00122082746867948,0.00484390515983722,-0.0107148815819604,0.00827322664460148,0.801019080423139
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX9,Sorting nexin-9,39106,0.00157783685559145,0.00628028011570813,-0.0107315121711965,0.0138871858823794,0.80163449720649
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF830,Zinc finger protein 830,36731,-0.00182486242180955,0.00731254685041172,-0.0161574542486165,0.0125077294049974,0.802937622008505
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN2,Prefoldin subunit 2,38741,0.00124329471092545,0.00506754666727839,-0.00868909675694019,0.0111756861787911,0.806193080488865
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36363,-0.00119969891267902,0.00489557691769566,-0.0107950296713625,0.00839563184600448,0.806415761970832
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCHE,Cholinesterase,36571,-0.000607233108257145,0.00248580520579831,-0.00547941131162182,0.00426494509510754,0.807017723937456
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL25,Interleukin-25,36286,0.000758916356508188,0.00311981187739391,-0.00535591492318388,0.00687374763620025,0.807810259224998
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,36743,0.00166047473396873,0.00697127863914126,-0.0120032313987481,0.0153241808666856,0.811739092369125
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,39182,0.00101325777068909,0.00427496492848688,-0.00736567348914519,0.00939218903052338,0.812643430056228
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6,Seizure protein 6 homolog,36421,0.000666138751627124,0.00282153383853245,-0.00486406757189647,0.00619634507515072,0.813365905142331
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA6C,Semaphorin-6C,36430,-0.00054966556085838,0.00233802681255588,-0.0051321981134679,0.00403286699175114,0.81413645630717
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",36510,0.0013729675438728,0.00584077910781166,-0.0100749595074381,0.0128208945951836,0.814161450163664
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,36731,-0.000761231129057173,0.00324328004618913,-0.00711806001958787,0.00559559776147352,0.814437351129688
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,36421,0.00175988887366624,0.00755047600959741,-0.0130390441051447,0.0165588218524772,0.815700622287155
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,36375,0.00175544414389877,0.00759693289607382,-0.0131345443324059,0.0166454326202035,0.817262065267094
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOS,Proto-oncogene c-Fos,36311,0.000741106828524419,0.00321276508386656,-0.00555591273585404,0.00703812639290287,0.81757054446062
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,36538,0.00110501229889577,0.00479493196810362,-0.00829305435858733,0.0105030789563789,0.817742552865904
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,39106,-0.0011704978764315,0.00514592871942109,-0.0112565181664968,0.00891552241363384,0.820068374575992
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD3,Extracellular superoxide dismutase,36796,-0.00125052646587021,0.00550792078192164,-0.0120460511984366,0.0095449982666962,0.820395078437898
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,36339,0.00177810093551317,0.00787329034827207,-0.0136535481471001,0.0172097500181264,0.82132985575107
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD2,Bromodomain-containing protein 2,36363,0.000689950667794123,0.00308355326710676,-0.00535381373573513,0.00673371507132337,0.822954074124645
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,36420,0.00205026024811366,0.00925357219816926,-0.0160867412602981,0.0201872617565254,0.824656762174376
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",36421,0.000787379845121452,0.00357073507233046,-0.00621126089664626,0.00778602058688916,0.825478211336974
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOC1,Apolipoprotein C-I,36779,-0.000742787742767145,0.00336866532368962,-0.0073453717771988,0.00585979629166451,0.825485941173705
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF5,Fibroblast growth factor 5,38841,-0.000656433651502719,0.00298490174884903,-0.00650684107924682,0.00519397377624138,0.82593800645257
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53,Cellular tumor antigen p53,38727,0.000879983025691408,0.00400253530158226,-0.00696498616540982,0.00872495221679264,0.825986007211987
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36363,-0.00109854960913855,0.00500427207274138,-0.0109069228717117,0.00870982365343456,0.826246748415199
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,36767,-0.00134412930300987,0.00616555783771416,-0.0134286226649296,0.0107403640589099,0.827427794330969
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH1,Acid ceramidase,36698,0.000923543040280446,0.00428582685280977,-0.00747667759122671,0.0093237636717876,0.829390511398088
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,38841,0.000761029365900519,0.00354132954486635,-0.00617997654203752,0.00770203527383856,0.829848728158825
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,36421,-0.000738783075892005,0.00343937439314773,-0.00747995688646156,0.00600239073467755,0.829925503055528
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,39162,-0.00244733674802311,0.0114403120876154,-0.0248703484397493,0.0199756749437031,0.830610576884966
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,38727,0.000607655050183329,0.00284656723304521,-0.00497161672658527,0.00618692682695193,0.830963767521146
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18BP,Interleukin-18-binding protein,39165,-0.000566433606582688,0.0026799129212039,-0.00581906293214234,0.00468619571897696,0.832607081540213
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,38832,0.00185751854937665,0.00880706823392641,-0.0154043351891191,0.0191193722878724,0.832958617868955
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD7,FERM domain-containing protein 7,36421,0.000639385129095845,0.00304863473792833,-0.00533593895724368,0.00661470921543537,0.833883099931797
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,36391,-0.000906352433674711,0.00433412810146653,-0.00940124351254911,0.00758853864519969,0.83435803965719
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN6,Prefoldin subunit 6,36421,0.00125539619114308,0.00601070976578144,-0.0105255949497885,0.0130363873320747,0.834561002031701
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,36391,0.00111292793549708,0.0053451099062981,-0.0093634874808472,0.0115893433518414,0.835065083196928
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,36421,0.000545512365475624,0.00263569932384353,-0.00462045830925769,0.00571148304020894,0.836036145860645
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,36792,0.00152418635376652,0.00740465224067732,-0.012988932037961,0.0160373047454941,0.836917791204666
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,36421,-0.000671209003046111,0.00334421524373752,-0.00722587088077166,0.00588345287467944,0.840930562657366
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCP11,T-complex protein 11 homolog,36538,0.00106604719957102,0.0053781424462025,-0.00947511199498589,0.0116072063941279,0.842877310646472
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,39093,-0.00091366671334916,0.00466284421331998,-0.0100528413714563,0.008225507944758,0.84465487121149
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB10,Ras-related protein Rab-10,36792,0.000947497975125677,0.00485507093904263,-0.00856844106539789,0.0104634370156492,0.845273607180417
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSTN,Osteocrin,36421,-0.000726904925827954,0.00374138763978493,-0.00806002469980643,0.00660621484815052,0.845953898952066
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,36420,0.00128411875376313,0.00661970210294509,-0.0116904973680092,0.0142587348755355,0.846191256053887
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,36421,-0.000720774006565682,0.00371829106758007,-0.00800862449902261,0.00656707648589125,0.846299990062678
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",36421,-0.00134837659007789,0.0069648869256611,-0.0149995549643736,0.0123028017842179,0.846495097620975
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,36339,0.000928425670715634,0.00479871253841363,-0.00847705090457508,0.0103339022460063,0.846590986810881
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,36391,0.0011316598318824,0.00594113633558572,-0.0105129673858656,0.0127762870496304,0.848937130514932
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,39023,0.000369240110883963,0.00194952034998205,-0.00345181977508086,0.00419029999684878,0.849781474983777
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36363,-0.000965030120270934,0.00525967487608201,-0.0112739928773917,0.0093439326368498,0.85442662662661
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENR,Density-regulated protein,36430,0.00095719903125998,0.00525229974614644,-0.00933730847118705,0.011251706533707,0.85539434483835
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,36339,0.000829621331431352,0.00459819455455988,-0.008182839995506,0.00984208265836871,0.856823211252803
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD1,Bromodomain-containing protein 1,36538,0.000500237132723619,0.00279094450584123,-0.00497001409872519,0.00597048836417243,0.857755429583782
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,36796,-0.00075253668620914,0.00420469481942847,-0.00899373853228895,0.00748866515987067,0.857959867513414
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF3,Neurotrophin-3,39099,-0.000545381015144739,0.00304937273021942,-0.00652215156637479,0.00543138953608532,0.858057680597445
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,38294,0.000577788200948964,0.00324028758556681,-0.00577317546676198,0.0069287518686599,0.858478993575288
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,38727,-0.00103659522463292,0.00594394209006722,-0.0126867217211647,0.0106135312718988,0.861557227270317
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLN,Promotilin,39099,0.00140079924563449,0.00803905327686496,-0.0143557451770208,0.0171573436682898,0.861671872679251
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL3,C-C motif chemokine 3,39099,0.000958729583677386,0.00554993883903349,-0.00991915054082825,0.011836609708183,0.862853400038274
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,39093,0.000517751070797085,0.00301011262556524,-0.00538206967531078,0.00641757181690495,0.86343675834952
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39079,-0.000952936181098418,0.00556093450698155,-0.0118523678147823,0.00994649545258543,0.863940940908596
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,36538,0.00175992657463276,0.0103061808327315,-0.018440187857521,0.0219600410067866,0.864411916311921
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,38727,-0.000696475642470734,0.0040911366140583,-0.00871510340602501,0.00732215212108354,0.864823607041751
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,36538,0.000782963333771633,0.00463061886029682,-0.00829304963241013,0.0098589762999534,0.865733305695386
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNST,Consortin,39106,0.00163060998679877,0.00977291257607334,-0.017524298662305,0.0207855186359025,0.867490326840435
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPIND1,Heparin cofactor 2,36779,0.000423430071073896,0.00255065216973677,-0.00457584818161017,0.00542270832375796,0.868152818505387
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP8,Caspase-8,39211,-0.00092679073761636,0.00558754518697547,-0.0118783793040883,0.0100247978288556,0.868263607821887
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCOR1,REST corepressor 1,38832,0.000677896945440578,0.00408734353027555,-0.00733329637389949,0.00868909026478065,0.868275114044273
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39191,-0.000416411438300623,0.0025126644559275,-0.00534123377191853,0.00450841089531728,0.868375518173944
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRV1,Acrosomal protein SP-10,36430,0.00109686953126479,0.00664946352211816,-0.0119360789720868,0.0141298180346164,0.868981192812172
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,36421,0.000816668691846946,0.00496236245625045,-0.00890956172240395,0.0105428991060978,0.869283078919235
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,39234,-0.000473787860790681,0.00288660429347432,-0.00613153227600035,0.00518395655441899,0.869628372877989
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,36391,0.000658235512616242,0.00401074877777126,-0.00720283209181542,0.0085193031170479,0.869641007895054
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP9,Caspase-9,36430,0.000942872346599169,0.00575308779264785,-0.0103331797269906,0.012218924420189,0.86982054025264
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,39255,0.000827728566932048,0.00505880744575117,-0.00908753402674025,0.0107429911606043,0.870031436568967
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL19,Interleukin-19,38677,0.00101538295135101,0.00621975574076152,-0.0111753383005416,0.0132061042032436,0.870322835586912
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECM1,Extracellular matrix protein 1,36470,-0.000523773766140758,0.00328183313031703,-0.00695616670156213,0.00590861916928062,0.873200367751222
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPT1,Translationally-controlled tumor protein,38841,0.000928448886797165,0.00589584829435187,-0.0106274137701325,0.0124843115437268,0.874872607828288
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMT,Catechol O-methyltransferase,38658,-0.00119901501205432,0.00769672093814645,-0.0162845880508214,0.0138865580267127,0.876206530412968
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD7,T-cell antigen CD7,36414,0.00060038524170305,0.00386049139522429,-0.00696617789293655,0.00816694837634265,0.876413557655161
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN2,Prorelaxin H2,36472,-0.0019632681999551,0.0126566500573569,-0.0267703023123746,0.0228437659124644,0.876731150730217
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TF,Serotransferrin,36806,0.000305273483098896,0.00197350513245799,-0.00356279657651876,0.00417334354271656,0.877071331555419
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,36355,0.00048257993223414,0.00312009847336858,-0.00563281307556827,0.00659797294003655,0.877085419936517
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR15L,Protein GPR15L,36743,0.000854172495793924,0.0055447073481835,-0.0100134539066457,0.0117217988982336,0.877571256003102
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,38741,-0.00195796597040157,0.0128266154106722,-0.0270981321753191,0.0231822002345159,0.87867739968081
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX9,Transcription factor SOX-9,36421,-0.000371987423127541,0.00246029946390569,-0.0051941743723827,0.00445019952612761,0.879823538220647
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,36339,0.000558923309638382,0.00369914634862022,-0.00669140353365725,0.00780925015293402,0.879903049994714
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAPPA,Pappalysin-1,38841,0.000646092003694584,0.00429058257688139,-0.00776344984699294,0.00905563385438211,0.880306110089961
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO1A,Coronin-1A,38775,-0.00117543972057784,0.00807481597554308,-0.0170020790326423,0.0146511995914866,0.884263918323971
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",36466,-0.00113465373467724,0.00782144230492026,-0.0164646806523209,0.0141953731829665,0.884658216271823
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,38841,0.000764237614453849,0.00526882792390441,-0.00956266511639879,0.0110911403453065,0.884674226701691
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGF,Hepatoma-derived growth factor,39239,-0.00121533966402276,0.00849148265060055,-0.0178586456591998,0.0154279663311543,0.886193688663432
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",39095,-0.00118664504711189,0.00847408866378432,-0.0177958588281292,0.0154225687339054,0.888636421827556
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAVL4,ELAV-like protein 4,36363,-0.00105288158754667,0.00770901820325027,-0.0161625572659172,0.0140567940908239,0.891366637782968
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,36743,0.00031336554511609,0.00231543189918566,-0.00422488097728781,0.00485161206751999,0.89234688498986
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAGLN3,Transgelin-3,36339,-0.000733419218906842,0.00546360183078275,-0.011442078807241,0.00997524036942734,0.893217087646493
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,39106,0.000822200849107169,0.00616711140815571,-0.011265337510878,0.0129097392090924,0.893941871103817
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,39255,0.000358344257810481,0.00268976904327023,-0.00491360306699918,0.00563029158262014,0.894017246776994
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTH3,Cytohesin-3,36339,-0.000876938168262481,0.00658584222693902,-0.013785188933063,0.012031312596538,0.894072904059628
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGF,Placenta growth factor,39291,0.000303326350570694,0.00232671941407833,-0.00425704370102284,0.00486369640216422,0.896278140231505
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,36391,-0.00051521353919665,0.00401874224861976,-0.00839194834649137,0.00736152126809807,0.897990634042395
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,36430,0.000786034836218081,0.0061430985802729,-0.0112544383811168,0.012826508053553,0.898187320157003
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,39283,-0.000350418580486846,0.00283217177357748,-0.00590147525669872,0.00520063809572502,0.901532356600015
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,38727,0.00038866798663844,0.00318235454878779,-0.00584874692898562,0.0066260829022625,0.902795965495643
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,36538,-0.000708901541688886,0.00586202838782175,-0.0121984771818195,0.0107806740984417,0.90374752505768
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,38727,-0.000370087289858758,0.00306995600878295,-0.00638720106707334,0.00564702648735583,0.904048047105686
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,36791,-0.00147322280809544,0.0122616583353386,-0.0255060731453591,0.0225596275291682,0.90436718910786
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,39045,-0.000374530027098656,0.0031230526162769,-0.00649571315500138,0.00574665310080407,0.904544668776935
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB2,Lamin-B2,36747,-0.000296763815357166,0.00248245765991838,-0.00516238082879719,0.00456885319808285,0.904845960203153
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF6,Fibroblast growth factor 6,36430,0.000441061628479627,0.00369580628781855,-0.00680271869564473,0.00768484195260398,0.905007021461083
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANPEP,Aminopeptidase N,39128,-0.000299587552610393,0.00253313995828101,-0.00526454187084117,0.00466536676562039,0.905857444282755
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,38727,0.00039499665560168,0.00336065012429049,-0.00619187758800767,0.00698187089921103,0.906437074765231
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,36767,-0.000554600104872795,0.00476215274810387,-0.00988841949115637,0.00877921928141078,0.907289831576893
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN4,Alpha-actinin-4,38841,0.000321030897963169,0.00282840257191417,-0.0052226381429886,0.00586469993891494,0.909633664234957
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,36519,0.000559027403813272,0.00495287769766902,-0.00914861288361801,0.0102666676912446,0.910136035143327
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLLT1,Protein ENL,36339,-0.000717596625137173,0.00650655479822573,-0.0134704440296596,0.0120352507793853,0.912182538966541
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2B3,SH2B adapter protein 3,38727,-0.000968697160885293,0.00891597656398676,-0.0184440112262993,0.0165066169045287,0.913483675213129
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD8,Frizzled-8,36363,0.000413529710193367,0.00386820051606609,-0.00716814330129617,0.0079952027216829,0.9148661162418
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53BP1,TP53-binding protein 1,36430,-0.000846629981549841,0.00794666523417827,-0.0164220938405393,0.0147288338774396,0.915156392711956
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",38741,-0.0004190073428361,0.00396260665118482,-0.00818571637915835,0.00734770169348615,0.915789804648394
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,38727,-0.000449099710159071,0.0042857634083996,-0.00884919599062228,0.00795099657030414,0.916544865547287
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",38741,0.00048942573571578,0.00492855346604761,-0.00917053905773754,0.0101493905291691,0.92089813349823
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF6,SLAM family member 6,38727,0.000328162445892802,0.00341775805103794,-0.00637064333414157,0.00702696822592717,0.923508464711125
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,36430,-0.000662125205668103,0.0069252085298447,-0.0142355339241637,0.0129112835128275,0.923831156627804
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAFB2,Scaffold attachment factor B2,36767,0.000232789021016989,0.00249236762860046,-0.00465225153103992,0.0051178295730739,0.925586639558022
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,36767,-0.000499545107927854,0.00538055179019972,-0.0110454266167193,0.0100463364008636,0.926029946283709
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,38727,0.000266815290087019,0.00291855854806191,-0.00545355946411432,0.00598719004428835,0.927159920506276
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS53,Serine protease 53,36747,-0.000301747538235454,0.00338149932657664,-0.00692948621832567,0.00632599114185476,0.928896667253413
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF174,Zinc finger protein 174,36430,0.000306363975363311,0.00344416333667893,-0.00644419616452738,0.00705692411525401,0.929121760909663
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,39023,0.000523162560463341,0.00590468217177956,-0.0110500144962246,0.0120963396171513,0.929399939082893
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,39271,0.000416788280695357,0.00472455243453907,-0.00884333449100123,0.00967691105239194,0.929704941963574
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,39057,0.00022087715736665,0.00257065786656515,-0.00481761226110105,0.00525936657583434,0.931529216897006
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,39243,0.000634296458391773,0.00742082374315624,-0.0139105180781945,0.015179110994978,0.931884716270435
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RA,Interleukin-17 receptor A,39093,-0.000337847624719978,0.00397571991208252,-0.00813025865240171,0.00745456340296175,0.932280217988521
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROS1,Vitamin K-dependent protein S,36806,0.00018781790514355,0.00221264108406507,-0.004148958619624,0.0045245944299111,0.932354896069543
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,36339,-0.000678980937511562,0.0083417441828927,-0.0170287995359812,0.0156708376609581,0.935128685505192
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36339,-0.000426579321907118,0.00526616625955653,-0.0107482651906379,0.00989510654682369,0.935440253139052
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,36430,0.000305041217789653,0.00376819025585233,-0.00708061168368091,0.00769069411926022,0.93548169293373
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN2,Ficolin-2,39049,0.000294839861325781,0.00365602009241821,-0.00687095951981391,0.00746063924246547,0.935725314084987
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D2,DCN1-like protein 2,36339,0.000580025638438918,0.00728675416933928,-0.0137020125334661,0.0148620638103439,0.936556670870993
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,36792,0.000227904493199662,0.00290268682928131,-0.00546136169219171,0.00591717067859103,0.937419603465586
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP2,Methionine aminopeptidase 2,39237,-0.000408164595188359,0.00521458827405886,-0.0106287576123437,0.009812428421967,0.93761143585784
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,36743,-0.000177244017457165,0.00226593955626845,-0.00461848554774333,0.004263997512829,0.937653486648172
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,36420,0.000183462025411077,0.00235203336769433,-0.00442652337526981,0.00479344742609196,0.937828137937395
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,39291,-0.000250770707300276,0.00328125141660586,-0.00668202348384777,0.00618048206924721,0.939081712539854
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,36363,0.000399361708175223,0.00531347453760963,-0.0100150483855397,0.0108137718018901,0.940088468089951
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39099,-0.000295566428557823,0.00396333450426005,-0.00806370205690752,0.00747256919979187,0.940553692523835
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDSN,Corneodesmosin,39227,-0.000280618886247165,0.00380664527536358,-0.00774164362595977,0.00718040585346544,0.941235607832031
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,36339,-0.000585659947888922,0.00797106608590456,-0.0162089494762619,0.015037629580484,0.941430725826485
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSR,Insulin receptor,36430,0.000109192846533591,0.00150906734776247,-0.00284857915508086,0.00306696484814804,0.942318290607648
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,36339,-0.000529115008334294,0.00742862779219752,-0.0150892254810414,0.0140309954643728,0.943218648386494
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,36743,0.00108639423258649,0.0154129885711462,-0.0291230633668601,0.031295851832033,0.943808230553904
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,36391,0.000315329848700173,0.00471932949033024,-0.0089345559523471,0.00956521564974745,0.94672872376124
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",38951,-0.000442147656936184,0.00662335610448271,-0.0134239256217223,0.0125396303078499,0.946776969064448
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMIP,C-Maf-inducing protein,36731,0.000502307619774095,0.00752639759830282,-0.0142494316728994,0.0152540469124476,0.94679016608063
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,39099,-0.000257219450192788,0.00395167942059258,-0.00800251111455424,0.00748807221416867,0.948102261979923
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,36538,-0.0003734977878593,0.00623676970089262,-0.0125975664016088,0.0118505708258902,0.952247042455182
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRN1,Neuritin,36767,-0.00018592920928494,0.00318930042107055,-0.00643695803458321,0.00606509961601333,0.953512319567124
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,36767,-0.000352109186945242,0.00614428687579691,-0.0123949114635072,0.0116906930896167,0.954301720831492
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39099,0.000364491445053119,0.00663291260596271,-0.0126360172626338,0.01336500015274,0.956177469050123
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1R,Complement C1r subcomponent,36806,-9.64346027845675e-05,0.00175595865001598,-0.00353811355681589,0.00334524435124675,0.956204246294244
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERC2,ERC protein 2,36421,0.000363535310136391,0.00681473657933586,-0.0129933483853619,0.0137204190056347,0.957457502089585
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,36363,-0.000562328151210006,0.0105556267237156,-0.0212513565296926,0.0201267002272726,0.957515375811797
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,38727,-0.00044517852009329,0.00837279695676047,-0.0168558605553438,0.0159655035151572,0.957597467138203
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,36731,-0.000229480241437321,0.0043692837824387,-0.00879327645501716,0.00833431597214252,0.958114179527138
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,38841,0.000187247563829891,0.00357318004732975,-0.00681618532893641,0.00719068045659619,0.958207789681149
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,38741,-0.000268689353440725,0.00514305747411379,-0.0103490820027038,0.00981170329582231,0.958335678647407
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,36731,0.000398304406878528,0.00772004643374929,-0.0147329866032701,0.0155295954170271,0.958853379594016
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCC,Netrin receptor DCC,36421,-0.000105119138844544,0.00206236628120173,-0.00414735704999994,0.00393711877231085,0.959350109145344
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,36731,-0.000482560641056371,0.00976912125109948,-0.0196300382932113,0.0186649170110986,0.960604063975596
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTR,Transthyretin,36670,-0.000110270389252699,0.0022705783275987,-0.00456060391134614,0.00434006313284074,0.961266806874952
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN2,Centrin-2,38741,0.000294873769281617,0.00614036256358063,-0.0117402368553364,0.0123299843938996,0.961699187906567
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR2,Toll-like receptor 2,36538,9.85814872462153e-05,0.00206152233717153,-0.00394200229360998,0.00413916526810241,0.961860647842313
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSAP,Gamma-secretase-activating protein,38727,0.000374657461720572,0.00793261925481957,-0.0151732762777258,0.0159225912011669,0.962330566676129
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,36792,-0.000308263357573693,0.00662889017238871,-0.0133008880954556,0.0126843613803082,0.962910051714578
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK3,Prostate-specific antigen,36791,-0.000324459299422724,0.00716995915473867,-0.0143775792427105,0.0137286606438651,0.963906666546467
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD2,Leiomodin-2,36363,-0.000253151344789646,0.00584213941158131,-0.011703744591489,0.0111974419019097,0.965437607586145
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,38841,0.000263493483240224,0.00608818960355927,-0.0116693581397359,0.0121963451062164,0.965479351064682
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL14,C-C motif chemokine 14,39083,-0.000152366644183172,0.00352390868299919,-0.00705922766286158,0.00675449437449524,0.965512407884633
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGF,Hepatocyte growth factor,39291,-0.000130864388223756,0.00306418796217969,-0.00613667279409594,0.00587494401764843,0.965935102352167
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F10,Coagulation factor X,36796,0.000102406563043453,0.00240425116564842,-0.00460992572162744,0.00481473884771435,0.966025872677305
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,36391,0.000174666972387106,0.00416511085248317,-0.00798895029847991,0.00833828424325413,0.966550599560325
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,36538,0.000254046350061371,0.00609590849583851,-0.0116939343017821,0.0122020270019049,0.966758523250406
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,38727,-0.000288215327487867,0.00707983885915522,-0.0141646994914321,0.0135882688364564,0.967528189171926
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",39147,0.000222042684555068,0.00557487197194385,-0.0107047063804549,0.011148791749565,0.968229817463116
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,36391,0.000136206471832202,0.0034448018228687,-0.00661560510099045,0.00688801804465485,0.968460722579825
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39023,-8.34560224126959e-05,0.00211647307038402,-0.00423174324036538,0.00406483119553999,0.968546766705217
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39099,-0.000114312343800113,0.00296637886359588,-0.00592841491644803,0.0056997902288478,0.969260842352845
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,36391,-0.000178294533638237,0.00463295532259723,-0.00925888696592882,0.00890229789865234,0.969302421705877
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP13,Collagenase 3,38741,0.000109092076503256,0.00289479780681252,-0.00556471162484928,0.00578289577785579,0.96993889475827
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,36792,-0.000115472358948696,0.00308822580215594,-0.00616839493117434,0.00593745021327695,0.970173694603607
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,36430,-9.98574748497459e-05,0.00268796361487125,-0.00536826615999739,0.0051685512102979,0.970366105984724
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",36430,-0.000147715548633223,0.00415007224820684,-0.00828185715511863,0.00798642605785219,0.971607065676346
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,36339,-9.18223136696527e-05,0.00269243678698508,-0.0053689984161604,0.0051853537888211,0.972794927294262
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,36731,-0.000116382077707619,0.00342314189289485,-0.00682574018778152,0.00659297603236628,0.972878783638361
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,36430,-0.000180406638271501,0.00585281332295741,-0.011651920751268,0.011291107474725,0.975410454996003
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,36791,-5.96029159533424e-05,0.00201079724386396,-0.0040007655139267,0.00388155968202001,0.976353476847629
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEFL,Neurofilament light polypeptide,38692,-0.000116514541460986,0.00393087963502778,-0.00782103862611543,0.00758800954319346,0.976353899470262
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRC,Chymotrypsin-C,39089,0.000155705056797266,0.00557733622147974,-0.010775873937303,0.0110872840508976,0.977728349192284
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSB,Lupus La protein,38741,-0.000146197558196595,0.00553818350391241,-0.0110010372258649,0.0107086421094717,0.978940158355425
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF2,Growth/differentiation factor 2,39106,7.099047761585e-05,0.00319496569190062,-0.00619114227850936,0.00633312323374106,0.982273169080712
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDRG1,Protein NDRG1,38741,-0.000138455918153313,0.00626823992082544,-0.0124242061629712,0.0121472943266645,0.982377668704706
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,38727,0.00010536127349653,0.00483452689112391,-0.00937031143310634,0.0095810339800994,0.982612969747238
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX5,Syntaxin-5,36430,-7.39446004101664e-05,0.00364758539544972,-0.00722321197549161,0.00707532277467128,0.983826549853233
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,36430,7.84041739503387e-05,0.00390099804845806,-0.00756755200102746,0.00772436034892814,0.983965122955923
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39106,-7.0926498692417e-05,0.00442380438885735,-0.00874158310085283,0.00859973010346799,0.987208339068163
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN4,Prefoldin subunit 4,36339,-7.74572713516566e-05,0.00492279269463593,-0.00972613095283808,0.00957121641013477,0.987446521409645
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39023,5.42605012450133e-05,0.00345082729814141,-0.00670936100311215,0.00681788200560218,0.9874548580241
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,39241,7.63090090412995e-05,0.0050699387452674,-0.0098607709316828,0.0100133889497654,0.987991473917191
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSTB,Cystatin-B,38863,-5.67512260834897e-05,0.00384043168654137,-0.00758399733170457,0.00747049487953759,0.988210042971366
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,36538,0.000102859055607687,0.00696712349372591,-0.0135527029920951,0.0137584211033105,0.988221099748573
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,36391,-8.66228338918414e-05,0.00609042208293834,-0.012023850116451,0.0118506044486673,0.988652459269798
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST6,Cystatin-M,38773,5.77112691709438e-05,0.00424500813498981,-0.00826250467540909,0.00837792721375098,0.989153203293991
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",36391,4.59030167306557e-05,0.00366872107726014,-0.00714479029469922,0.00723659632816053,0.99001733267927
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,39162,0.000116631757858971,0.00942606539440295,-0.0183584564151708,0.0185917199308887,0.990127929305585
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,36747,0.000265561617983438,0.0216215312008293,-0.0421126395356419,0.0426437627716088,0.990200597961067
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",36339,0.000102872334235021,0.00842202823425719,-0.0164043030049091,0.0166100476733791,0.990254537331104
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A13,Protein S100-A13,36430,-3.41724233686476e-05,0.00315004901126775,-0.00620826848545344,0.00613992363871614,0.991344715008436
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,36747,-3.88147046746458e-05,0.0040268306972567,-0.00793140287129777,0.00785377346194848,0.992309442451509
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",36747,2.14507501674556e-05,0.00228939963637588,-0.00446577253712927,0.00450867403746418,0.992524398253156
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11,Coagulation factor XI,36610,-2.61586701943687e-05,0.00285424094068455,-0.0056204709139361,0.00556815357354736,0.992687758996633
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBPL,FK506-binding protein-like,36743,3.63923586382111e-05,0.00541228503801834,-0.0105716863158777,0.0106444710331542,0.994635146042707
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PENK,Proenkephalin-A,36500,1.67125045084606e-05,0.00263549097645112,-0.00514884980933572,0.00518227481835265,0.994940488763642
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,36743,-2.92299809420341e-05,0.0050100354806192,-0.00984889952295566,0.00979043956107159,0.995345029849055
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,36420,3.6718035151326e-05,0.00657001541338298,-0.0128405121750793,0.012913948245382,0.995540951449918
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",38336,1.18731552526578e-05,0.00261990721663059,-0.00512314498934329,0.00514689129984861,0.99638414247239
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,36538,-3.24757417575603e-05,0.00962853445298373,-0.0189044032696057,0.0188394517860906,0.997308901683213
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,36792,-2.47488098980071e-06,0.00264580167450987,-0.00518824616302915,0.00518329640104954,0.999253673890636
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI1,Neuroserpin,36466,9.08042162530577e-07,0.002784530397389,-0.0054567715367199,0.00545858762104496,0.999739813060899
